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ABC-AP avidin-biotin complex-alkaline phosphatase
APC adenomatous polyposis cell
ARF alternative reading frame
ASK apoptosis signal-regulating kinase 1
APUD amine precursor uptake and decarboxylation
BAL bronchoalveolar lavage





BSA bovine serum albumin
CaCl2 calcium chloride
CAS cadherin associated substrate
CC10 Clara cell lOkDa protein
CC16 Clara cell 16kDa protein
CCSP Clara cell secretory protein
cDNA complementary DNA
Cdk cyclin-dependent kinase
CDKI cyclin dependent kinase inhibitor
CEBPa CCAAT/enhancer binding protein a
CFA cryptogenic fibrosing alveolitis
CFTR cystic fibrosis transmembrane regulator
CIP Cdk-inhibitory protein
CKI cyclin kinase inhibitors
cr chloride ion
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Coll IV collagen IV
Con A Concanavalin A
COPD chronic obstructive pulmonary disease







DNA MTase DNA-(cytosine-5) methyltransferase
dNTP deoxynucleoside triphosphate
Dsh dishevelled protein
E2F early region factor 2
ECM extracellular matrix
EDTA ethylene diamino tetraacetic acid
EGF epidermal growth factor
EGFr epidermal growth factor receptor
ERK1 extracellular signal regulated kinase 1
ERK2 extracellular signal regulated kinase 2
FAK focal adhesion kinase
FCS foetal calf serum
Fen 1 flap endonuclease 1
Fn fibronectin
g grams




GADD45 growth and DNA damage protein








Ig-CAM immunoglobulin-cell adhesion molecules




IRS-1 insulin receptor substrate 1
JNK c-Jun N-terminal kinase
1 litres





MAPK mitogen activated protein kinase
MDM2 mouse double minute chromosome
MEK MAPK-ERK kinase
MEKK-1 MEK kinase-1
mRNA messenger ribonucleic acid
MgCl2 magnesium chloride










NCAM neural cell adhesion molecules
NFkB nuclear factor kB
NGF nerve growth factor
NLS nuclear localisation signal
p21 ko p21 knockout
PBS phosphate buffered saline
PBST phosphate buffered saline tween
PCNA proliferating cell nuclear antigen
PCR polymerase chain reaction




Pol 5 DNA polymerase S
Pol e DNA polymerase 8
R restriction point
Rb retinoblastoma
RER rough endoplasmic reticulum
RGD Arginine-Glycine-Aspartanine sequence
rpm revolutions per minute
RPTPs receptor protein tyrosine phosphatases
S synthesis of DNA
SAPK stress-activated protein kinases
SD standard deviation
SDS sodium dodecyl sulphate
SER smooth endoplasmic reticulum
SP-A surfactant protein A
SP-B surfactant protein B
SP-D surfactant protein D
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STAT signal transducer and activator of transcription
TBE tris / boric acid / EDTA
TBS tris buffered saline
TBST tris buffered saline Tween-20
TCR T-cell receptor
TE tris EDTA solution
TGF-P transforming growth factor-P






UP1 urinary protein 1
UV ultra violet (radiation)
V volts
VCAM-1 vascular cell adhesion molecule-1
WAF wild-type p53 activated factor
WGA wheat germ antigen




After lung injury epithelial cells are damaged may be shed thus denuding the
basement membrane. The normal response to injury is usually an inflammatory
reaction, deposition of new extracellular matrix that incorporates various growth
factors, influx of inflammatory cells and regeneration of lost epithelial cells.
Regeneration involves migration, proliferation and differentiation of stem cells to
cover the exposed area. In the lung bronchiolar region Clara cells are thought to be
the progenitor cells. Changes in cell cycle and behaviour of lung epithelial cells in
several models of lung injury and in vitro primary culture were studied. The
expression of the cell cycle control genes, p21, p53, PCNA and p27, in mouse
models of three important human diseases mainly fibrosis, asthma and
Mycobacterium tuberculosis infection were investigated. p21 expression by
epithelial cells increased in fibrosis, decreased in asthma but did not change after TB
infection. Clara cells were isolated from mice and cultured in serum free conditions
for up to five days. They were characterised in terms of proliferation (BrdU, PCNA
& mitosis), differentiation (lectins, integrins, cytokeratins & CC10), death (apoptosis
and necrosis) and cell cycle regulation (p21, p53, EGFR & p27). The effects of cell
matrix interactions on Clara cell proliferation, differentiation, cell cycle control and
death were studied by varying the extracellular matrix composition and disruption of
cell-integrin interactions in both wildtype and p21 knockout mice. Matrix changes
did not influence significantly the proliferation, differentiation, death and cell cycle
regulation in Clara cell cultures in both wildtype and p21 knockout mice, except
when laminin was present. Significant differences in cytokeratin expression, cell
cycle regulation and death pathways were observed in wildtype mice when compared
to p21 knockouts. Some of the differences include lower expression of cytokeratin 8
and 19 in p21 ko mice, lower cytoplasmic but higher nuclear PCNA expression in
p21 ko mice, a lower necrotic rate in p21 ko mice, lower cytoplasmic but higher
nuclear p53 expression in p21 ko mice. By using a beta-1 blocking antibody the cell-
integrin disruption was carried. Significant differences were observed upon beta-1
integrin blocking including an increase in cytokeratin 8 and 19 expression in p21 ko
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mice, decrease in proliferation in both wt and p21 ko mice, an increase in
cytoplasmic PCNA in both wt and p21 ko mice, an increase in apoptosis rate in both
wt and p21 mice, increase in nuclear p21 in wt mice, an increase in nuclear p53 in
both wt and p21 ko mice, and a decrease in cytoplasmic but an increase in nuclear
p27. The two forms of p21 were studied and it was found that the cytoplasmic p21 is
a C-terminal truncated protein with a weight of 17 kDa. The complex of p21 in both
the cytoplasm and nucleus were studied. The nuclear p21 was found to form
complexes with PCNA, cdk2, cdk4, cdk6, cyclin D3 and cyclin E, while the
cytoplasmic p21 form complexes with cdk4 and cyclin D3.
In conclusion, the work presented in this thesis demonstrates that p21 is an important
factor for the proliferation, differentiation and death of Clara cells. It also
demonstrates that cell-matrix interactions form an important part in the regulation of
Clara cells. Two forms of p21, a cytoplasmic and a nuclear protein are identified and
their importance in the regulation and division of Clara cells is discussed.
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Chapter 1 - Introduction
1.1 Biology of small airway epithelium.
The lung is the principal organ of gas exchange in the body and also carries out a
number of non-ventilatory functions including humidification, thermal regulation,
mucociliary clearance and elimination of volatile substances.
The lung is divided into three main zones, the conducting airways, respiratory
bronchioles and alveolar airspaces. The conducting zone begins with the nasal cavity
and mouth, and then opens through the larynx into the trachea. The trachea divides
to form two bronchi that branch like a tree to form smaller passages, the bronchioles.
The conducting airways serve as conductors of air from the external environment to
the distal gaseous exchange area. The respiratory bronchioles, alveolar ducts and
alveoli particulate in gas exchange area and are classified as the terminal respiratory
unit, and are also called acinus (Figure 1.1).
The adult mammalian lung contains over 40 different cell types, of which at least 8
are found in the epithelial lining of the tracheobronchial airways. These epithelial
cells include ciliated cells, basal cells, brush cells, mucous globlet cells, serous cells,
Clara cells, type I, type II, neuroendocrine cells, and a variety of partially











Figure 1.1 - Lung structure showing the trachea, left and right
bronchiole, terminal bronchiole, bronchiole and alveoli regions.
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1.2 The Respiratory Bronchioles.
The epithelium of the respiratory bronchioles is pseudostratified, having two or more
rows of nuclei. It is composed of various cell types including ciliated, basal,
mucous, serous, neuroendocrine and Clara cells. All epithelial cells in
pseudostratified epithelium have contact with the basal lamina. (Figure 1.2)
1.2.1 Ciliated cells
Ciliated cells are terminally differentiated cells and although they are susceptible to
injury from inhaled irritants are unable to divide. Therefore, they exfoliate easily and
do not participate in the lung proliferative response (Ayers and Jeffery, 1988). These
cells are approximately 20 pm high and have a columnar shape. They are attached to
the adjacent cells by a junctional complex which consists of three elements, tight
junctions (also known as zonula occludens) which form an impermeable barrier
preventing macromolecules passing between cells, zonula adherens which link the
actin filament network, and desmosomes which connect the intermediate filament
network of adjacent cells such as basal cells (Frasca et al., 1968; Evans, 1973; Jeffery
and Reid, 1975; Tatrai et al., 1994).
Ciliated cells have a basally or centrally placed nucleus. At ultrastructural level
ciliated cells have a numerous mitochondria and basal bodies to which the cilia are
attached. These cilia form a more or less continuous surface above large airways
epithelium (Plopper and Dungworth, 1987). Their primary function is to sweep
layers of mucus, together with trapped particulate material and dead cells. On
average there are about 200 cilia per cell, although this number varies from a number
of studies and their length is about 6 pm (Mariassy, 1992).
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Alveoli
Figure 1.2 - Lung Bronchiolar region showing the cuboidal nature of




Basal cells are numerous in the trachea and decrease in number from the trachea to
the bronchioles. There are usually very few basal cells in the terminal bronchioles
and none in the respiratory bronchioles. These cells are small (10 - 15 pm), with
very small nuclear cytoplasmic ratio (Mariassy, 1992). They are round, triangular or
flat in shape, with a dense round nucleus and a strongly stained cytoplasm. They are
attached to the basal membrane with hemi-desmosomes and to the other epithelial
cells through numerous desmosomes. They do not extend to the airway surface
(Plopper et ah, 1987).
The exact role of the basal cells is still unclear and under debate. In the earliest
studies it was postulated that basal cells were the progenitor cells of the epithelium.
Basal cells were thought to divide to form new basal cells as well as intermediate
cells, capable of cell division and then, differentiate into mucous and ciliated cells.
Evidence suggests that mucus-secreting cells were also capable of division and that
basal cells do not seem to participate in the renewal of the respiratory epithelium.
This debate is further complicated by the fact that there are substantial differences
between species in the distribution and morphological characteristics of airway cell
types (Evans et ah, 1989; Inayama et al, 1988; Hicks et ah, 1997; Erjefalt et ah,
1997; Boers et ah, 1998; Nakajimaet ah, 1998).
1.2.3 Brush cells
Brush cells are non-ciliated epithelial cells and have been found in the conducting
airways of a number of species. Brush cells are characterised by a densely packed of
large, 2 to 3 pm long microvilli (Mariassy, 1992). The function of these cells has
not been determined however a number of possible functions have been suggested,
including chemoreception and monitoring the depth of the periciliary fluid. Brush
cells are relatively rare, and always less that 1% of the cell population.
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1.2.4 Mucous (Goblet cells)
In the trachea most cells are columnar, having round profiles when sectioned parallel
to the basement membrane. Only rare cells have the classical goblet shape. The
apical surface varies with stage of secretion. Junctional complexes make apical
attachment of mucous cells while desmosomal attachments anchor the mucous cells
to its neighbours or the lateral surfaces. Surface contact with the basal lamina are
often lacking in longitudinal section due to the attenuated cytoplasm forming the
stem (Mariassy, 1992).
Three dimensional reconstruction of a mucous goblet cell showed that the different
planes of sections present a number of morphologic features associated with different
stages of mucous cell secretion (Adler et al., 1982). Up to 60% of the mucous
(goblet) cell profile is occupied by membrane-bound secretory granules.
The term mucous cells is commonly used for cells that contain relatively
homogenous granules. The electron density of mucous cell granules may vary, since
they lack the dense, osmiophilic, proteinaceous granule core or the surrounding halo.
Cells that contain such granules are referred to as sero-mucous cells. The organelles
of the mucous cells include one or more Golgi bodies with associated vesicles and
granular endoplasmic reticulum profiles between the secretory granules (Mariassy,
1992).
1.2.5 Serous cells
Serous cells are found in abundance in many glands in variety of animal species and
humans (Basbaum et al., 1990). Depending on the source, the percentage of serous
cell in a species varies from 27% (Jeffery and Reid, 1975) to 37% (Plopper et al.,
1993) to 42% (Nikula et al., 1988). A cell type with generally serous cell
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characteristics that contained disc- (0.13 |im) and rod- (0.4 pm) shaped granules
were described in dogs (Frasca et al., 1968), humans (Plopper et al., 1980c; Plopper
et al., 1980b; Plopper et al., 1980a) and cats (Jeffery and Reid, 1975; Ayers and
Jeffery, 1988). These cells are referred to a specialised type cells but their function is
not known. There are no quantitative data available on this cell (Mariassy, 1992).
1.2.6 Neuroendocrine cells.
Neuroendocrine cells have been referred to by numerous names, including helle zelle
(clear cells), Feyrter's cells, Kultschitzky cells, APUD (amine precursor uptake and
decarboxylation), endocrine-like cells, enterochromaffin-like cells, and small granule
cells (Pearsall, 1989). Pulmonary neuroendocrine cells were shown to be progenitor
cells and capable of self-renewal (Reynolds et al., 2000).
1.2.7 Clara cells (non-ciliated bronchiolar cells)
1.2.7.1 Ultrastructure
Clara cells, the nonciliated population in the epithelial lining of bronchioles, are one
of the most heterogeneous and multifunctional cell types in the mammalian lung.
The best-defined markers for Clara cell differentiation in adult mammals are the
ultrastructural features (Table 1.1).
Clara cells are characterised as low cuboidal calls with minimal apical projections,
bound to each other by junctional complexes on the luminal aspects of the basolateral
membrane (Plopper et al., 1991; Massaro et al., 1994). The distribution of organelles
within the cytoplasm shows little polarization and includes small amounts (<10%) of
rough (RER) and smooth (SER) endoplasmic reticulum, mitochondria, and Golgi
apparatus. The nucleus is approximately one-third of the total volume of the cells
and is centrally placed. The apical portions of the cytoplasm generally contain a
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small number of ovoid, electron-dense membrane-bound secretory granules. This
structural composition has been defined for humans and in three species of macacque
monkeys (Plopperet ah, 1991).
The ultrastructure of the most of the mammalian species is slightly different from
each other and is characterised by:
(i) extensive apical projections into the airways
(ii) a polarized organisation of organelles
In most species there is an abundance of apical smooth endoplasmic reticulum. In
mouse, hamster, rat, guinea pig rabbit, pig, sheep and horse more than 40% of the
cytoplasmic volume consists of smooth endoplasmic reticulum (Plopper et ah,
1980b; Plopper et ah, 1980c; Plopper et ah, 1980a).
Component Rabbit Cat Bonnet monkey
Cell 471.8 + 51.8 496.1 ±40.8 418.9 + 36.1
Nucleus 83.0 + 7.0 132.5 + 45.6 119.9 + 18.4
SER 213.4 + 51.0 38.9 + 24.4 15.6 + 9.9
Glycogen 37.5+13.1 222.9 ± 36.4 0
RER 25.8+19.4 1.56 + 3.38 38.9 ±1.2
Mitochondria 75.4+17.7 70.9 ± 34.9 42.0 + 8.3
Granules 12.5 + 6.7 0 6.3 + 1.4
Golgi apparatus 5.7 + 5.7 14.6 + 13.1 24.1 ±2.8
Table 1.1 - Comparison of volumes (pm3) of cellular components in
Clara cells adapted from (Plopper et al., 1991).
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1.2.7.2 Clara cell functions
Clara cells have at least four roles in the normal lung function:
(a) contribute a secretion to the extracellular lining fluid
(b) progenitor cells for both themselves and for ciliated cells
(c) contain a variety of cytochrome p-450 monooxygenases that have an active
role in metabolism of xenobiotics.
(d) regulate fluid balance in the distal conducting airways
1.2.7.2 a Secretion products.
Clara cells secrete a number of proteins including surfactants SP-A, B and D, Clara
cell 10-kDa protein/uteroglobin, leukocyte protease inhibitors, (3-galactoside binding
lectin and a trypsin-like protease (Massaro et al., 1994; Peao et ah, 1993; Cardoso et
ah, 1993). It was proposed that Clara cell section is both aprocrine and merocrine,
the former prodominating (Peao et ah, 1993).
Clara cells 10-kDa protein (CC10) is the predominant product of Clara cells and is
distributed mainly in the bronchiole (Asabe et ah, 1998; Sagal and Nieto, 1998;
Singh and Katyal, 1997; Shijubo et ah, 1999a; Xu et ah, 1998). The protein has also
been referred to as Clara cell 16-kDa protein according to results using
electrospray/mass spectrometry. This protein was first identified in urine of patients
with renal failure and purified later from lung lavage (Broeckaert and Bernard, 2000;
Hermans et ah, 1998a; Hermans et ah, 1998b; Laing et ah, 2000). The entire human
CC16 gene has been sequenced and localised to chromosome 11, pl2-ql3, a region
occupied by several genes involved in the regulation of allergy and inflammation
(Broeckaert and Bernard, 2000). Human CC10 is identical to human urinary protein
1 (UP1) and human uteroglobin (UG) (Gutierrez and Nieto, 1998; Klug and Beato,
1996; Nord et ah, 1998; Reynolds et ah, 1999; Sagal and Nieto, 1998).
Changes in CC10 levels in sera and bronchoalveolar lavage (BAL) fluid have been
reported in various lung diseases and in patients exposed to different toxins including
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cigarette smoking (Asabe et al., 1998; Dodge et al., 1994; Shijubo et al., 1999a; Xu
et al., 1998; Szabo et al., 1998; Laing et al., 2000; Shijubo et al., 1999b; Arsalane et
al., 1999; Lesur et al., 1995; Johnston et al., 1998; Mango et al., 1998; Reynolds et
al., 2000; Reynolds et al., 1999). Although the function of CC10 is unclear, it may
play a role in regulation of inflammation.
Surfactant proteins and the mRNA for SP-B have been localised in the Clara cells
(Phelps and Flores, 1991). The detection of SP-B in Clara cells is more consistent
than that of SP-A. SP-A and SP-D are believed to be involved in host defence
against micro-organisms by their lectin like activity (Kuan et al., 1992). The role of
the surfactant proteins secreted by Clara cells is still unclear (Massaro et al., 1994;
Margana and Boggaram, 1997).
The 29-kDa (3-galactoside binding lectin may be the same as the 30-kDa Clara cell
tryptase, but their function and physiological role is still not clear. Clara cell tryptase
has been shown to cleave haemagglutinin and activate infectivity of influenza A
virus (Sakai et al., 1993; Tashiro et al., 1996; Kohri et al., 1996; Kido et al., 1997;
Wasano and Yamamoto, 1989)
The leukocyte protease inhibitor has been immuno-histochemically localised to Clara
cells. This protein inhibits leukocyte proteases, especially elastase (De Water et al.,
1986; Willems et al., 1989).
1.2.7.2 b Progenitor cells.
Clara cells are self replicative but also terminally differentiate into ciliated cells in
the bronchioles (Plopper et al., 1991; Plopper et al., 1992b; Ji et al., 1995; Ayers and
Jeffery, 1988). Clara cells isolated from the lungs of rabbit were shown to be able to
re-populate denuded tracheas (Hook et al., 1987). Clara cells were shown not to be
necessary for pulmonary neuroendocrine cell hyperplasia (Reynolds et al., 2000).
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1.2.7.2 c Metabolism of xenobiotics.
Among the other epithelial cells found in the lung epithelial bronchiolar region, Clara
cells are distinguished for their ability to metabolise xenobiotics via the cytochrome
P-450 (CYP) monooxygenase system and flavin-containing monooxygenases
(Overby et ah, 1992; Buckpitt et ah, 1992; Plopper et ah, 1993; Gebremichael et ah,
1995; Buckpitt et ah, 1995; Lakritz et ah, 1996; Watt et ah, 1998). Bronchiolar Clara
cells are considered to be one of the principal targets in the mammalian lung
pulmonary toxicants. These include a wide variety of compounds including furans,
chlorinated hydrocarbons, and aromatic hydrocarbons. Many compounds injure
Clara cells in most of the species but Clara cells in different species do not have the
same level of sensitivity to any one compound (Voigt et ah, 1989; Baron and Voigt,
1990; Buckpitt et ah, 1992; Plopper et ah, 1992a; Plopper et ah, 1992c; Buckpitt et
ah, 1995).
Changes in Clara cells are manifested as early as 1 hour after exposure and involve
clumping and margination of nuclear chromatin, mitochondrial swelling, dilation of
endoplasmic reticulum membrane and disruption of cell junctions. Within 24 hours
of exposure the injury there is cellular enlargement and formation of large numbers
of membrane-bound vacuoles (Chichester et ah, 1991; Plopper et ah, 1991; Plopper
et ah, 1992a; Plopper et ah, 1992c; Buckpitt et ah, 1992; Massaro et ah, 1994;
Lakritz et ah, 1996; Van Winkle et ah, 1996a; Buckpitt et ah, 1995).
There are a large number of studies showing the ability of Clara cells to metabolise a
number of xenobiotics including naphthalene and its metabolites (Kanekal et ah,
1991; Buckpitt et ah, 1995; Kanekal et ah, 1990; Plopper et ah, 1992a; Buckpitt et
ah, 1992; Plopper et ah, 1992c; Van Winkle et ah, 1995; Lakritz et ah, 1996; Van
Winkle LS et ah, 1996; Sauer et ah, 1997; Fanucchi et ah, 1997; Van Winkle et ah,
1997; Zheng et ah, 1997; Paige et ah, 1997), ozone (Castleman et ah, 1980; Nikula et
ah, 1988; Dodge et ah, 1994; Royce and Plopper, 1997; Watt et ah, 1998; Mango et
ah, 1998; Arsalane et ah, 1999), styrene and its compounds (Male et ah, 1985;
Cruzan et ah, 1997), benzo(a)pyrene and its derivative compounds (Bend et ah,
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1981; Jones et al., 1982b; Sivarajah et al., 1983; Horton et al., 1985; Stowers and
Anderson, 1985; Kontir et al., 1986; Overby et al., 1992; Boutin et al., 1998; Wu et
al., 1998b; Jyonouchi et al., 1999), cigarette smoke (Ji et al., 1994; Gebremichael et
al., 1995; Ji et al., 1998), coumarin (Born et al., 1998; Bom et al., 1999), methylene
chloride (Foster et al., 1994; Green, 1997), trichloroethylene (Green et al., 1997;
Giovanetti et al., 1998), amines (Masek and Richards, 1990), and nitrogen dioxide
(Evans et al., 1986). Dially sulfone, a derivative of garlic, was found to protect
against Clara cell injury caused by 1,1-dichloroethylene by conjugating a glutathione
with its reactive metabolites (Forkert et al., 1996; Forkert, 1997; Forkert, 1998;
Forkert et al., 1999).
1.2.7.2 d Regulation of fluid balances.
Due to the fact that bronchiolar epithelium has lateral projections, it has been
suggested that the airways epithelium of distal conducting airways is involved in re-
absorption and clearance of airway-lining fluid (Plopper and Dungworth, 1987; Van
Scott et al., 1987). It was shown that there is a net movement of sodium ions (Na+)
from the mucosal to the serosal side in cultured monolayers of rabbit Clara cells.
This movement is amiloride-sensitive and occurs under short- or open-circuit
conditions, thus most likely Clara cells are involved in fluid re-absorption. Chloride
ions (CF) secretion was observed to be induced by amiloride, but no net CI"
movement was observed under basal conditions (Van Scott et al., 1989). CI"
channels that can be stimulated by c-AMP-activating agents and extracellular ATP
were described in Clara cells. These channels share many bio-physiological
properties with the Cystic Fibrosis Transmembrane Regulator (CFTR)-related CI"
channel (Chinet et al., 1997).
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1.3 The Alveoli
The alveoli are the principal site of gas exchange in the lung. The alveolar
epithelium is composed of two cell types Type I and Type II cells (Evans et al.,
1975; Jones et al., 1982bb; Jones et al., 1982a; Sivarajah et al., 1983; Devereux,
1984; Horton et al., 1985; Devereux et al., 1985; Dobbs et al., 1985; Domin et al.,
1986; Dobbs et al., 1986; Marshall et al., 1988; Honda et al., 1989; Belinksy et al.,
1992; Belinksy et al., 1995; Harrison et al., 1995; Corti et al., 1996; Strayer et al.,
1998; Williams, 1999) (Figure 1.3).
1.3.1 Type I cells
Type I cells are squamous cells which cover 90% of the alveolar surface. The thin
and attenuated cytoplasm of type I cells facilitates gas exchange by minimising the
diffusion distance from alveolar to the blood.
1.3.2 Type II cells
Type II cells are cuboidal cells and occupy 10% of the alveolar surface. The primary
functions of type II cell are:
(a) synthesis and secretion of surface-active material
(b) maintenance of the alveolar epithelium by their ability to proliferate and to
differentiate into type I cells
(c) trans-epithelial transport of sodium from the apical to the basolateral surface





Figure 1.3 - The lung alveolar epithelium region showing the squamous
nature of the epithelium comprised of the extremely thin Type I cells and the
cuboidal Type II cells.
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1.4 Epithelial cell repair.
Airways are exposed to a number of inhaled toxins, pathogens, allergens, reactive
gases, aerosols and irritant particles. After a lung insult, some of the epithelial cells
are injured or damaged. These cells either detach or die thus disruption of cell-cell
and cell-matrix interaction and also exposing the basement membrane. The normal
response to the injury is a mass transportation of factors including extra cellular
matrix (ECM), various growth factors and inflammatory cells. The epithelial cells in
the margin of the damage flatten and move to eventually cover the wound (Rennard,
1999; Erjefalt et al., 1995; Persson, 1996; Persson et al., 1996; Erjefalt et al., 1996;
Erjefalt et al., 1997; Erjefalt and Persson, 1997). If this repair does not occur this
insult can result in a disease (Figure 1.4).
So far there are little data showing which cell types are involved and by what
mechanism this repair takes place. There are two main hypothesis how the repair
might take place. The first model postulates that basal cells act as the principal stem
cell in the conducting airways, giving rise to the various secretory cells and ciliated
cells. This model is based on the cell turnover studies of normal respiratory
epithelium (Nettesheim et al., 1990). The other model postulates that the secretory
cells are the progenitor cells from which most of the other cells develop. The
evidence on this second model is based from the regeneration of chemically or
physically injured epithelium (Nettesheim et al., 1990).
The most common basally situated cell, the 'basal' cell was described and proposed
as a progenitor cell (Blenkinsopp, 1967). In peripheral bronchioles where basal cells
are absent, the Clara cell is the progenitor cell (Evans, 1973; Evans et al., 1978;
Evans et al., 1986). Clara cells may divide in response to epithelial irritation and
subsequently differentiate to form mature secretory and ciliated cells (Elook et al.,
1987; Cardoso et al., 1993). In the alveolus, the type II cell is the progenitor cell








Figure 1.4 - Stages of injury and repair in lung bronchiolar region (A)
Normal epithelium (B) After an injury portions of basement membrane is de¬
nuded (C) provisional matrix is deposited and neighbouring cells migrate to fill
up the gaps in the epithelium (D) Progenitor cells proliferate and (E) cells
differentiate in order to restore the epithelium.
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1.5 Epithelial cell interactions
Cell interactions are an important factor for the maintenance of both three-
dimensional structure and normal function in tissues. The biochemical entities
mediating cell adhesion are multiprotein complexes comprising three broad classes
of macromolecules: the adhesion receptors, the extracellular matrix molecules and
the adhesion plaque proteins (Gumbiner, 1996).
The extracellular matrix has been traditionally viewed as either forming the
structurally stable support for cells and tissues or as being responsible for the
basement membrane formation (Puchelle and Zahm, 1996). It is known that
extracellular matrix-cell interactions regulate the morphology and cell functions
through a family of specific cell surface receptors - the integrins (Dunsmore and
Rannels, 1996; Chintala and Rao, 1996; Kettritz et al., 1999; Vitale et al., 1999;
Boudreau and Jones, 1999; Streuli, 1999; Geiger et al., 2001).
Cell adhesion receptors are typically transmembrane glycoproteins that mediate
binding to extracellular matrix (ECM) molecules or to counter-receptors on other
cells. These molecules determine the specificity of cell-cell and cell-ECM
interactions. The ECM proteins are usually fibrillar in nature and provide a complex
structural and functional nature that can interact simultaneously with multiple cell
surface receptors. The peripheral membrane proteins provide structural and
functional linkages between adhesion receptors and the actin microfilaments,
microtubules, and intermediate filaments of the cytoskeleton (Howe et al., 1998;
Aplin et al., 1998).
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1.5.1 Extracellular Matrix (ECM)
Extracellular matrix (ECM) is a general term that encompasses components of the
basement membrane and interstitial connective tissue. The extracellular matrix
contains signals that control cell shape, migration, proliferation, differentiation,
morphogenesis and survival (Lukashev and Werb, 1998; Boudreau and Jones, 1999;
Streuli, 1999). The basement membrane comprises collagen IV, laminins, entactin,
fibronectin and proteoglycans while the interstitial connective tissue is made of
fibrillar collagens, elastic fibers and proteoglycans (Sannes and Wang, 1997;
Dunsmore and Rannels, 1996; Lukashev and Werb, 1998; Coraux et al., 1998;
Klinowsks et al., 1999; Ploplis et al., 2000; Arroyo et al., 2000; Costa et al., 2001).
Interstitial connective tissue is important during development and wound repair
(Lukashev and Werb, 1998; Coraux et al., 1998; Klinowsks et al., 1999; Ploplis et
al., 2000; Arroyo et al., 2000; Costa et al., 2001).
ECMs act in concert with other signalling pathways, such as those initiated by
growth factors, to regulate cell behaviour (Damsky and Werb, 1992; Boudreau and
Jones, 1999; Geiger et al., 2001). Cells use a series of receptors for ECM including
integrins (Hynes, 1992; Lasky, 1997; van der Flier and Sonnenberg, 2001), cell
surface proteoglycans (Xu et al., 1996; Page, 1997), and cell-surface-expressed
tyrosine kinase receptors with direct affinity for ECM (Schlessinger and Ullrich,
1992; Vogel et al., 1997). The components of ECM include insoluble ECM proteins
such as collagens, laminins, fibronectin and proteoglycans, matricellular ECM
proteins that modulate cell-matrix interactions and other cellular responses such as
cell proliferation and ECM-associated proteins such as growth factors (Roskelley et
al., 1995; Lukashev and Werb, 1998; Damsky and Werb, 1992; Dunsmore and
Rannels, 1996; Streuli, 1999; Boudreau and Jones, 1999; Geiger et al., 2001; Talpale
and Keski-Oja, 1997).
During tissue injury, the composition of ECM and its cellular recognition sites are
altered in a number of significant ways. Increased vascular permeability results in
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recruitment of plasma-derived proteins including fibronectin, vitronectin and
fibrinogen into the ECM, whereas cells in the injury site are induced to release or
synthesise new components including thrombospondins, tenascins and alternatively
spliced fibronectins which regulate tissue repair (Chintala and Rao, 1996; Kettritz et
al., 1999; Vitale et al., 1999; Kriiger-Krasagakes et al., 1999; Ebihara et al., 2000).
Furthermore, tissue injury may result in alterations in existing ECM proteins within
tissues or in recruited ECM that reveal cryptic biologically active sites (matricryptic)
that provide important signals within the injury sites (Davis et al., 2000;
Montgomery et al., 1994).
Among the extracellular matrix proteins, fibronectin matrices appear critical to tissue
repair. Following tissue injury, the expression of fibronectin increase dramatically
(Reynolds et al., 1999; Sottile et al., 2000; Miyata et al., 2000; Danen and Yamada,
2001). Much of the fibronectin detected in injured lungs is of plasma origin, but it is
also locally synthesised by macrophages, fibroblasts, endothelial cells, and surface
epithelial cells (Lukashev and Werb, 1998; Dunsmore and Rannels, 1996; Chintala
and Rao, 1996; Kettritz et al., 1999; Streuli, 1999; Ebihara et al., 2000; Davis et al.,
2000). Fibronectin may serve multiple functions in tissue repair, acting as a chemo-
attractant and adhesive substrate for mesenchymal and epithelial cells, which migrate
into damaged tissue (Limper and Roman, 1992). In addition to fibronectin, two
components of the basement membrane, laminin and type IV collagen, can stimulate
bronchiole epithelial cell migration (Crystal et al., 1978; Sannes et al., 1998; Sannes
et al., 1998; Crystal et al., 1978; Vogel et al., 1997).
1.5.2 Integrins
The integrins are a family of cell-surface glycoproteins that act as receptors for ECM
proteins or for membrane-bound counter-receptors on other cells (Ingber, 1991;
Hynes, 1992; Schwartz, 1997; van der Flier and Sonnenberg, 2001). Integrins
mediating cell-ECM adhesion sites are complex specialised structures termed focal
contacts or focal adhesions (Turner, 2000). Each integrin is a heterodimer that
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contains an a and a (3 subunit, each subunit having a large extracellular domain, a
single membrane-spanning region and in most cases (other than P4), a short
cytoplasmic domain (Hynes, 1992; van der Flier and Sonnenberg, 2001).
The integrin receptor family of vertebrates include at least 16 distinct a subunits and
8 or more (3 subunits which can associate to form more than 20 distinct integrins
(Hynes, 1992; Hynes, 2000). The cc/(3 pairings specify the ligand-binding abilities of
the integrins heterodimers. Although the ligands for integrins are often large ECM
proteins such as collagen, laminin, vitronectin, or fibronectin, some integrins
recognise rather short peptide sequences within the larger proteins, for example, the
RGD (Arg-Gly-Asp) sequence found in the fibronectin and vitronectin. In other
cases, however, integrin-ligand recognition depends on the overall conformation of
the ligand protein. For example, some integrins interact with members of other
adhesion receptor families, including Ig-Cams and cadherins, in a manner that does
not involve RGD motifs (Kumar, 1998). Some integrins such as CC5P1 bind to a
single ECM protein in this case fibronectin (Danen and Yamada, 2001), while other
integrins such as av(33 has been reported to bind to vitronectin, fibrinogen, von
Willebrand factor, thrombospondin, fibronectin, osteoporotin and collagen (Hynes,
1992; Fomaro and Languino, 1997; van der Flier and Sonnenberg, 2001) (Table 1.2).
Cells often display multiple integrins capable of interacting with a particular ECM
protein, thus integrin expression is often apparently redundant, at least in terms of
simple cell adhesion. Some integrin subunits undergo alternative splicing of their
cytoplasmic domain regions in a tissue-type specific and developmentally regulated
manner, which suggests that there are discrete intracellular functions for individual
integrins (Schwartz and Assoian, 2001; O'Toole, 1997; Clark and Brugge, 1995).
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Subunits Ligands and counter-receptors
ai Collagens, laminin, fibronectin
a2 Collagens, laminin











CCM ICAM-1, fibrinogen, factor X
Pa ax Fibrinogen
Pa
OCiib Fibrinogen, fibronectin, von Willebrand factor, vitronectin,
thrombospondin
av Vitronectin, fibrinogen, von Willebrand factor,








Table 1.2 - The integrin receptor family and putative ligands. (Hynes,
1992; Kumar, 1998; Damsky and Werb, 1992; Fornaro and Languino, 1997;
Sheppard, 2000; van der Flier and Sonnenberg, 2001)
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The integrin cytoplasmic domains determine the interactions between the
extracellular environment, intracellular structure and cascades signalling. Both the a
and (3 subunit cytoplasmic domains make important contributions to various aspects
of overall integrin function including cytoskeletal organisation, cell motility, signal
transduction, and modulation of integrin affinity for ligands (Ingber, 1991; Hynes,
1992; Schwartz, 1997; Frisch and Ruoslahti, 1997; Lasky, 1997; Shyy and Chien,
1997; van der Flier and Sonnenberg, 2001).
The a subunit cytoplasmic domain inhibits certain functions of the (3 cytoplasmic
domain (eg, the focal contact recruitment) but the binding of a ligand to the integrin
relieves this inhibition, possibly by allowing the subunits to swing apart like a hinge
(Lasky, 1997; Aplin et al., 1998). The |3 cytoplasmic domain is also important in
signal transduction, particularly integrin activation of FAK, whereas the
truncation/mutation of the a cytoplasmic domain has little effect on this process
(Mould et al., 1996; Vasioukhin et al., 2000)
Several cytoplasmic proteins including talin, a-actinin, and possibly focal adhesion
kinase (FAK) bind directly to the Pi cytoplasmic domain and contribute to integrin-
cytoskeletal interactions and bidirectional transmembrane signalling (Ingber, 1991;
Clark and Brugge, 1995; Maniotis et al., 1997; Aplin et al., 1998; Schwartz and
Assoian, 2001; Schlaepfer and Hunter, 1998; Laflamme et al., 1997; Dedhar and
Hannigan, 1996). Table 1.3 summarises the various intracellular proteins that
interact with integrin subunit cytoplasmic domains.
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Proteins Integrin subunit(s)
a-actinin Pi, P2, P3
Cytoskeletal
Proteins
Talin Pi, P2, P3
Filamin P2
Tensin, vinculin, paxillin, actin P.
F-actin a2
Endonexin P3






FAK Pi, P2, P3
ILK Pi, P2, P3
IRS-1 avp3
p-190 ccvp3
C-CSK, P13K, Rho, Ras, Grb2, ?
Other signalling MEKK, MEK, ERK1, ERK2, CAS,
molecules Src family kinases
Table 1.3 Intracellular proteins suggested to interact with integrin subunit
cytoplasmic domains. (Hemler, 1998; Dedhar and Hannigan, 1996)
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Integrins activate a number of a large array of signalling intermediates. Their effects
include activation of Rho-family GTP-ases leading to changes in cytoskeletal
organisation, activation of mitogen-activated protein (MAP) kinase pathways, and
activation of an array of proteins and lipid kinases. These signalling pathways allow
integrins to influence cell-cycle progression, cell survival and gene expression in
addition to their effect on cell adhesion and morphology (Hynes, 2000; Clark and
Brugge, 1995; Hemler, 1998; Cary et al., 1999; Howe et al., 1998; Giancotti, 1997;
Giancotti and Ruoslahti, 1999; Pu and Streuli, 2002; Schwartz and Assoian, 2001;
O'Toole, 1997; Schlaepfer and Hunter, 1998; Carmeliet, 2002). In fact, most cells
will not proliferate or survive unless they are adhering to a substrate - so called
anchorage dependence (Schulze et al., 1996; Day et al., 1997; Schwartz, 1997; Orend
et al., 1998).
Various biological responses are affected by integrins, including cytoskeletal
organisation and cell spreading (Schwartz, 1997; Maniotis et al., 1997), cell motility
(Ingber, 1991; Hynes, 1992; Shyy and Chien, 1997; Frisch and Ruoslahti, 1997;
Maniotis et al., 1997), cell survival (Shyy and Chien, 1997) and cell proliferation
(Vivinus-Nebot et al., 1999; Schwartz and Assoian, 2001). A simplified pathway
showing the signalling mediated adhesion receptors and signalling intermediates is
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1.5.3 Cadherins
Cadherins comprise a family of transmembrane proteins that share an extracellular
domain consisting of multiple repeats of a cadherin-specific motif (Suzuki, 1996).
The "classical" subfamily is calcium dependent homotypic cell-cell adhesion
molecules. Several members which fall in this subfamily have been characterised
including N-, P-, R-, B- and E-cadherin as well as approximately 10 others (Takeichi,
1995). These molecules are present in specialised sites of cell-to-cell adhesion
(termed adherence junction), whereby they can establish linkages with the actin-
containing cytoskeleton known as "adhesion zippers" (Aplin et al., 1998). The
classical cadherins play a key role in developmental processes (Takeichi, 1995;
Reithamacher et ah, 1995).
Another important subfamily of cadherins involved in the adhesion is represented by
the desmogleins and desmocollins, a group of desmosome-associated cadherins that
form intracellular linkages to intermediate filaments rather than actin filaments
(Cowin and Burke, 1996).
The cytoplasmic domains of cadherins interact strongly with a group of intracellular
proteins known as catenins. It was shown that catenins are essential for cadherin
function. Truncation of the cadherin cytoplasmic domain to delete catenin binding
sites lead to a loss of cadherin-mediated adhesion (Takeichi, 1995; Gumbiner, 1996).
Due to the fact that different classic cadherins have considerable homology among
their cytoplasmic domains, they compete for the same catenins (Kinter, 1992). Three
forms of catenin proteins have been described, a-, (3- and y-catenin. The structure of
a-catenin shows substantial homology to the protein vinculin, which binds a-actinin
and talin and is critical for cytoskeletal assembly at integrin-mediated focal adhesion
sites (Aberle et al., 1996). (3-catenin binds directly to the cadherin cytoplasmic
domain, subsequently, a-catenin binds to (3-catenin and links the complex to the
actin cytoskeleton by direct interaction with actin and by binding a-actinin (Cowin
41
and Burke, 1996). (3-catenin does not only interacts with cadherins but also with
components of the wingless/Wnt signalling pathway and thus can stimulate
transcription of target gene (Moon et ah, 1997; Peifer, 1996; Bremnes et ah, 2002)
(Figure 1.6).
1.5.4 Immunoglobulin-Cell adhesion molecules (Ig-
CAMs)
Immunoglobulin superfamily cell adhesion molecules (Ig-CAMs) are defined by the
presence of one or more copies of the Ig fold, a compact structure with two cysteine
residues separated by 55 to 75 amino acids arranged as two anti-parallel (3 sheets
(Vaughn and Bjorkman, 1996). In many cases, Ig-CAMs contain one or more
copies of a fibronectin type III repeat domain (Aplin et al., 1998).
Some examples of the Ig-CAMs superfamily include: neural cell adhesion molecules
(NCAM) (Baldwin et ah, 1996; Tessier-Lavigne and Goodman, 1996; Edelman and
Crossin, 1991), EpH (Tessier-Lavigne and Goodman, 1996), CD2, CD4, CD8
(Dustin and Springer, 1991; Springer, 1995), intercellular adhesion molecule 1 & 2,
(ICAM-1, ICAM-2) (Rosales and Juliano, 1995; Dustin and Springer, 1991;
Springer, 1995), T-cell receptor (TCR) (Dustin and Springer, 1991; Springer, 1995;
Rosales and Juliano, 1995), lysophosphatidic acid (LFA-3) (Aplin et ah, 1998),
vascular cell adhesion molecule-1 (VCAM-1) (Aplin et ah, 1998), platelet
endothelial cell adhesion molecule-1 (PECAM-1) (DeLessier et ah, 1994), receptor
protein tyrosine phosphatases (RPTPs) and others.
Ig-CAMs play multiple roles in the developing embryo and in the adult organisms.
They are important in tissue organisation and cellular trafficking in the immune













Figure 1.6 - Schematic presentation of the Wnt/p-catenin pathway. In
absence of a mitotic signal, P-catenin is sequestered in a complex with
adenomatous polyposis coli (APC), glycogen synthetase kinase (GSK-3) and
scaffolding protein axin and is phosphorylated by GSK-3, enabling its
degradation. An activation of Wnt pathway leads to activation of dishevelled
(Dsh) protein which downregulates the complex so that it no longer
phosphorylates P-catenin. The increased level of free P-catenin translocates to
the nucleus, bind to transcription factors (LEF-l/Tcf), and stimulate
transcription of target gene. Free P-catenin can be inhibited by p53. (Aplin et
al., 1998; Bremnes et al., 2002; Moon et al., 2002).
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1.5.5 Selectins
Selectins are a small family of lectin-like adhesion receptors composed of three
members, L-, E- and P- selectin (Lasky, 1995; Rosen and Bertozzi, 1994; Tedder et
ah, 1995). The structure of a selectin includes an amino-terminal domain that is
homologous to calcium-dependent animal lectins, followed by an epidermal growth
factor (EGF)-type domain, two to nine complement regulatory protein repeats, a
transmembrane helical segment, and a short cytoplasmic tail (Aplin et ah, 1998).
Selectins mediate heterotypic cell-cell interactions through calcium-dependent
recognition of sialyated glycans. The physiological role of selectins concerns
leukocyte adherence to endothelial cells and platelets during inflammatory processes
(Rosales and Juliano, 1995; Springer, 1995).
P-selectin is present in latent form in endothelial cells and platelets and it is rapidly
translocated from secretory granules to the cell surface upon activation by thrombin
or other agonists (Rosen and Bertozzi, 1994; Lasky, 1995; Tedder et ah, 1995). P-
selectin was found to be upregulated in bleomycin induced injury in rats and this was
associated with neutrophil recruitment in response to bleomycin (Serrano-Mollar et
ah, 2002). E-selectin is synthesised and expressed on endothelial cells in response to
inflammatory cytokines such as tumour necrosis factor (TNF) or interleukin-1 (IL-1)
(Rosen and Bertozzi, 1994; Lasky, 1995; Tedder et ah, 1995). L-selectin is expressed
constitutively on leukocytes, but its presentation at the cell surface may be regulated
(Rosen and Bertozzi, 1994; Lasky, 1995; Tedder et ah, 1995). The precise identities
of the ligands for the three currently known selectins are still not clear and are a
matter of some controversy (Varki, 1997).
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1.6 Cell cycle control
The cell cycle control machinery is divided in four phases: G1 (gap 1), S (synthesis
of DNA), G2 (gap 2) and M (mitosis) phase regulated by a complex network of
cyclins and cyclin dependent kinase (CDK) (Pagano et al., 1994; Lane, 1998; Lane,
2001; Nigg, 2001; Bartek et al., 2001; Brooksbank, 2000; Grana and Reddy, 1995;
Nigg, 1995; Elledge, 1996; Paggi et al., 1996; Beijersbergen and Bernards, 1996;
Sherr, 1996; Yamauchi and Bloom, 1997; Nurse et al., 1998; Ekholm and Reed,
2000; Murakami and Nurse, 2000; Jones and Kazlauskas, 2001; Furukawa, 2002). A
simplified diagram representing the cell cycle control is shown in Figure 1.7.
Cell-cycle progression in higher eukaryotic cells is regulated by the cyclin-dependent
kinases (CDKs). G1 cyclins include D-cyclin (Dl, D2 and D3), cyclin E, and their
catalytic subunits CDKs, (cdk4, cdk6 or cdk2) play an essential role in the G1 to S
phase transition (Reed et al., 1994; Mann and Jones, 1995; Deng et al., 1995; Linke
et al., 1996; Kramer et al., 1996; Juan et al., 1998; Cayrol et al., 1998; Moll et al.,
2000; Ekholm and Reed, 2000; Bartek and Lukas, 2001).
E2F binds to retinoblastoma (Rb) protein and its relatives pl07 and pl30 (Windle et
al., 1990; Beijersbergen and Bernards, 1996; Baldi et al., 1996; Kinoshita et al.,
1996; Paggi et al., 1996; Herwig and Strauss, 1997; Dosaka-Akita et al., 1997;
Philips et al., 1997; Amellem et al., 1998; Garriga et al., 1998; Marchetti et al.,
1998). The formed complexes are able to bind to E2F transactivation domains,
repressing E2F dependent transcription (Mann and Jones, 1995; Shiyanov et al.,
1996; Day et al., 1997; Yamasaki, 1999; Delavaine and La Thangue, 1999; Gartel et
al., 2000; Jiang et al., 2000). Hyperphosphorylation of Rb by Cdk in late G1 disrupts
the Rb-E2F complex and prevents the formation of complex with newly synthesised
E2F molecules. Underphosphorylation of Rb is a negative regulation of DNA
synthesis, making phosphorylation of Rb by Cdk a crucial event regulating
restriction point (R-point) transit (Day et al., 1997; Medema et al., 1995;
Beijersbergen and Bernards, 1996; Paggi et al., 1996; Garriga et al., 1998; Marchetti
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et al., 1998). Phosphorylation of Rb in G1 is sufficient to allow cells to pass the R-
point, but not sufficient to permit entry intro S-phase (Beijersbergen and Bernards,
1996; Paggi et ah, 1996; Herwig and Strauss, 1997; Day et ah, 1997). The E-type
cyclins are the other important positive regulatory of transcriptional control and
DNA replication since they activate the transcriptional factor E2F (Day et al., 1997;
Yamasaki, 1999; Delavaine and La Thangue, 1999; Jiang et al., 2000).
In the S phase, the cyclin E is exchanged with cyclin A. The cyclin A-Cdk2 complex
is needed in replication foci for DNA synthesis as well as suppression of E2F
transcriptional activity by phosphorylating Rb in the complex with E2F (Mann and
Jones, 1995; Shiyanov et al., 1996; Yamasaki, 1999). Cyclin A also binds with Cdkl
(Cdc 2) in the G2 phase and then is suddenly degraded (Tchou et al., 1996; Cayrol et
al., 1998; Niculescu et al., 1998; Dulic et al., 1998; Grana and Reddy, 1995; Garriga
et al., 1998). Entry into mitosis (M phase) is triggered by the Maturation Promoting
Factor (MPF), which is composed of Cdkl and Cyclin B (Grana and Reddy, 1995;
Nigg, 1995; Elledge, 1996; Beijersbergen and Bernards, 1996; Sherr, 1996; Herwig
and Strauss, 1997; Nurse et al., 1998; Jones and Kazlauskas, 2001). Cyclin B
destruction is required for mitosis exit (King et al., 1994; Waldman et al., 1996;
Dulic et al., 1998).
A number of cyclin-dependent kinase inhibitors (CKIs) play a major role in the
control of the cell cycle machinery including pl5,pl6, pl8, p21 and p27 (Pagano et
al., 1994; Mann and Jones, 1995; Grana and Reddy, 1995; Nigg, 1995; Hangaishi et
al., 1996; Elledge, 1996; Paggi et al., 1996; Beijersbergen and Bernards, 1996; Linke
et al., 1996; Sherr, 1996; Gadbois and Lxhnert, 1997; Somasundaram et al., 1997;
Herwig and Strauss, 1997; Yamauchi and Bloom, 1997; Ji et al., 1997; Cai and
Dynlacht, 1998; Nurse et al., 1998; Cayrol et al., 1998; Costanzi-Strauss et al., 1998;
Niculescu et al., 1998; Ekholm and Reed, 2000; Jones and Kazlauskas, 2001; Bartek



































































1.7 Biology of p21
p21WAF1/Cipl belongs to the Cip/Kip family of cyclin kinase inhibitors (CKI)
(p21Wafl/Cipl, p27Kipl, p57Kipl). p2iWafl/Cipl was first described as a potent and
universal inhibitor of cyclin-dependent kinases (Cdks) (Harper et al., 1993; El-Deiry
et al., 1995; Ball, 1997). p21 functions as a checkpoint in the cell cycle by inhibiting
cdks at the Gl/S and G2/M interfaces (Zhang et al., 1993; Ji et al., 1997; Cayrol et
al., 1998; Cai and Dynlacht, 1998; Bates et al., 1998; Niculescu et al., 1998; Dotto,
2000; Bartek and Lukas, 2001; Jones and Kazlauskas, 2001). p21 has been shown to
bind to cyclin-cdk complexes, preventing phosphorylation of the retinoblastoma
protein (Gartel et al., 1998; Costanzi-Strauss et al., 1998; Windle et al., 1990; Paggi
et al., 1996; Herwig and Strauss, 1997; Yamauchi and Bloom, 1997; Day et al.,
1997; Amellem et al., 1998; Garriga et al., 1998). When this happens the E2F
pathway is blocked and the cell cycle is arrested at the Gl/S interface (Cai and
Dynlacht, 1998; Bates et al., 1998; Dotto, 2000; Delavaine and La Thangue, 1999;
Gartel et al., 2000; Jiang et al., 2000).
Variation in the p21 levels has been shown in epithelial cells in several lung diseases
(Takeshima et al., 1998; Kuwano et al., 1996; Rancourt et al., 2001; McGrath, 1998;
Mishra et al., 2000; Kuwano et al., 2000; Gadbois and Lehnert, 1997; Guinee et al.,
1996), upon cell-matrix disruption (Wu and Schonthal, 1997; Ilic et al., 1998; Howe,
2001; Vitale et al., 1999) and to be influenced by several integrins (Bachelder et al.,
1999a; Clarke et al., 1995; Stromblad et al., 1996).
p21 expression is usually controlled at the transcriptional level by either the p53-
dependent or -independent pathway (Michieli et al., 1994; Prost et al., 1998; Nurse et
al., 1998; Murakami and Nurse, 2000; Zeng and El-Deiry, 1996), but p21 expression
can also be regulated at the post-transcriptional level. Short wavelength UVC was
found to induce p21 in a p53-dependent fashion by post-transcriptional modifications
that led to enhanced stability of p21 mRNA (Gorospe et al., 1998; Wang et al.,
2000). The transcription factors C/EBPa and C/EBP(3 were found to interact with
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p21 protein and protect it from proteolytic degradation (Timchenko et al., 1996;
Timchenko et al., 1997; Kramer et al., 1996; Cram et al., 1998; Cortes-Canteli et al.,
2002). In a number of other cell lines, post-transcriptional events strongly influence
p21 expression following genotoxic stress (Butz et al., 1998). Stress-activated
kinases p38a and JNK 1 were shown to stabilise p21 by phosphorylation at serine
130 (Kim et al., 2002).
p21 was shown to promote apoptosis (McKay et al., 1998; Gervais et al., 2000),
protect cells from undergoing apoptosis (McKay et al., 1998; Lu et al., 1998; Bulavin
et al., 1999; Asada et al., 1999; Zhang et al., 1999; Gervais et al., 2000), inhibit
differentiation (Yamamoto et al., 1998; Harvat et al., 1998) and promote
differentiation (Steinman et al., 1994; Liu et al., 1996a; Liu et al., 1996b; Billon et
al., 1996; Matsumura et al., 1997; Nadal et al., 1997). p21 was also found to be
present in the cytoplasm and various forms and sizes have been described (Orend et
al., 1998; Asada et al., 1999; Poon and Hunter, 1998; Donato and Perez, 1998; Tchou
et al., 1996; Gervais et al., 2000; Zhang et al., 1999; Jin et al., 2000).
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1.7.1 Structure and protein interactions of p2iWaf1/Cip1.
Cip/Kip family (p21Wafl/c,pl, p27Kipl, p57Kip2 share significant sequence homology in
their amino-terminal (Sherr, 1996; Nigg, 1995; Grana and Reddy, 1995; Elledge,
1996; Nurse et al., 1998). The amino-terminal domain of p21, like the corresponding
domains of p27 or p57, is both necessary and sufficient to inhibit cyclin/CDK
activity. The unique carboxy-terminal domain of p2iWafl/Cipl associated with the
proliferating nuclear antigen (PCNA), a subunit of DNA polymerase 5 and can
inhibit DNA replication directly, without affecting DNA repair (Li et al., 1995a;
Stillman, 1996; Cayrol et al., 1998; Oku et al., 1998; Rousseau et al., 1999).
p21Wjn/Cipi was identified as a mediator of p53-induced growth arrest (El-Deiry et
al., 1993; El-Deiry et al., 1995) and a direct regulator of CDK activity (Harper et al.,
1993; Elledge et al., 1996). p2iWjll/Cipl plays a critical role in the negative control of
cell growth, and is generally up-regulated in cell arrest either by cell contact, serum
deprivation, differentiation or senescence (Harper et al., 1993; Elledge et al., 1996;
Elledge, 1996; Noda et al., 1994; Cai and Dynlacht, 1998; Dotto, 2000).
The human p21 gene consists of 3 exons (68, 450 and 1600 bp) but the first exon is
not translated. The human p21 protein is 164 amino acids with a molecular mass of
21 kDa, and has been conserved during evolution (El-Deiry et al., 1993).
p21Wa"/Cipi interacts directly with cyclins through a conserved region close to the N-
terminus (Cyc 1), however it has a second weak cyclin binding near its C-terminus
region (Cyc 2), which overlaps with its PCNA binding region domain. Moreover,
p21 has a separate cyclin-dependant kinase domain (Cdk) binding site in its N-
terminus region (Chen et al., 1996) (Figure 1.8). For optimal cyclin-Cdk inhibition,
the binding to this site as well as one of the cyclins is required. p21 was shown to
compete with pl07 and pl30 for binding to cyclin/Cdks, and to disrupt already
formed complexes among these molecules (Shiyanov et al., 1996).
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p21 was found to cause repression of the E2F-dependent transcription possibly by
direct association with E2F factor (Delavaine and La Thangue, 1999). This means
that E2F could function as an anchor of p21, bringing it in juxtaposition with an E2F-
dependent transcription initiation complex, thereby inhibiting its function (Dotto,
2000; Shiyanov et ah, 1996; Delavaine and La Thangue, 1999; Gartel et al., 2000;
Jiang et al., 2000).
p21 can bind to the N-terminus of c-Myc, to interfere with the c-Myc-Max
association, but at the same time, the interaction between c-Myc and p21 can directly
counteract p21-dependent inhibition of DNA synthesis, as c-Myc binds to the C-
terminus of p21 in competition with PCNA (Kitaura et al., 2000)
p21 can enhance the function of transcription co-activators such as p300 (Perkins et
al., 1997; Snowden et al., 2000). The ability of p300 to interact with NFkB-
dependent transcription is negatively controlled by association of p300 with active
cyclin/CDK complexes. Thus the inhibition of cyclin/CDK activity could be a way
of explaining the capability of p21 to activate p300-dependent transcription. It was
shown that stimulation of p300 activity could occur by p21 independently of the
intrinsic histone acetyltransferase activity of this co-activator and its cyclin/CDK
binding region. This occurs because p21 can relieve the effects of a previously
uncharacterised transcription repression domain present in p300 (Snowden et al.,
2000; Billon et al., 1996; Owen et al., 1998).
The E7 protein of human papilloma virus 16 (HPV-16) binds to p21 and competes
with PCNA for binding to the carboxy-terminus domain of p21 (Funk et al., 1997;
Jones et al., 1997). The association of E7 to p21, blocks the ability of p21 to inhibit
cyclin/CDK activity as well as PCNA-dependent DNA synthesis. E7 does not
disrupt the association of p21 with cyclin/CDK complexes, but it is thought to relieve
p21-dependent suppression of CDK activity (Funk et al., 1997; Jones et al., 1997;
Amellem et al., 1998).
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Two DNA metabolising enzymes Fen 1 (Fap endonuclease I) and DNA-(cytosine-5)
methytransferase (DNA MTase) bind to p21 in competition with PCNA. PCNA
interacts physically with Fen I and stimulates its enzymatic activity. The central
residues of the PCNA binding domain of p21 are the most highly conserved with Fen
1, and likely to mediate their mutually exclusive binding to PCNA (Li et ah, 1995b;
Wu et ah, 1996; Warbrick et ah, 1997). DNA MTase was shown to bind directly to
PCNA and the PCNA-DNA MTase association was disrupted by p21. Newly
replicated DNA must be methylated before histone HI is incorporated into the
nucleosome. This suggests that p21 can control DNA methylation levels during
replication and possibly during DNA repair (Chuang et ah, 1997).
In addition to DNA metabolising enzymes, GADD45 is also involved in p21-PCNA
interactions. GADD45, like p21 is a nuclear protein and has been implicated in
induction of growth arrest, apoptosis, excision repair and DNA stability (Smith et ah,
1994; Hall et ah, 1995; Kearsey et ah, 1995; Vairapandi et ah, 1996; Hollander et ah,
1999). Although GADD45 interacts with PCNA through a region distinct from that
recognised by p21, both p21 and GADD45 compete with each other to bind PCNA
(Smith et ah, 1994; Hall et ah, 1995; Kearsey et ah, 1995). GADD45 and its related
homologue MyD118, can directly associate with p21 (Kearsey et ah, 1995;
Vairapandi et ah, 1996). GADD45 does not appear to inhibit cyclin-Cdk complexes
either by itself or in combination of p21 (Smith et ah, 1994).
p21 binds directly to procaspase 3 at its N-terminus and is involved in death
induction and suppression. p21 also bind to SAPK at its N-terminus and was found
to block its phosphorylation and also the activation by the upstream MKK4 kinase
(Pochampally et ah, 1999; Suzuki et ah, 1999; Swanton et ah, 1999).
p21 was shown to interact with other regulatory proteins, such as protein kinase,
CK2 (Gotz et ah, 1996), calmodulin (CaM) (Taules et ah, 1999), a novel cell
regulatory protein with oncogenic potential, SET (Estanyol et ah, 1999), and the
transcription factor C/EBP-a (Timchenko et ah, 1997; Chinery et ah, 1997; Nord et
ah, 1998).
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The cell-cycle inhibitory activity of p2iCipl/Wafl is associated with its nuclear
localisation. However a 10-amino acid truncation from the C-terminal form of p21
was reported in UV-irradiated normal diploid fibroblasts and many tumour cells
mainly localised in the cytoplasm (Poon and Hunter, 1998).
A physical association between cytoplasmic p21 and ASK1 has been described and
was found to suppress the activity of ASK 1 and MAPK (SAPK/JNK) cascade
activation thus preventing the cell from undergoing apoptosis (Asada et al., 1999).
It has been suggested that cytoplasmic p21 is formed by cleavage or truncation
during apoptosis (Prabhu et al., 1997; Donato and Perez, 1998; Gervais et al., 2000;
Jin et al., 2000; Zhang et al., 1999). Other forms of cytoplasmic p21 have been
described but their roles are still unclear (Donato and Perez, 1998; Tchou et al.,
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1.7.2 p53-dependent induction of p21 transcription.
The p53 tumour suppressor protein is an inducible transcription factor required for
the transactivation of a number of genes involved in cell cycle control (Elledge,
1996; Lane, 1992; Vogelstein et al., 2000; Paggi et al., 1996; Sherr, 1996; Nurse et
al., 1998; Ekholm and Reed, 2000; Jones and Kazlauskas, 2001). p21 expression is
normal in embryos and most tissues from p53 knockout (p53 -/-) mice (Macleod et
al., 1995).
Although p53 is not required for p21 transcription, the regulation of p21 is p53-
dependent following DNA damage by y-radiation (Macleod et al., 1995). Cultured
p21-deficient mouse embryonic fibroblasts still had the ability to undergo G1 arrest
in response to DNA damage, thus p53 may induce an additional gene that
participates in cell arrest (Deng et al., 1995; Brugarolas et al., 1995). p21
transcription and cell cycle arrest was observed in irradiated human cell lines (Dulic
et al., 1994; Namba et al., 1995).
The expression of p21 was found to increase via the p53-dependent pathway in
murine embryonic fibroblasts following treatment with the spindle disrupter
nocodazole (Lanni and Jacks, 1998). Ribonucleotide biosynthesis inhibitors such as
pyrazofurin and cyclopentenylcytosine were shown to induce p53-dependent p21
expression in the absence of DNA damage, and resulted in hypophosphorylation of
retinoblastoma in normal human fibroblasts and cell growth arrest (Linke et al.,
1996).
Transcriptional induction of p21 by p53 may prevent cells undergoing apoptosis and
instead lead to cell-cycle arrest (Polyak et al., 1996). A summary of the induction of
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1.7.3 p53-independent regulation of p21 expression.
A number of agents activate p21 transcription independent of the p53 pathway.
These agents induce binding of different transcription factors to specific cis-acting
elements located within the p21 promoter (Table 1.4).
The region between -119 bp and start of transcription of the human p21 gene
contains six Spl binding sites (Spl-1 to Spl-6). Spl is a member of a multigene
family that binds to DNA through C-terminal zinc-finger motifs. Sp2, Sp3 and Sp4
share extensive structural and sequence homology with Spl (Kennett et al., 1997).
Phorbol ester (PMA) and okadaic acid induce p21 through Spl (Kennett et al., 1997;
Biggs et al., 1996). The tumour suppressor protein BRCA1 activates p21 via the
region from -143 to -93 bp which contains the Spl-1 and Spl-2 sites and inhibits
DNA synthesis (Somasundaram et al., 1997). Transforming growth factor-(3 (TGF-
(3) (Datto et al., 1995; Li et al., 1998), calcium (Prowse et al., 1997), butyrate
(Nakano et al., 1997), lovastatin (Lee et al., 1998), histone deacetylase inhibitor
Trichostatin A (TSA) (Sowa et al., 1997; Nakano et al., 1997) and nerve growth
factor (NGF) (Billon et al., 1996) has been shown to induce p21 via the Spl-3 site in
the p21 promoter. TGF-(3 and butyrate inhibited proliferation and induced G1 cell
cycle arrest in various cells (Datto et al., 1995; Li et al., 1998; Sowa et al., 1997;
Nakano et al., 1997), calcium induced differentiation of cultured mouse keratinocytes
(Prowse et al., 1997) whereas lovastatin induced cell cycle arrest in p53-null human
prostate carcinoma cells (Lee et al., 1998).
The addition of nerve growth factor (NGF) to PC12 cells induced p21 expression and
differentiation through Spl, Sp3 sites and p300 transcriptional co-activator (Billon et
al., 1996; Yan and Ziff, 1997). Progesterone was found to increase the level of p21
and promote growth arrest. The progesterone receptor (PR) was found complexed
with p300 and Spl (Owen et al., 1998).
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A variety of other transcription factors such as AP2 (Zeng et al., 1997), E2F (Mann
and Jones, 1995; Shiyanov et al., 1996; Yamasaki, 1999; Delavaine and La Thangue,
1999; Gartel et al., 2000), STATs (Chin et al., 1996; Grandis et al., 1998; Lee et al.,
1998; Coqueret and Gascan, 2000) and C/EBPa (Chinery et al., 1997; Nord et al.,














Lovastatin Spl, Sp3 -82 1-11 bp (Lee et ah, 1998)
Trichostatin A Spl, Sp3 -821-11 bp;
-69/-64 bp
(Sowa et ah, 1997)
TGF-p Spl, Smad 3/4, Smad
2/4, p300
-82 1-11 bp (Datto et ah, 1995;
Li et ah, 1998;
Moustakas and
Kardassis, 1998)
NGF Spl, Sp3, p300 -821-11 bp (Billon et ah, 1996)
Calcium Sp3 -82 1-11 bp (Prowse et ah,
1997)
Progesterone Spl, p300 -82 1-11 bp;
-69/-64 bp
(Owen et ah, 1998)




(Biggs et ah, 1996)
Ap2 -102/-94 bp (Zeng et ah, 1997)
TPA Ap2 -102/-94 bp (Zeng et ah, 1997)
PMA Spl, Sp3(?) -119/-114 bp;
-109/-104 bp
(Biggs et ah, 1996)
BRCA1 -143/-93 bp (Somasundaram et
ah, 1997)
E2A (E47) -162/-157 bp;
-20/-15 bp;
-5/-1 bp










Vitamin D3 VDR -779/-765 bp (Liu et al., 1996b)
Retinoic acid RAR -1212/-1194 bp (Liu et al., 1996a)
Dexamethasone C/EBPa -1270/-1256 bp (Cram et al., 1998)
Vitamin E C/EBPa -1928/-1920 bp (Chinery et al.,
1997)
EGF STAT 1, STAT 3 -4236/-4288 bp;
-2561/-2553 bp;
-696/-688 bp
(Chin et al., 1996)
IFN-Y STAT 1 -4236/-4228 bp;
-2561/-2553 bp;
-696/-688 bp
(Chin et al., 1996)




IL6 STAT 3 -696/-688 bp (Bellino et al.,
1998)
Table 1.4 - p21 inducing agents that activate p21 transcription
independent of p53 and their specific cis-acting elements located within the p21
promoter. Adapted from (Gartel and Tyner, 1999).
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1.7.4 p21 and differentiation
Exit from the cell cycle is a prerequisite for terminal differentiation, and p21
expression is induced during terminal differentiation both in vitro and in vivo
(Michieli et al., 1994; Steinman et al., 1994; Halevy et al., 1995; Missero et al.,
1995). p21 expression promotes differentiation in megakaryoblast leukemia cell line
(CMK) (Matsumura et al., 1997), in megakaryocytes cells (CD34+) (Baccini et al.,
2001), in myelomonocytic cell line (U937) (Liu et al., 1996a; Liu et al., 1996b), in
chondrosarcoma cells (SW1353) (Hiraoka et al., 2002), in dendritic cells and
macrophages from human peripheral blood monocytes (Kramer et al., 2002), in
skeletal muscles (Park and Chung, 2001), in mice lungs (Park and Chung, 2001), in
peripheral nervous system neurons in response to nerve growth factor mediated by
p300 protein (Billon et al., 1996), in myotube differentiation from myoblasts under
the influence of the transcription factor MyoD (Halevy et al., 1995) and in laryngeal
tumours (Nadal et al., 1997). Interestingly, p21 was also shown to inhibit
differentiation in terminally differentiated of mouse keratinocytes (Di Cunto et al.,
1998) but not those of humans (Harvat et al., 1998) and decrease differentiation in
human colon cancer cell line HT29 (Yamamoto et al., 1998). The p21 was found not
to be involved in the regulation of differentiation of the mouse skin tumours
(Weinberg et al., 1999) and in mouse keratinocytes (Weinberg et al., 1997).
In the p21 null mice, normal differentiation has been observed thus implying that p21
is not a mutually exclusive agent that promotes differentiation (Paramio et al., 2001;
Cox, 1997; McDonald et al., 1996; Deng et al., 1995). Various other genes are
thought to be involved and maybe cooperate with p21 to regulate differentiation
including pl5 (Paramio et al., 2001), pl6 (Harvat et al., 1998; Paramio et al., 2001;
Furukawa, 2002), pl8 (Paramio et al., 2001), pl9 (Paramio et al., 2001), p27
(Yamamoto et al., 1998; Harvat et al., 1998; Furukawa, 2002; Deschenes et al.,
2001), p53 (Soddu et al., 1996; Macleod et al., 1995; Nadal et al., 1997; Xue et al.,
2002), p57 (Dyer and Cepko, 2000; Park and Chung, 2001; Nakai et al., 2002) and
Rb (Baccini et al., 2001; Deschenes et al., 2001; Xue et al., 2002).
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1.7.5 p21 and proliferation
p21 is usually assumed to inhibit proliferation both in vitro and in vivo (Balomenos
et al., 2000; Sugibayashi et al., 2002) and by the introduction of p21 expression
constructs into normal (Harper et al., 1993) and tumour cell lines (El-Deiry et al.,
1993) resulted in cell cycle arrest at the G1 phase of the cell cycle (Harper et al.,
1995). Paradoxically, p21 has been shown to promote proliferation under certain
circumstances (Mantel et al., 1996; Lai et al., 2002).
Various mechanisms have been described by which p21 can regulate proliferation
(Niculescu et al., 1998). p21 may induce growth arrest by inhibiting the activity of
cyclin-dependent kinases (Cdks) or of proliferating cell nuclear antigen (PCNA)
(Kelman, 1997). The unique carboxy-terminal domain of p21 can associate with
PCNA and DNA polymerase 5 and 8 and can inhibit DNA replication directly,
without affecting DNA repair (Chen et al., 1996; Mantel et al., 1996; Oku et al.,
1998; Li et al., 1995a; Warbrick et al., 1997; Funk et al., 1997; Chuang et al., 1997;
Cayrol et al., 1998; Rousseau et al., 1999; Li et al., 1994; Shivji et al., 1994). p21
may act as an assembly factor for Cdk/cyclin complexes. p21 was found to promotes
the assembly of Cdk4/6 and cyclin D in vitro and was found associated with
cyclinD/Cdk4 complexes during cell-cycle progression (LaBaer et al., 1997;
Morisaki et al., 1999; Cheng et al., 1999; Wong et al., 2001). p21 was also shown to
complex with cdk2 and thus lead to growth arrest (Niculescu et al., 1998; Shiyanov
et al., 1996; Jones et al., 1997; Orend et al., 1998; Morisaki et al., 1999; Aikawa et
al., 2001). The role of p21 as an assembly activator or inhibitor depends on its
expression level. At low and intermediate concentrations it is an assembly factor,
while at high concentrations it is an inhibitor (LaBaer et al., 1997; Hiyama et al.,
1997; Morisaki et al., 1999).
p21 has been shown to be part of a quaternary complex that contains cyclin, Cdk and
PCNA (Zhang et al., 1993). The transition between active and inactive states occurs
through changes in p21 stoichiometry, particularly when multiple p21 molecules
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versus a single p21 molecule bind to these complexes (Harper et al., 1995; Zhang et
al., 1994).
The role of p21 to either promote or inhibit proliferation could depend on the specific
cellular context (Bearss et al., 2002). Mammary tumour-susceptible MMTV-ras
mice displayed higher S-phase fractions and an increase in tumours in p21 knockout
mice, whereas MMTV-c-Myc exhibited lower S-phase and a decrease in tumours
(Bearss et al., 2002).
Summary of the regulation of proliferation by p21 is shown in Figure 1.10.
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PROLIFERATION
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1.7.6 p21 and apoptosis
p21 can both promote and inhibit apoptosis although it generally counteracts the
apoptotic process (Dotto, 2000). p53-dependent apoptosis occurs normally in cells
from p21 knockout mice (Waldman et al., 1996). Expression of p21 appears to
protect colorectal carcinoma, and melanoma cells from p53-induced apoptosis
(Polyak et ah, 1996; Gorospe et ah, 1998; Wang et ah, 2000; Gorospe et ah, 1997;
Mahyar-Roemer and Roemer, 2001), while suppression of p21 expression by anti-
sense technology and homologous recombinations was shown to shift cells from the
cell-cycle arrest pathway to apoptosis (Polyak et ah, 1996). While the majority of
evidence supports a role of p21 in protection against apoptosis, over-expression of
p21 has been associated with the induction of apoptosis in human retinoblastoma
cells lines (Kondo et ah, 1997) and T-cells (Fotedar et ah, 1999).
Cells from p21 knockout mice were shown to contain very high levels of apoptosis
after y-irradiation (Deng et ah, 1995; Alan Wang et ah, 1997; Bulavin et ah, 1999).
These findings might suggest that p21 protein normally protects cells from
undergoing p53-mediated apoptosis by holding them in cell-cycle arrest (Cox, 1997;
Deng et ah, 1995; Alan Wang et ah, 1997) (Figure 1.9).
Activation of the MAPKs of the SAPK (JNK) and p38 kinase families are also key
events in the apoptotic response of many cells and p21 has been found to associate
and control both types of molecules (Shim et ah, 1996; Kim et ah, 2002; Bacus et ah,
2001). p21 was also found to form complexes with caspase 3 (Pochampally et ah,
1999; Suzuki et ah, 1998; Bachelder et ah, 1999b; Suzuki et ah, 1999; Swanton et ah,
1999; Jin et ah, 2000), and MEKKs (ASK1) (Asada et ah, 1999). The association
with these molecules could be favoured by the fact that p21 itself is a caspase
substrate, and becomes localised to the cytoplasm as a consequence of caspase-
dependent cleavage of its nuclear localisation C-terminus domain and is unable to
suppress growth as well as apoptosis (Gervais et ah, 2000; Levkau et ah, 1998b; Park
et ah, 1998). This truncation would also compromise the ability of p21 to promote
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cyclin/CDK nuclear localisation, with the same biological end point effect (Gervais
et al., 2000).
p21 can also protect cells from undergoing apoptosis due to the cyclin/CDK
inhibition (Sekiguchi and Hunter, 1998; Wu et al., 1998a; Jin et al., 2000; Wong et
al., 2001; Harper et al., 1993; Zhang et al., 1994; Harper et al., 1995; De Luca et al.,
1996; Chin et al., 1996; Chen et al., 1996; Sheikh et al., 1997; Ball, 1997; Owen et
al., 1998; Morisaki et al., 1999; Rousseau et al., 1999). Direct interaction between
p21 and GADD45 is thought to promote apoptosis rather than cell cycle arrest
(Kearsey et al., 1995; Vairapandi et al., 1996; Hollander et al., 1999).
Two novel proteins, p21B and p21C, which are variants of p21 were found to be
induced by DNA damage, p53 and p73. p21B have two unique exons and encodes a
protein that is not homologous to p21 or any other known protein. p21B was found
to induce cell cycle arrest and apoptosis. p21C uses an extended version of the p21B
exon I, but is spliced to the second and third exons of p21 and encodes the p21
protein (Nozell and Chen, 2002).
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1.8 Hypothesis and Aims
After lung injury, Clara cells are damaged and may be shed thus disrupting the cell-
cell and cell-matrix interaction and also denuding the basement membrane. The
normal response to injury is usually an inflammatory reaction and the deposition of
new extracellular matrix that incorporates various growth factors and inflammatory
cells that help to regenerate the lost epithelial cells. Regeneration is carried out by
migration, proliferation and differentiation of stem cells to cover the exposed area.
The main hypotheses of this thesis are:
1. p21 is a critical regulator of Clara cell proliferation, differentiation and death.
2. Clara cell response to changes in the environment is through integrin
mediated changes in p21.
The main aims of this thesis are:
1. Describe what is happening in terms of cell cycle control in animal mouse
models of lung injury.
2. To isolate, culture and characterise murine Clara cells.
3. Study the effect of extracellular matrix (ECM) and integrins on Clara cell
proliferation, differentiation and death through p21 regulation.
4. Investigate the regulation of the cyclin kinase inhibitor p2lCipl/Wafl in Clara
cells.
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Chapter 2 Materials and Methods
All materials, glassware and plasticware used throughout this project were sterile to
prevent contamination or degradation of nucleic acid or proteins. Gloves were worn
at all times. All procedures involving culturing were carried out using aseptic
techniques. Before working with animals the author had to undergo training for
small animal handling as required by the Scientific Procedures Act 1986. A
cetificate was issued by ScotPil Training Committie in 1999, certificate number
SCT-E99016. Since this work involved the use of transgenic animals, the auther
had to undergo a Genetic Modification Traning couse organised by the Health and
Safety Department, Univerisity of Edinburgh. All the procedures were assessed and
appropriate COSSH forms signed.
Receipts ofbuffers and solutions that form part ofkits are given in the text. Receipes
for buffers and solutions that do notform part of kits are given in Appendix 1. Names
of manufacturers are given in brackets. Full postal address of suppliers is given in
Appendix 2.
2.1 Primary Clara cell culture
2.1.1 Isolation and culturing of mouse bronchiolar cells.
Clara cells were isolated using a modification of methods described previously.
(Belinksy et al., 1995; Van Scott et al., 1987; Masek and Richards, 1990; Richards et
al., 1990; Oreffo et al., 1990). The procedure used here has been previously reported
(McBride et al., 2000) and differs from that of Masek and Richards, (1990) as
indicated in sections 2.1.2, 2.1.3 and 2.1.4. The procedure used to isolated Clara cells
from p21 ko mice was the same used for wt mice. Summary of the isolation
procedure is given in Figure 2.1.
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Figure 2.1 - Clara cell isolation procedure.
A. Mice were sacrificed and dissected. Cannula was inserted inside the
trachea
B. Lungs were perfused by inflating the lungs with air through the cannula
and by introducing sterile saline into the right ventricle of the heart
C. Lungs were removed from the animal and trypsin was instilled into the
lung. Lungs were incubated at 37°C for 15 minutes and chopped with scissors.
D. Cell suspension was filtered through 150 p and 30p nylon filters, washed
with DNase I solution and centrifuged at low speed (32g).
E. Cells were transferred to a sterile petri-dish and incubated for 2 hours at
37°C. Macrophages and fibroblasts were removed by differential attachment.
F. Clara cells were collected by centrifugation, culture medium was added
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2.1.2 Dissection and lung perfusion.
Mice (C3H/HE strain or p21 ko mice either male or female, between 4 to 8 weeks
old) were sacrificed by lethal intraperitoneal injection of 0.5ml pentabarbitone
(Sagatal™). In this thesis about 3000 mice were used, approximately 1000 of which
were p21 ko mice (section 2.4.1). The ventral surface skin was removed and a
midline incision was made to allow entry into the peritoneal cavity. The
gastrointestinal tract was displaced to the right and the major dorsal blood vessels
cut. The position of the trachea was located, and a cannula (1mm Luer cannula,
CAN1004, Scientific Lab. Supplies) was inserted from a partial cut at the top of the
trachea. The diaphragm was carefully opened by a small incision just below the
xiphisternum following by widened this cut in both directions. The rib cage was
removed and care was taken not to puncture the lungs. A portion of the thymus was
removed for easier access to the vessels around the heart.
The lower region of the heart was gripped with a haemostat, and a cannula (1.7mm
Luer cannula, CAN1008, Scientific Lab. Supplies) was inserted into the pulmonary
artery through an incision in the pericardium. Sterile saline (0.15M NaCl) was
gravity fed through the cannula, causing an increase in size of the left atrium. An
incision was made in the left atrium to allow fluid exit. Lungs were artificially
ventilated with a 1.0ml syringe of air. After 3 ventilations, the lungs were totally
free of blood and appeared completely white. The heart was detached and discarded.
2.1.3 Lung digestion.
A syringe containing preheated trypsin at 37°C was attached to the cannula and
trypsin (T8003, Sigma) was intratracheally instilled. The lungs were detached at the
bottom by cutting the oesophagus, the posterior vena cave and any strands of tissue
holding them to the diaphragm and then the whole preparation was turned around so
as to work from the top of the trachea. The lung was freed and removed intact from
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the cavity. The lung was cleaned from any remains of oesophagus and any other
debris. The lung was transferred into a vial containing preheated PBS at 37°C and
incubated for 15 minutes at 37°C.
2.1.4 Cell isolation and purification.
From the point onwards the isolation was carried out in a sterile laminar flow tissue
culture hood (Class II) using aseptic techniques and sterile solutions. Digested lungs
from 8 mice were place in a sterile plastic petri dish and chopped with sterile scissors
to small pieces of about 1mm. Foetal bovine serum (2mls/lungs) was added to the
minced lungs to inhibit further trypsin activity. The minced lungs were transferred to
a 50ml centrifuge tube and DNase I solution (3 mis/lungs) was added. Treatment the
DNase I reduce viscosity. The mixture was hand-shaken for 4 minutes. The
suspension was filtered through 150 p and 30 p nylon filters and topped-up to 50ml
with DNase 2 solution. The tube was centrifuged at low speed 32g at 10°C for 6
minutes in order to obtain functionally active Clara cells. The supernatant was
removed and 50 ml of DNase 2 solution was added to the pellet at the bottom of the
tube. The tube was hand-shaken for 1 minute and centrifuged at 32g at 10°C for 6
minutes.
The supernatant was removed and 10 ml medium (1:1 M199/HamF12, 1%
glutamine, 1% streptomycin) was added and hand-shaken for 1 minute. At this point
the isolation consists predominantly of bronchiolar cells, macrophages and
fibroblasts. The latter two cell types have an increased capacity for adherence than
epithelial bronchiolar cells. The suspension was transferred to a sterile non-tissue
culture petri-dish and incubated at 37°C for 2 hours at 5%CC>2/air to allow
differential attachment.
The suspension was transferred to a 50 ml centrifuge tube and centrifuged at lOOg
for 5 minutes at 10°C. The supernatant was removed and appropriate culture
medium (section 2.1.6) was added to an approximately 1 x 104 clumps/ml. 50pl
aliquots were taken for an approximate cell count.
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2.1.5 Cell culture
Cells were counted using a haemocytometer. However, this apparatus if designed
primarily for quantification of single cell suspension. Isolated Clara cells are usually
in clumps and with typical 'bunch of grapes' morphology. Thus for cell estimation,
the number of clumps and individual cells were recorded and an estimate made of
total cell number.
Once isolated, cells were either cytospun onto glass slides (time 0 hours) at 100 g for
6 minutes and then fixed with methanol at -20°C or plated onto 16-well glass
chamber slides (Gibco) which had been pre-coated with appropriate ECM (section
2.1.7) and incubated at 37°C, 5% C02/air. Cells were allowed to attach overnight
after which the medium was replaced to remove dead and unattached cells. Medium
was subsequently replaced every 2 days. Cells were fixed at time 24, 72 and 120
hours by methanol at -20°C.
2.1.6 Culture medium.
Mouse bronchiolar cells were cultured in a 1:1 mixture of Hams F12 (Gibco) and M-
199 medium (Gibco). The medium was supplemented with 2 mM L-glutamine, 10
p,g/ml insulin, 5 p,g/ml transferrin, 100 ng/ml hydrocortisone, 10 ng/ml EGF, 0.1
ng/ml retinyl acetate and Pen/Strep. (Belinksy et al., 1995; Van Winkle et al., 1996a;
Richards et ah, 1990; Oreffo et ah, 1990; McBride et ah, 2000).
2.1.7 Extracellular matrix (ECM) coated chamber slides.
16-well chamber slides (wells having 6mm diameter) (Gibco) were coated with 50pg
of ECM overnight at 4°C. The next morning the chamber slides were washed with
sterile PBS and stored and -20°C. Three different types of ECM components were
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used in this study: fibronectin (Fn) (Sigma), collagen IV (Coll IV) (Sigma) and
laminin (Lam) (Sigma). Fibronectin was used for the basal culture conditions of all





Lam/Fn/Coll IV 50pg/ml of each added simultaneously
Coll IV/Fn 50pg/ml of each added simultaneously
Coll IV/Lam 50pg/ml of each added simultaneously




Table 2.1 - Different ECMs combinations and the concentrations upon
which Clara cells were cultured.
2.2 Cell Biology
2.2.1 Tissue Sections
Lung tissues were fixed in buffered formalin for 16 hours and then processed to
paraffin wax in vacuum impregnating processor. Paraffin emebedded sections were
cut on a microtone to a thickness of 3 pm.
2.2.1.1 De-waxing and re-hydration of slides
Paraffin tissue sections were place in xylene for 15 minutes. The sections were then
transferred in a series of alcohol gradients from 100% to 74% to 64% and then tap
water for 10 minutes each.
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2.2.1.2 Antigen Retrieval
2.2.1.2.1 Trypsin antigen retrieval
A glass slide container was pre-warmed in 37°C incubator. Trypsin solution (lOOmg
trypsin, 100 mg calcium chloride, 100 ml H20, adjusted to pH 7.6 using 0.2 M Tris)
was pre-warmed for 5-10 minutes in a 37°C in a water bath. Slides that were de-
waxed and rehydrated (as described above) were placed in glass slide container
containing the pre-warmed trypsin for 30 minutes at 37°C. Then slides were rinsed
with H20 and equilibrated in TBS.
2.2.1.2.2 Microwave antigen retrieval
DAKO antigen retrieval solution was prepared by dilution 1:100 with distilled water.
A microwave dish was filled up with antigen retrieval solution and pre-heated in a
microwave to boiling point. Slides that were de-waxed and rehydrated (as described
above) were placed in a plastic slide rack and placed in a microwave dish containing
the pre-heated antigen retrieval solution, and were microwaved three times for 5
minutes each. The slides were allowed to cool for 30 minutes and then were rinsed
with H20 and equilibrated in TBS.
2.2.2 Immunohisto/cytochemistry studies.
Slides were equilibrated in TBS for 5 minutes. The slides were blocked with an
appropriate serum in which the secondary antibody had been raised. Primary
antibody at a concentration specified in the table 2.2 was applied for 2 hours,
followed by three 5 minute washes with TBST. Secondary antibody was put on for
30 minutes then washed three times for 5 minutes each with TBST and then
visualised using the ABC kit. For immunofluorescence a secondary antibody
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conjugated to an Alexa™ dye was used as described below. A negative control was
carried out by using TBS instead of the primary antibody.
2.2.2.1 ABC vector red.
ABC was prepared by incubation 5ml of PBA with one drop of reagent A (avidin)
and with one drop of reagent B (biotin). After the incubation with the secondary
antibody 2 drops of ABC-AP reagent were incubated for 30 minutes. The slides
were washed three times for 5 min. each with TBST. Two drops of the vector red
stain (2.5ml 100mm Tris.HCl (pH 8.2) + 1 drop A + 1 drop B + 1 drop AP + 25 pi
levamisole) were put on the slide and incubated for about 10-20 minutes until colour
developed. The slides was washed with water and counterstained with haematoxylin.
The slides were mounted using DAKO aqueous mounting medium.
2.2.2.2 Alexa™ dyes
After the primary antibodies the slides were washed three times of 5 minutes each
with TBST. An Alexa™ conjugated secondary antibody (diluted 1:200 in serum)
was put on the slide and incubated for 3 minutes. The slides were then washed three
times for 5 minutes each and mounted using DAKO fluorescent mounting medium.
The slides were then visualised using either a ultra-violet (UV) microscope or
confocal microscope.
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Antibody against Concentration Supplier Catalogue number
CC10 1/1000 Gift1
p21 1/10 DAKO M7207
p53 1/100 Vector Lab NCL-p53-CM5p
PCNA 1/5000 SIGMA P8825
EGFR 1/10 DAKO M0886
cytokeratin 8 1/10 ICN 10526
cytokeratin 18 1/10 ICN 10500
cytokeratin 19 1/10 ICN 11417
0C5- integrin 1/10 Gift2
av- integrin 1/10 Gift2
oc<5- integrin 1/10 Gift2
(3i - integrin 1/10 Gift2
P3 - integrin 1/10 Gift2
P4 - integrin 1/100 CHEMICON AB1922
p27 1/200 SIGMA P2092
Gift1 - Prof. Gurmukh Singh, Dept. Veterans Affairs Medical Centre,
Pittsburgh, Pennsylvania
Gift2 - Prof. Hideo Yagita, Department of Immunology, Juntendo University
School of Medicine, Tokyo, Japan
Table 2.2 - Details of the primary antibody used for immuno-
cyto/histochemistry and their relative concentrations.
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2.2.3 Bromodeoxyllridine (BrdU) incorporation.
Cultured Clara cells were exposed to medium containing lOpM BrdU for 6 hours,
after which they were fixed using 80% ethanol at 4°C overnight. After fixation cells
were rinsed in PBS for 10 minutes and incubated in 5M HC1 for 45 minutes at room
temperature. Cells were then washed four times in PBS for 5 minutes each and
incubated in 1% H2O2 for 10 minutes. Cells were washed twice in PBS for 5 minutes
and incubated in blocking solution (PBS + 20% rabbit serum + 0.05% Tween) for 10
minutes. The slides was drained and incubated in rat anti-BrdU antibody (Boehringer
Mannheim) diluted 1:10 in blocking solution for 60 minutes. The slide was then
washed three times in PBS for 5 minutes each, and DAB solution (100 pi DAB +
4.8ml 0.05M Tris + 100 pi 1% H2O2) was added for 5 minutes or until the colour
developed. The slides was then rinsed with water and counterstained with
haematoxylin, time according to strength of solution. The slide was mounted using
DAKO aqueous mounting medium. A negative control was carried out by using
TBS instead of the primary antibody.
2.2.4 Lectin studies.
Cytospun cells and plated cells were fixed at appropriate time points in 4% buffered
formalin (pH 7.4) for 30 seconds at room temperature. Biotinylated lectins were
diluted to a final concentration of 20 pg/ml in TBS, pH 7.4, which contained 10 mM
CaCl2, 0.2 mM MgCl2, and 1 mM MnCl2. All incubations were carried out at room
temperature. Cells were incubated with lectin for 20 min., rinsed with TBS and
incubated for 30 min. with ABC-AP. Binding was visualised using Vector Red. As
controls for specificity, lectins were pre-incubated overnight at 4°C with appropriate
hapten sugars before incubation with cells (Table 2.3). Lectin binding was
completely blocked or significantly weakened by hapten treatment.
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Lectin Blocking sugar
Bauhinia purpurea (BPA) N-acetyl glucosamine
Concanavalin A (Con A) D(+) mannose and D(+) glucose
Helix pomatia (HPA) N-acetyl galactosamine
Maclura pomifera (MPA) D(+)-galactose
Wheat germ (WGA) N-acetyl glucosamine
Table 2.3 - List of the lectins used and their relative blocking sugars.
(Zieske and Bernstein, 1982; Dobbs et ah, 1985; Honda et ah, 1989; Geleff et ah,
1986)
2.2.5 Nitrotetrazolium blue assay.
The nitrotetrazolium blue (NBT) solution consisted of 100 pi of NBT stock solution
(Boehringer Mannheim) in 10 ml staining buffer (10ml 0.1M Tris buffer, pH 9.5;
0.05M MgCl2, 0.1M NaCl) with 0.1% NADPH (lOmg in 10ml) (Boehringer
Mannheim). Cells were fixed in formalin as above and incubated with the NBT
solution for 10 min. at 37°C. Positive cells stained purple.
2.2.6 Feulgen staining
After the culturing cells were fixed in Bouin's fixative overnight at 4°C, the slides
were incubated in denaturing solution (5M HC1) for 45 minutes at room temperature.
Slides were washed for about 15 minutes using tap water and then incubated in
Schiffs reagent for 1 hour at room temperature and then washed in tap water until
pink colour developed. Slides were counterstained in 0.1% Light Green and
mounted in Cedarwood oil and stored at 4°C in the dark.
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2.2.7 Electron Microscopy
Cells were harvested by trypsinisation and washed by centrifugation and
resuspension 3 times in PBS. The pellets were then resuspended gently in a 10%
glutaraldehyde/PBS solution (v/v) and stored overnight at 4°C. The cells were then
centrifuged again (500 g, 5 minutes) and were postfixed in osmium tetroxide,
processed to Araldite, sectioned at 0.25pm, and stained with uranyl acetate. Analysis
of the sections was carried out in collaboration with Dr. Tim Smith, University of
Leicester, England.
2.2.8 Cell counting
In immunocyto/histochemistry a whole range of variation in the degree of staining
was observed. Thus, strongly stained cells, cytoplasm or nuclei (as the case may be)
were considered as positive staining, while negatively or weakly stained cells were
considered as negative. Experiments and counts were repeated at least three times
and standard deviation was calculated using Microsoft Excel. Counts of 500 cells
were sufficient to achieve a stable running mean.
2.3 Western Blot
2.3.1 Isolation of total protein extracts.
Freshly isolated cells were centrifuged at 500 g for 5 minutes and supernatant
removed. The cells were washed three times with 1ml cold PBS and were then lysed
using RIPA buffer containing a cocktail of proteinase inhibitors for 30 minutes at
4°"C. The cell lysate was scraped from the culture well using a yellow tip and
transferred to a clean, cold microfuge tube. 100 pi of RIPA buffer was used to lyse
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about 1 x 106 cells. The lysate was then centrifuged at 15,000 g for 10 minutes at
4°C. The supernatant was removed and stored at -80°C.
2.3.2 Isolation of cytoplasmic and nuclear protein
extracts.
Freshly isolated cells were centrifuged at 500 g for 5 minutes and supernatant
removed. Cells were washed three times with 1ml of cold PBS. lOOpl of
cytoplasmic lysis buffer was added to about 1 x 106 cells, vortexed and incubated on
ice for 10 minutes. In the case of cultured cells, the same procedure was followed
but the washing with ice cold PBS and lysing with cytoplasmic lysis buffer was
carried out in the chamber slides containing the cells. The lysate was centrifuged at
6000 g for 10 min. at 4°C and the cytoplasmic extract (supernatant) was removed and
stored at -80°C. 100p.l of nuclear lysis buffer was added to the remaining cell extract
and incubated on ice for 10 minutes. The lysate was centrifuged at 15,000 g for 10
minute at 4°C. The nuclear extract (supernatant) was removed and stored at -80°C.
2.3.3 Immunoprecipitation
IMMUNOcatcher kit (CytoSignal) was used for immunoprecipitation. The sample
was divided into equally sized aliquots and place in a microfuge tube. The volume
was adjusted to 180pl with lysis buffer. 10pl of primary antiserum directed against
the target protein (Table 2.4) was added and incubated for 1 hour at room
temperature. 10pl of the protein A/G resin suspension was added and mixed for 30
minutes at room temperature.
Spin filters were pre-coated by filling them with lysis solution for 5 minutes and
centrifuged at 14,000 g for 1 minute. The suspension was transferred to pre-coated
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spin filters and the microcentrifuge tube was rinsed with 200pJ of lysis solution to
dislodge any resin sticking to the wall of the tube. The contents were transferred to
the spin filter and centrifuged at 14,000 g for 1 minute. The flow-through was
discarded and 0.5ml of lysis solution was added to the spin filter and centrifuged at
14,000 g for 1 minute. This was repeated twice.
The spin filter was placed in a clean collection tube and 40|al of SDS-PAGE solution
was added to the spin filter and incubated for 15 minutes at room temperature. Care
was taken to completely cover the resin with the solution. The protein was collected
by centrifugation at 14,000 g for 1 minute and stored at -80°C.
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Antibody against Final Concentration Supplier Catalogue number
p21 (C-terminal) 1/10 Santa Cruz sc-397
p21 (full length) 1/10 Santa Cruz sc-6246
PCNA 1/10 Sigma P8825
cdk2 1/10 Sigma C5223
cdk4 1/10 Sigma C8218
cdk6 1/10 Sigma C4976
Cyclin D3 1/10 Sigma C7214
Cyclin E 1/10 Sigma P2092
Table 2.4 - Details of the antibodies used for immunoprecipitation and
the concentrations at which they were used.
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2.3.4 Western Blotting
Proteins for western blot analysis were separated by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE). SDS-polyacrylamide gel electrophoresis was carried
out on precast gels in an XCell II™ tank (Novex) in accordance with manufacturer's
instructions. The appropriate protein sample was boiled for 3 minutes and loaded
onto a 14% Tris-Glycine precast gel (Novex). Electrophoresis was carried out in
running buffer (Appendix 1) at a constant voltage of 125V for about 2.5 hours or
until the bromophenol blue dye front reached the bottom of the gel.
Proteins were then transferred onto Hybond™ECL™ nitrocellulose membrane
(Amersham) using a Trans-Blot Semi-Dry electrophoresis transfer cell (BioRad) in
accordance to manufacturer's instructions. The transfer was carried out in Towbin
transfer buffer (Appendix 1) at constant voltage of 15 volts for about 30 minutes.
The nitrocellulose membrane was then removed and washed twice for 10 minutes
each in TBST. The membrane was incubated in 10% blocking solution in TBST for 1
hour at room temperature, to prevent non-specific binding. All incubations steps
from now on, including the blocking step, were carried out on a revolving apparatus
to ensure even exposure of the membrane to all reagents. After blocking, the
membrane was briefly rinsed twice with TBST and then washed once for 15 minutes
followed by two washes for 5 minutes each. The membrane was incubated in 1/200
diluted primary antibody (Table 2.5) overnight at 4°C. The membrane was then
washed (as described above) and incubated in 1/2000 diluted HRP secondary
antibody (Table 2.6) for 1 hour. Membrane was then washed once for 15 minutes
and then 4 times for 5 minutes each with TBST.
Chemiluminescence detection was carried out using ECL™ Western Blotting
detection reagents (Amersham Pharmacia Biotech). The blot was exposed to
ECM™ film (Amersham Pharmacia Biotech) and was developed in a
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Hyperprocessor developer (Amersham Pharmacia Biotech) in accordance with
manufacturer's instructions.
Antibody against Dilution Supplier Catalogue number
p21 (C-terminal) 1/200 Santa Cruz sc-397
p21 (full length) 1/200 Santa Cruz sc-6246
Table 2.5 - Details of the primary antibodies used for western blotting and
their concentrations
Antibody against Dilution Supplier Catalogue number
anti-rabbit IgG-HRP 1/2000 Santa Cruz sc-2004
anti-mouse IgG-HRP 1/2000 Santa Cruz sc-2005
Table 2.6 - Details of the secondary antibodies used for western blotting and
their concentrations
2.4 Genotyping of transgenic animals.
2.4.1 Transgenic animals
p21 knockout mice were used in this thesis. p21 knockout mice were obtained from
Prof. Philip Leder, Harvard Medical School, Boston, Massachusetts, USA (Deng et
ah, 1995) Before using the animals the mice were genotyped. DNA was extracted
from tail tips and a PCR reaction was carried out.
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2.4.2 PCR Reaction.
PCR strategies were accomplished using RedTaq™ DNA polymerase (Sigma) and
accompanying reaction buffer. Magnesium chloride (llmM) and potassium chloride
(500mM) were included in RedTaq™ buffer at lOx stock concentrations. Pharmacia
Biotech supplied all deoxyribonucleoside-triphosphates (dNTPs). PCR reactions
were accomplished in a thermocycler (Hybaid) and the PCR products were analysed
on 2% agarose gel. Conditions for PCR are summarised in Table 2.6 and 2.7
Genotype Primer sequences








Table 2.7 - PCR primers used to genotype the wt and p21 ko mice as
described in (Deng et al., 1995).
Genotype Melting Annealing Extension No of cycles
p21 wt 94°C, 60 sec 58°C, 60 sec 72°C, 60 sec 30
p21 ko 94°C, 60 sec 58°C, 60 sec 72°C, 60 sec 30
Table 2.8 - PCR thermal profile used to genotype the wt and p21 ko
mice as described in (Deng et al., 1995).
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2.4.3 Detection of PCR products.
A 2% agarose gel was prepared in TAE buffer and melted in a microwave oven. The
agarose solution was allowed to cool to about 50°C and 0.003% of a lOmg/ml
ethidium bromide solution was added to the gel. The agarose solution was then
poured in a horizontal Submarine Agarose Unit and combs were placed in the gel to
form wells. The gel was allowed to set for about 30 minutes after which the combs
were carefully removed and the gel placed in the electrophoresis tank in TAE buffer.
PCR products were prepared by adding 10 pi of samples to 2 pi of 6 x loading buffer
in a microtitration plate. 10 - 20 pi of the samples were run on the gel at 100V for
about 1 hour. The gel was removed from the apparatus and visualised on a UV trans-
illuminator.
2.5 Statistical Analysis.
Statistical analysis was carried out using Microsoft Minitab software. The general
linear model test (ANOVA) with Bonferoni corrections for multiple tests, was used
to find out significant changes in cell behaviour upon cell-matrix disruption and to
find out differences in Clara cells from wt and p21 ko mice. Experiments and counts
were repeated at least three times. For all tests a p value less than 0.05 was
considered significant.
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Chapter 3 - Regulation of cell cycle control in
mouse models of tuberculosis, asthma and
bleomycin-induced fibrosis.
3.1 Introduction.
About 20% of the population worldwide die of lung related diseases, 17% of which
are due to infections. Asthma and tuberculosis are common diseases in humans. TB
is responsible for approximately 3 million deaths per year worldwide, pulmonary
fibrosis affect about 100,000 people in the United States, while asthma is to blame
for 200,000 deaths per year worldwide.
Various animal models have been used to study the pathogenesis of lung disease but
to date few studies have looked at changed in expression of cell cycle control genes
in these conditions. The p53 pathway was found to be involved upon exposure of
lung epithelial cells to either hyperoxia (O'Reilly et. al, 1998; Barazzone et al., 1998;
McGrath 1998), or to a number of DNA damaging agents and carcinogens (Fujishita
et al., 1995; Guinee et al., 1996; Gadbois and Lehnert, 1997; Corroyer et al., 1996).
The expression of pl6 (Sabourin et al., 1998), p21 (Guinee et al., 1996, McGrath,
1998), Rb (Sabourin et al., 1998; Fujishita et al., 1995), c-jun (Dolan et al., 1994;
Flaase et al., 1997), c-Fos (Haase et al., 1997), TNF-a (Lee and Rannels, 1998; Yao
et al., 1998) , TGF-P (Lee et al., 1998), BAX (Guinee et al., 1997) and Bcl-2 (Guinee
et al., 1997) were reported to be influenced by a number of DNA damaging agents
and pollutants but the exact mechanism is still unclear.
The aim of this chapter is to study the variation in the expression of p21, p53, p27
and PCNA in three common human diseases namely Mycobacterium tuberculosis
infections, OVA sensitised lungs and Bleomycin-induced fibrosis using animal
mouse models and try to find out what is happening in terms of cell cycle control in
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each disease. Studying the cell cycle control in these diseases may help in the
understanding the cellular and molecular pathology of the diseases and hopefully
would lead to better and more effective diagnosis and treatment.
3.2 Tuberculosis
Mycobacterium tuberculosis is responsible for approximately 3 million deaths per
year worldwide (Bloom and Murray, 1992). The bacterium is mainly transmitted
through the respiratory route and causes tuberculosis infection in 10-15% of infected
persons (Caruso et ah, 1999). M. tuberculosis replicates inside the host macrophages
and these activated macrophages are essential to limit the degree of the infection.
Macrophages are usually activated by interferon-y (IFN-y), tumour necrosis factor-a
(TNF-a), c-fos or bacterial products such as lipopolysaccharide (LPS) and
lipoarabinomanna to produce reactive nitrogen intermediates (RNI) which are
involved in killing intracellular mycobacteria. RNI are required in vivo and in vitro
to control M. tuberculosis infections (Roach et ah, 1993; MacMicking et ah, 1997;
Flynn et ah, 1998; Barnes et ah, 1991). Superoxide dismutase catalyses the
conversion of superoxide anion to hydrogen peroxide and contributes to the virulence
of intracellular pathogens. Pathogenic mycobacteria produce 93 times more
superoxide dismutase as compared with non-pathogenic mycobacteria (Edwards et
ah, 2001). It is thought that superoxide dismutase contributes to the pathogenesis of
tuberculosis by preventing the early elimination of M. tuberculosis by innate immune
responses, which include the early mononuclear cell infiltration of infected tissues
and apoptosis (Tobin, 2002).
3.2.1 Mouse model
Mouse tissue sections of Mycobacterium tuberculosis infected lungs were a kind gift
of Prof. JoAnne Flynn, University of Pittsburgh School of Medicine, Pittsburgh,
Pennsylvania, U.S.A. The method for tuberculosis infection is described in (Caruso
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et al., 1999). In brief, specific pathogen-free homozygous C57BL/6 mice, 8-10
weeks old (18-25 g in weight) were infected via the aerosol route with about 75 CFU
of Erdman strain of Mycobacterium tuberculosis. Mice were sacrificed after day 16,
week 4 and week 8.
3.2.2 Histopathology
Initially mice developed focal and non-specific chronic inflammatory infiltrates
consisting largely of macrophages and some lymphocytes with only occasional
plasma cells. At later time points there was an increase in numbers of fibroblasts,
with deposition of collagen. Tissue destruction was minimal and only seen at later
time points. Occasional granulomas were seen although caseation was rare and giant
cells infrequent (Figure 3.1).
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3.2.3 Immunohistochemistry
Although p21, p27, p53 and PCNA were all present in both bronchiolar and alveolar
regions in the lungs of Mycobacterium tuberculosis infected lungs at day 16, week 4
and week 8, no difference in the degree and intensity of staining could be seen
(Figure 3.3 A, B, C, D, E, F, G, H, I, J, K and L). Although PCNA staining was
infrequent in both the bronchiolar and alveolar regions in the disease, PCNA positive
lymphocytes were present (Figure 3.2 G, H and I).
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Figure 3.2 - Immunohistochemistry of Mycobacterium tuberculosis
infected lung tissue sections.
A, B and C - p21 immunohistochemistry using Alexa™ 546 conjugated
secondary antibody, of formalin Fixed lung tissue sections infected at day 16,
week 4 and week 8 respectively. Weak cytoplasmic p21 staining in bronchiolar
epithelium but no difference over time. Absence of p21 nuclear staining in the
bronchiolar epithelium. Magnification xlOO.
D, E and F - p53 immunohistochemistry using Alexa488 conjugated
secondary antibody, of formalin fixed lung tissue sections infected at day 16,
week 4 and week 8 respectively. Absence of p53 nuclear staining in both the
bronchiolar and alveolar regions. Magnification xlOO
G, H and I - PCNA immunohistochemistry using Alexa1M 546
conjugated secondary antibody, of formalin fixed lung tissue sections infected at
day 16, week 4 and week 8 respectively. Overall cell sporadic nuclear staining in
alveolar and bronchiolar epithelium but only increase in inflammatory
infiltrates. Magnification x 100.
J, K and L - p27 immunohistochemistry using AlexaIM 488 conjugated
secondary antibody, of formalin fixed lung tissue sections infected at day 16,
week 4 and week 8 respectively. Overall cell sporadic nuclear staining in
alveolar and bronchiolar epithelium. Magnification x 100.
M - Negative control. Primary antibody was omitted whilst using
Alexa1 NI 546 conjugated secondary antibody. No staining. Magnification x 100.
N - Negative control. Primary antibody was omitted whilst using
Alexa ni 488 conjugated secondary antibody. No staining. Magnification x 100.
94
 
3.3 Ova sensitised lung (Asthma)
Airway inflammation is associated with asthma and is more pronounced with
increasing asthma severity (Tobin, 2001; Bousquet et al., 2000). Apoptosis, a
dynamic process involved in repair and tissue remodelling tends to limit
inflammatory tissue injury and promote resolution rather than progression of
inflammation (Druilhe et al., 1998). A significantly higher number of non-apoptotic
airway eosinophils and macrophages in subjects with asthma compared with patients
with chronic bronchitis has been found. This suggests that these cells can survive
longer in the airways of asthmatic subjects (Vignola et al., 2001; Tobin, 2001; Ellia,
2000; Druilhe et al., 1998; Bousquet et al., 2000). The mechanism leading to
persistent accumulation of inflammatory cells is not fully understood. It is also
unclear whether asthmatics have a primary genetic deregulation of apoptosis
pathways or if the reduced apoptosis is a secondary phenomenon in the context of a
variety of topically released pro-inflammatory and pro-survival cytokines (Tobin,
2001; Ellia, 2000; Bousquet et al., 2000).
Many different pathways are involved in apoptosis, the main ones being signalling
through death receptors such as FAS, TNFR1, the p53 pathway, the Bcl-2 family and
the caspases (Wyllie et al., 1994; Wyllie et al., 1998; Wyllie, 1987; Haake and
Polakowska, 1993; Guo and Hay, 1999; Gervais et al., 2000; Fleck et al., 1998;
Dowen, 1993; Clarke et al., 1995; Bulavin et al., 1999; Brutsche et al., 2001; Druilhe
et al., 1998; Bellamy et al., 1995). These complex pathways can lead to pro- and
anti-apoptotic effects. Thus a reduction in apoptosis can be due to reduced in the
expression of pro-apoptotic factors or increased in the expression of pro-survival
products.
Clara cell 10-kDa protein (CC10) (also known as CC16) the predominant product
from non-ciliated cells in the epithelial lining, has been shown to have
immunomodulatory and anti-inflammatory activity and play a role in controlling
airway inflammation (Szabo et al., 1998; Singh and Katyal, 1997; Sagal and Nieto,
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1998; Asabe et al., 1998; Hermans et al., 1998b; Hermans et al., 1998a; Broeckaert
and Bernard, 2000). CC10 was found to be lower is asthmatic non-smokers patient
compared to healthy non-smokers. (Shijubo et al., 1999a; Shijubo et al., 1999b;
Laing et al., 2000). A decrease in CClO-positive cells, mainly Clara cells was found
in the epithelial lining of bronchioles in smokers who had a normal pulmonary
function (Shijubo et al., 1999b; Shijubo et ah, 1999a). The decrease in the CC10
production may reflect the remodelling of small airways in asthma (Shijubo et ah,
1999a).
The CC16 gene has been screened for mutations and a polymorphism (A38G) was
identified and associated with an increased risk of asthma (Laing et ah, 2000; Laing
et ah, 1998b; Laing et ah, 1998a).
3.3.1 Mouse model
Mouse tissue sections of OVA sensitised and saline treated lungs were a kind gift of
Prof. Paul Foster, John Curtin School of Medical Research, Canberra, Australia. The
method for OVA sensitisation and saline treatment of lungs is described in (Xiong et
ah, 1999; Mould et ah, 2000). Briefly, mice 8-10 weeks of age were sensitised by
two intraperitoneal injections 50pg OVA in lmg alhydrogel given on day 0 and 12.
Non-sensitised controls received lmg of alhydrogel in normal saline. On day 24,
sensitised mice were exposed to aerosolised OVA (lOmg/ml in normal saline) for 30
minute period at intervals of 30 minutes, and the process was repeated every second
day for 6 days. Non-sensitised mice received aerosolised saline only. Mice were
sacrificed on day 31, 24 hours after the last aerosol.
3.3.2 Histopathology
Inflammatory infiltrates were predominantly peri-bronchiolar. Large numbers of
lymphocytes, macrophages, plasma cells, neutrophils were present and a small
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number of eosinophils and increased mast cells. The inflammatory infiltrate expands
the peri-vascular and peri-bronchiolar connective tissue but there is not definite
fibrosis (Figure 3.3).
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3.3.3 Immunohistochemistry
There was no difference in the degree and intensity of staining of p27 and PCNA
from the OVA-sensitised lung sections compared to the saline-sensitised lung tissue
section (Figure 3.4 C, D, E, F, G and H). There was a change in the p53 and p21
staining in the bronchiolar region. In the negative control (non-disease, saline-
sensitised lung) p53 and p21 are present in the bronchiolar and alveolar regions. In
the OVA-sensitised asthmatic/hyperreactive lung p53 and p21 was not detected in
the bronchiolar region but still present in the alveolar regions (Figure 3.4 A and B).
Thus there seem to be a decrease in the p53 and p21 expression in the bronchiolar
region of the OVA-sensitised asthmatic/hyperreactive lung.
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Figure 3.4 - Immunohistochemistry of OVA sensitised and saline
sensitised mouse lung tissue sections.
A and B - p21 immunohistochemistry using Alexa™1 546 conjugated
secondary antibody of OVA sensitised and saline sensitised formalin fixed lung
tissue sections respectively. No positive nuclear staining in the bronchiolar
region but some staining in the alveolar regions. There is a decrease in the
cytoplasmic staining in the OVA sensitised lungs (A) compared to the saline
sensitised (B). Magnification x 100
C and D - p53 immunohistochemistry using Alexa1*1 488 conjugated
secondary antibody of OVA sensitised and saline sensitised formalin fixed lung
tissue sections respectively. No positive nuclear staining in the alveolar and
bronchiolar epithelial regions. The cytoplasmic expression of p53 decreases in
the OVA sensitised lungs (C) when compared to the saline sensitised (D).
Magnification x 100
E and F - PCNA immunohistochemistry using Alexa™ 546
conjugated secondary antibody of OVA sensitised and saline sensitised formalin
fixed lung tissue sections respectively. Nuclear and cytoplasmic staining present
in both alveolar and bronchiolar epithelial regions. No difference in PCNA
expression between the OVA sensitised lungs (E) and saline sensitised (F).
Magnification x 100
G and H - p27 immunohistochemistry using AIexa1M 488 conjugated
secondary antibody of OVA sensitised and saline sensitised formalin fixed lung
tissue sections respectively. Nuclear and cytoplasmic staining present in both
alveolar and bronchiolar epithelial regions. No difference in p27 expression
between the OVA sensitised lungs (G) and saline sensitised (H). Magnification x
100
I and J - Negative controls. Primary antibody was omitted whilst
using AlexallsI 488 and 546 conjugated secondary antibody respectively. No
staining. Magnification x 100.
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3.4 Bleomycin induced fibrosis
Pulmonary interstitial fibrosis is defined as thickening and stiffening of the lining of
the air sacs (alveoli) of the lungs causing progressive breathlessness (Crystal et al.,
1976; Crystal et al., 1978; Crouch, 1990; Cantin et al., 1987).
The pathology of Idiopathic Pulmonary Fibrosis (IPF) also known as Cryptogenic
Fibrosing Alveolitis (CFA) shows an initial alveolitis with persistent accumulation of
inflammatory cells including neutrophils, alveolar macrophages and lymphocytes in
the lower respiratory tract. This is followed by parenchymal cell injury including
extensive destruction of type I alveolar epithelial cells and re-population of the
epithelial cell surface by proliferating type II alveolar epithelial cells, resulting in
alterations in lung extracellular matrix, fibroblast proliferation and enhanced
collagen synthesis with the accumulation of excess connective tissue in the lung
(Crystal et al., 1976; Crystal et al., 1978; Crouch, 1990; Christensen et al., 1999;
Cantin et al., 1987).
3.4.1 Mouse model
Mouse tissue sections of bleomycin-induced fibrosis and saline treated (negative
controls) were a kind gift of Prof. Thomas Strandjord, Department of Pediatrics,
Seattle, USA. The method for bleomycin-induction is described in (Hormuzudi et
al., 1999). In brief, specific pathogen-free homozygous C57BL/6 mice, 8-10 weeks
old (18-25 g in weight) were treated 3.5mU/g bleomycin sulfate in 2.33p.l/g sterile
saline given via transtracheal puncture, under intraperitoneal Avertin anesthesia.
Lungs were harvested at 14 days after instillation after overdose of intraperitoneal
Avertin anesthesia and pulmonary arteries perfused with PBS. The left lung was
fixed by intracheal instillation of 4% paraformaldehyde in PBS at 30cm H20
pressure for 2 hours, then fixed overnight in 4% paraformaldehyde in PBS at 4°C and
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embedded in paraffin. For the bleomycin negative control, the mice were treated
with transtracheal sterile saline alone, 2.33pl/g.
3.4.2 Histopathology
The injury following intratracheal bleomycin-injury tends to be patchy, which
probably reflects where bleomycin droplets go, and variable in intensity. Later the
inflammatory response was fairly intense and widespread (Figure 3.5 A and B). The
saline-treated lung appears completely normal (Figure 3.5 C).
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3.4.3 Immunohistochemistry
There was no difference in the degree and intensity of staining of p53 and PCNA
from the bleomycin-induced fibrosis lung sections compared to the saline-induced
non-fibrotic lung tissue section (Figure 3.6 C, D, E and F). The degree of staining of
p27 seems to be the same in fibrotic tissue compared to the non-fibrotic but the
intensity seems to be higher (Figure 3.6 G and H). It is quite difficult to explain why,
since this could be an experimental artifact or that that actually more cells are
expressing or stabilising more p27 following the bleomycin-injury/disease.
Although no nuclear p21 expression was found, the level of cytoplasmic p2I
expression (both degree and intensity of staining) is higher the bronchiolar and
alveolar regions in the fibrotic lung compared to the non-fibrotic lung tissue sections
(Figure 3.6 A and B).
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Figure 3.6 - Immunohistochemistry of bleomycin-treated and saline-
treated mouse tissue sections.
A and B - p21 immunohistochemistry using Alexa1M 546 conjugated
secondary antibody in bleomycin treated and saline treated formalin fixed lung
tissue sections respectively. Nuclear and cytoplasmic staining present in both
alveolar and bronchiolar epithelial regions. p21 expression is greater in the
fibrotic lung (A) and non-fibrotic lung (B). Magnification x 100.
C and D - p53 immunohistochemistry using Alexa1 N1 488 conjugated
secondary antibody in bleomycin treated and saline treated formalin fixed lung
tissue sections respectively. Cytoplasmic staining present in both alveolar and
bronchiolar epithelial regions in both fibrotic (C) and non-fibrotic lungs (D).
Magnification x 100.
E and F - PCNA immunohistochemistry using Alexa™ 546
conjugated secondary antibody in bleomycin treated and saline treated formalin
fixed lung tissue sections respectively. Nuclear and cytoplasmic staining present
in both alveolar and bronchiolar epithelial regions. No difference between
fibrotic (E) and non-fibrotic (F) lungs. Magnification x 100.
G and H - p27 immunohistochemistry using Alexa1 M 488 conjugated
secondary antibody of bleomycin treated and saline treated formalin fixed lung
tissue sections respectively. Nuclear and cytoplasmic staining present in both
alveolar and epithelial regions. An increase p27 expression in fibrotic (G)
compared to non-fibrotic lungs (H). Magnification x 100
I and J - Negative controls. Primary antibody was omitted whilst
using Alexa11X1 488 and 546 conjugated secondary antibody respectively. No
staining. Magnification x 100.
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3.4.4 Gene expression analysis.
The gene expression studies were carried out in collaboration with Prof. Dean
Sheppard's group, University of California, San Francisco, U.S.A. The method is
described in (Kaminski et al., 2000). Protein distribution was assessed by
immunohistochemistry in Edinburgh and parallel gene array studies in USA. Briefly,
total RNA was isolated from bleomycin-treated mice and saline treated mice 7 or 14
days after treatment. cRNA was prepared and hybridised to GENECFQP array. The
GENECHIP array was then analysed using GENECHIP 3.1 software (Affymetrix).
The gene expression data for p21, p53, PCNA and CC10 is shown in Table 3.1.
From the data it can be seen that p53 and PCNA did not change significantly from
the fibrotic lungs generated by bleomycin treated lungs at day 7 and at day 14
compared to the negative control, saline treated lung. Two CC10 markers have been
used, only one of which gave a significant result in the fibrotic lung at day 7. Thus
no significant conclusion can be obtained from the CC10 results.
An interesting result was obtained regarding p21 expression. The levels of p21
expression in fibrotic lung at 14 days were statistically significant higher (p = 0.05)
when compared to the negative fibrotic lung. This data fits quite well with the
results obtained by immunohistochemistry (Figure 3.7), whereby p21 expression was
found to be higher in the bleomycin injured lungs at day 14 compared to the negative
fibrotic lung. From the immunohistochemistry studies there was no variation in the
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3.5 Discussion
3.5.1 Bleomycin induced fibrosis.
Bleomycin, a potent cancer chemotherapeutic agent, causes fibrogenic lung disease
in rats and mice similar to that seen in human subjects. Bleomycin affects many
cellular pathways, but it is believed that the cytotoxic effect is due to its ability to
bind and cleave DNA bleomycin (Mori et ah, 1989). A number of reports indicate
that bleomycin generates reactive oxygen species in vitro (Yi et ah, 1998; Wu et ah,
1998b; Mori et ah, 1989; Daly et ah, 1998; Daly et ah, 1997).
The p53 tumour suppressor protein is a DNA damage-inducible protein (Zaika et ah,
1999; Wyllie et ah, 1994; Wu et ah, 1998a; Vogelstein et ah, 2000; Sigal and Rotter,
2000; Sheikh et ah, 1997; May and May, 1999; Matlashewshi, 1999; Lane, 1992;
Lakin and Jackson, 1999; Kaelin, 1999a; Kaelin, 1999b; Brambilla and Brambilla,
1997; Ashcroft and Vousden, 1999; Albrechtsen et ah, 1999). Thus one would expect
to find an increase in p53 expression in a bleomycin induced-fibrosis model. In the
bleomycin-induced fibrosis mouse model there was no difference in the degree and
intensity of staining of p53 in the fibrosis (at day 14) and non-fibrotic tissue sections.
In the gene expression analysis no statistically significant changes in the p53
expression was found in fibrotic lungs generated by bleomycin treated lung at day 7
and at day 14 compared to the non-fibrotic lungs. Mishra et ah, 2000, found that
there was an increase p53 immunostaining in the lung cells of bleomycin induced
fibrosis tissue at day 3 and day 7 but a decrease in day 9 and no evidence of p53
expression at day 14.
In this study no differences was found in the immunostaining of PCNA from the
fibrotic (day 14) to non-fibrotic tissue. Also the degree of PCNA expression as
determined by gene expression analysis was the same in fibrotic lungs (at days 7 and
14) and non-fibrotic lungs. This data was similar to the data by (Mishra et ah, 2000).
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From immunostaining of p21, the level of p21 staining was found to be higher in
fibrotic (day 14) tissue compared to non-fibrotic tissue. The level of p21 expression
in fibrotic lungs at day 7 was not statistically higher when compared to the non-
fibrotic lungs. At day 14, the expression of 21 was statistically higher (p = 0.05)
when compared to non-fibrotic lungs. Mishra et al., (2000) found out p21
overexpression at day 5 and day 7 after exposure but most intense p21 nuclear
staining in epithelial cells was at day 9.
The level of mRNA levels of p53 and p21 have been studied in bleomycin induced
fibrosis lungs at 1 hours, 6 hours, 1, 3, 5, 7 and 14 days by Kuwano et al., (1996 and
2000). Kuwano et al., (2000) found out that lung mRNA levels of p53 and p21 were
upregulated at 1 hour to day 7 after bleomycin instillation, while only p21 mRNA,
but not p53 mRNA was detectable at 14 days.
From the above data it appears that following bleomycin induction, an increase in
p21 induction via p53-dependent pathways may be involved. Since p53 were mainly
induced in the early phase, it is likely that p53 may have an important role in the
initial phase of the disease, that is when DNA were mainly damaged by bleomycin
itself but not at a later stage when DNA was damaged by infiltrating inflammatory
cells.
p21 is most probably playing an important role in the p53-induced G1 arrest because
it is a potential inhibitor of cyclin-dependent kinase activity (Wu et al., 1998a;
Tomoda et al., 1999; Sheikh et al., 1997; Rousseau et al., 1999; Haapajarvi et al.,
1999; Cheng et al., 1999). It has been shown previously that serum or individual
growth factors such a platelet-derived growth factor, fibroblast growth factor and
epidermal growth factor but not insulin are able to induce p21 in quiescent p53-
deficient cells as well as normal cells (Michieli et al., 1994). Thus the induction of
p21 without up-regulation of p53 mRNA at 14 days after bleomycin-induction may
be dependent on growth factors, such as platelet-derived growth factor and fibroblast
growth factor.
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Apart from direct DNA damage from bleomycin and subsequent cell death, fibrosis
could have resulted from inflammatory cell recruitment, fibroblast proliferation or
collagen synthesis. Inflammatory cells, including neutrophils and monocytes can
release toxic oxygen reactive species that can damage the DNA (Sato and
Muramatsu, 1985; Sato et al., 1999).
Recent evidence suggests that cell-ECM interaction may be more important in
modulating fibrosis than simply the degree of inflammation (Sheppard, 2001b).
Although many of the normal lung development processes are still unknown, it is
clear an important part of the network of reciprocal inductive and inhibitory signals
involves the mesenchymal cells, pulmonary epithelial cells and components of the
ECM (Ebihara et al., 2000).
Several lines of evidence suggest that TGF-P is involved in the regulation of
pulmonary fibrosis (Coker et al., 1996; Gauldie et al., 2002). TGF-Pl has been
shown to be activated via integrins mainly avp6 (Sheppard, 2001a). The binding
and activation of latent or inactive TGF-P 1 could be a mechanism whereby
pulmonary fibrosis and inflammation could be regulated (Munger et al., 1999). It
has also been shown that P6 integrin expression is associated with sites of neutrophil
influx in lung epithelium (Miller et al., 2001).
Mice that are homozygous for a null mutation of the P6 subunit gene phenotypically
exhibit pronounced lymphocyte accumulation in conducting airways, suggesting that
the avP6 integrin complex may play a role in down-regulating inflammation in the
lung (Huang et al., 1996). P6 knockout mice are protected from development of
TGF-P 1 dependent bleomycin-induced pulmonary fibrosis, yet leukocyte recruitment
into the lung after treatment with bleomycin was not inhibited (Munger et al., 1999).
This further suggests the important role of avP6 during inflammatory events in the
airways.
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From immunostaining, the degree of p27 staining was found to be the same but the
intensity seems to be higher in fibrotic (day 14) tissue compared to non-fibrotic
tissue. The increase in the degree of p27 staining could be either due to probable
increase in TGF-(3 or due to changes in cell-cell interactions (Slingerland and
Pagano, 2000; Lloyd et al., 1999). It is quite difficult to make any conclusion about
p27 since the effects of TGF-(3, rapamycin, and contact inhibition on cell
proliferation remained unchanged in p27 null mice (Nakayama et ah, 1996).
From the gene expression analysis studies, only one CC10 marker gave a significant
result in fibrotic lung at day 7, but no significant conclusion can be made since only
one of the CC10 was statistically significant. A decrease in the number of Clara cells
evaluated by CC10 mRNA expression in the airway epithelial lining was described at
28 days following bleomycin induction (Daly et ah, 1997). Daly et ah, 1998
suggested that where CC10 mRNA expression was lost and SPB mRNA remained
the same thus the cells could be an intermediate cell type that is a precursor to either
mature Clara cells or ciliated cells.
3.5.2 OVA-sensitised lungs.
There was no difference in the degree and intensity of staining of p27 and PCNA
from the OVA-sensitised lung sections compared to the saline-sensitised lung tissue
section. It was previously reported that PCNA was highly increased in the
epithelium from steroid-treated asthmatics (Vignola et ah, 2001; Druilhe et ah,
1998). It was suggested that steroid could facilitate the process of epithelium
proliferation and survival (Druilhe et ah, 1998).
In the negative control (non-disease, saline-sensitised lung) p53 and p21 are present
in the bronchiolar and alveolar regions while in the OVA-sensitised
asthmatic/hyperreactive lung p53 and p21 seems not to be present in the bronchiolar
region but still present in the alveolar regions. There seems to be a decrease in the
p53 and p21 expression in the bronchiolar region of the OVA-sensitised
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asthmatic/hyperreactive lung. A reduction in the levels of p53, together with an
increased amount of granulocyte-macrophage colony-stimulating factor (GM-CSF)
and Bcl-2 has been described in bronchiolar biopsy (Vignola et al., 1999). An
increase in the expression of p53-neutralising protein MDM2 and a four-fold
reduction of ataxia telangiectasia gene (ATM) had been described (Brutsche et al.,
2001).
A reduction in p53 and p21 expression in asthmatic lung could result in the reduced
induction of apoptosis via the p53 pathway. A role for reduced apoptosis has been
postulated as contributing towards accumulation of inflammatory cells in the lungs of
asthmatics (Vignola et al., 1999; Druilhe et al., 1998; Brutsche et al., 2001).
The immunostaining of p27 was similar in OVA-sensitised lungs as compared to
saline treated lungs. One of the roles of p27 is to promote apoptosis and this could
be another reason for the decrease in apoptosis in asthmatic lungs.
3.5.3 Mycobacterium tuberculosis infected lungs.
Although p21, p27, p53 and PCNA are all present in both bronchiolar and alveolar
regions in the lungs of Mycobacterium tuberculosis infected lung at day 16, week 4
and week 8 no difference in the degree and intensity of staining could be visualised.
Although it is known that in M. tuberculosis reactive nitrogen intermediates (RNI)
(Roach et al., 1993; MacMicking et al., 1997; Flynn et al., 1998; Barnes et al., 1991)
and superoxide dismutase (Edwards et al., 2001) are involved in contributing the
virulence of intracellular pathogens, these do not seen to damage the DNA and thus
the p53 pathways in most probably not involved.
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3.5.4 Conclusions.
p21 expression was increased in bleomycin-induced fibrosis, decreased in OVA-
sensitised lungs, a model for asthma and while no changes in the expression of p21
were observed in Mycobacterium tuberculosis infected lungs. p21 expression was
found to increase independent of p53 at 14 days after bleomycin-induction. Thus
other factors such as cell-cell interactions, cell-integrin interactions, changes in ECM
composition and time scale could determine the expression of p21.
Since p21 is known to be involved in cell proliferation, death and differentiation, it is
important to study p21 expression in a progenitor cell type such as Clara cells. p21
was found to be expressed both in the cytoplasm and in the nucleus. From the
literature little is known about the functional role of cytoplasmic p21 thus further
studies need to be carried out to determine its role in lung injury and diseases.
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Chapter 4 - Isolation and Characterisation of Clara
cells.
4.1 Introduction
After a lung injury, epithelial cells are damaged and shed leaving the basement
membrane 'nude'. The normal response to injury is usually a mass transportation of
factors including extracellular matrix (ECM), various growth factors and
inflammatory cells that help regenerate the lost epithelial cells (Persson et al., 1996;
Erjefalt et al., 1997; Erjefalt et al., 1996; Erjefalt and Persson, 1997; Erjefalt et al.,
1995; Rennard, 1999). This regeneration is carried out by stretching of the stem cell
to cover the exposed area, proliferation and differentiation.
Although a number of publications suggest possible mechanisms of lung repair after
an insult or injury, it is still not fully understood. In the mouse, bronchiolar region
Clara cells contribute to a secretion to the extracellular lining fluid and are progenitor
cells for self replication and for ciliated cells. They contain a variety of cytochrome
p450 monooxygenases that have an active role in the metabolism of xenobiotics.
Relatively few studies have been carried out so far to maintain Clara cells in culture
(Van Winkle et al., 1996a; Oreffo et al., 1990; Masek and Richards, 1990; Devereux
and Fouts, 1980; Devereux, 1984; Belinksy et al., 1995). Thus the aim of this chapter
is to:
1. Isolate Clara cells from mouse
2. Culture Clara cells in serum free condition
3. Characterise in vivo and in vitro Clara cells in terms of proliferation,
differentiation, death and cell cycle control regulatory proteins.
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4.2 Clara cell isolation and culturing.
Clara cells have been characterised previously (Belinksy et al., 1995; Devereux,
1984; Devereux and Fouts, 1980; Oreffo et ah, 1990; Masek and Richards, 1990;
Richards et al., 1990; Chinet et al., 1997; McBride et al., 2000). In this study various
modifications of original technique were carried out in order to improve purity and
obtain healthy cells and to standardise the method. Some of these modifications
included the use of plastic and glass slides treated in various ways including
electrical treated plastic chamber slides, glass chamber slides treated with fibronectin
and collagen IV, glass chamber slides treated with fibronectin, and glass chamber
slides treated with collagen IV. The best results were obtained when using glass
chamber slides treated with 50 pg/ml fibronectin. The extracellular matrix (ECM)
should be further studied to improve the cell attachment to the chamber slides and
also to study the effect of the ECM on cell differentiation and proliferation (Sannes
et al., 1996; Dunsmore and Rannels, 1996; Sannes et al., 1998)
From one mouse approximately 250,000 cells were isolated most of which are Clara
cells as determined by CC10 expression (section 4.3), NBT assay (section 4.4) and
electron microscopy (section 4.7). Oreffo et al., (1990) obtained about 550,000 cells
from mice containing about 68% Clara cells. Typical Clara cells at time 0 and 120
hours in culture are shown in figure 4.1.
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A B
Figure 4.1 - Clara cell culture. Freshly isolated Clara cells at
(time 0 hours), most cells are in clumps and are moving around (A). Clara cells
at 120 hours in culture, most cells have attached to the ECM and spread. Some
cells still remain in clumps (B). Magnification of xlOO.
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4.3 Clara cells 10kDa protein (CC10) expression.
CC10 immunoreactivity was demonstrated in the apical membrane regions of
bronchiolar cells in mouse lung tissue (figure 4.2A). Freshly isolated cells (time 0
hours) were strongly positive for CC10 immunoreactivity and remained so at time 72
hours in culture (figure 4.2B). Staining appeared stronger within clumps of cells that
had not spread fully compared with larger, flattened cells. At 120 hours in culture,
CC10 immunoreactivity was slightly reduced (figure 4.2C).
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4.4 Nitrotetrazolium blue (NBT) assay.
Functional Clara cells contain high levels of the enzyme NBT reductase (Devereux
and Fouts, 1980; Oreffo et al., 1990). This can be detected histochemically using an
NBT in which a colourless NBT solution is converted a purple formazan product by
NBT (reductase in the presence of NADPH). Brief fixation with formalin prior to
staining eliminated the low levels of NBT reductase activity present in other cell
types (Oreffo et al., 1990). Following staining, approximately 75% freshly isolated
cells were dark purple in colour, indicating that these were functional Clara cells
(Figure 4.3A). Most positive cells were present within clumps. The number of
NBT-positive cells declined in culture. At day 1 and day 5, approximately 50% and
40% respectively stained purple (Figure 4.3B). Again, most positive cells were




Figure 4.3 - Nitrotetrazolium blue (NBT) assay
A Freshly isolated Clara cells, approximately 75% of cells were NBT
positive, magnification x 200
B Cultured Clara cells at day 5, approximately 40% of cells were NBT
positive, magnification x 200.
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4.5 Lectin characterisation.
Lectins have been used as tools to distinguish between cell types on the basic of their
binding to specific carbohydrates groups, usually at the cell surface (Geleff et ah,
1986; McBride et al., 2000). These lectin binding sites may be involved in
intracellular recognition and binding to yeast, bacteria and other microorganisms to
host cells (Sato and Muramatsu, 1985). The specific nature of these interactions
means that lectins are potentially useful markers for early epithelial changes in lung
diseases as well as markers for in vitro differentiation investigations (Joyce-Brady
and Brody, 1990; Kasper et al., 1994).
The binding activities of 5 lectins (BPA, Bauhinia purpurea - pea; ConA, Canavalia
ensiformis - jack bean; HPA, Helix pomatia - snail; MPA, Maclura pomifera - osage
orange and WGA, Triticum vulgarare - wheat germ, were examined to mouse
bronchiolar cells over 5 days in culture (Table 4.1).
In mouse lung tissue sections BPA, MPA, Con A and WGA reacted strongly with the
apical membrane of bronchiolar Clara. HPA showed no reactivity. Lectin binding
was completely blocked or significantly weakened by control hapten treatment.
Figures 4.4 A and 4.4 D illustrated lectin binding of BPA and MPA in mouse tissue
sections respectively. WGA and MPA bind strongly to the apical membranes of
bronchiolar epithelial cells and also to alveolar epithelial cells. BPA also binds to
apical membranes of bronchiolar cells, but more weakly than WGA and MPA. BPA
was also found to bind to alveolar cells. ConA was found to bind strongly to all
types of cells.
ConA and WGA both showed very strong binding activity to freshly isolated cells,
and all cells were stained. Staining remained strong at 24 hours and 120 hours in
culture, thus there seem to be no variation during cell culture. BPA showed no
reactivity with freshly isolated cells and only few scattered positive cells (less 1%)
were present at 24 hours in culture (Figure 4.4 B). However, at 120 hours in culture,
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30-40% cells bound BPA (Figure 4.4 C). MPA produced moderately strong positive
staining in freshly isolated cells and cultured cells at 24 and 120 hours were all
strongly positive (Figures 4.4 E and 4.4 F). HPA showed no reactivity with isolated
or cultured cells at any stage.
BPA ConA HPA MPA WGA
lung tissue ++ ++++ ++ +++ +++
cells dO 0 ++++ 0 ++ +++
cells d1 ± ++++ 0 +++ +++
cells d5 ++ ++++ 0 +++ +++




± very weak positive
0 no stain
Table 4.1 - Variation of lectin expression (BPA, Bauhinia purpurea -
pea; ConA, Canavalia ensiformis - jack bean; HPA, Helix pomatia - snail; MPA,
Maclura pomifera - osage orange and WGA, Triticum vulgarare - wheat germ) in









Figure 4.4 - Lectin binding studies using ABC Vector Red
detection solution.
A Bauhinia purpurea (BPA) staining, Lung bronchiolar mouse tissue
section, formalin fixed, magnification x400.
B BPA, freshly isolated Clara cells, formalin fixed, magnification x200.
C BPA, cultured Clara cells at day 5, formalin fixed, magnification x200.
D Maclura pomifera MPA staining, Lung bronchiolar mouse tissue section,
formalin fixed, magnification x400.
E MPA, freshly isolated Clara cells, formalin fixed, magnification x200.
F MPA, cultured Clara cells at day 5, formalin fixed, magnification x200.
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4.6 Cytokeratin expression in Clara cell cultures.
Keratin intermediate filaments are among the most differentiation-specific proteins
synthesised in epithelial cells. More than 20 different cellular keratins (known as
cytokeratins to distinguish from the keratins present in nails and hair) have been
identified each of which appears to have a distinctive pattern of synthesis in normal
epithelia (McBride et ah, 1999; Mukhopadhyay and Roth, 1996; Gunning et ah,
1992).
Approximately 90% freshly isolated Clara cells contained keratin 8 and 18, as
detected immunocytochemically indicating their epithelial origin (Figure 4.5). At 24
hours and 120 hours in culture, all cells were keratin-positive suggesting that
contaminating non-epithelial cells such as macrophages or fibroblasts present in
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4.7 Changes in Clara cell ultrastructure upon
culturing.
Electron microscopy (EM) probably remains the definitive method presently
available to characterise a cell type. The organelles contained by a cell can be
determined and localised and stained procedure can be carried out to identify
material contained within a cell. The organelle complement of a cell is specific to
the function of that cell and therefore, EM allows accurate diagnosis of cell type
(Peao et al., 1993; Ten Have-Opbroek et al., 1991).
At time 0 hours in culture, 78% of the observed cells were Clara cells. The other
22% were almost all ciliated cells (n = 107). Clara cells were in good condition,
although there were less granules than would perhaps be expected, and the smooth
endoplasmic reticulum was not as distinct as might be anticipated. The prevalent
feature of these cells was the abundance of mitochondria. A striking abnormal
feature in many of both the Clara and ciliated cells is the presence of large vacuoles
within the cytoplasm (Figure 4.6 A).
At time 24 hours in culture, 80% of the observed cells were Clara cells (n = 104).
Morphologically these Clara cells were indistinguishable from the time 0 hours
samples, the viable cells possessing an abundance of mitochondria but very few
granules (Figure 4.6 B). As at time 0 hours, many of the cells contained a single,
often large vacuole in the cytoplasm. At time 120 hours in culture, 85% of the
observed cells were Clara cells (n = 100). There was little change in the cell purity
and viability from 24 hours in culture perhaps indicating that once the initial increase
in necrosis has occurred, the remaining cells stay viable. The vacuolation was again
evident, but more obviously, both the nucleus and cytoplasm appeared more diffuse
in these cells compared to 24 hours. Furthermore, there also appeared to be a drop in






Figure 4.6 - Ultrastructure of Clara cells
(A) Freshly isolated Clara cells with a ciliated cell, magnification x 10,400.
There was a decrease in the number of mitochondria (M) in Clara cells at 120
hours in culture (C) compared to Clara cells at 24 hours in culture (B). (N) is the
cell nucleus. Magnifications: (B) x 13,900; (C) x 8,400.
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4.8 Proliferation in Clara cell cultures.
Two populations of nuclei have been identified in Clara cell cultures: normal regular
sized nuclei and abnormal larger nuclei (Figure 4.7B). From 24 hours to 120 hours
in culture there seems to be an increase in the total of larger nuclei. From 24 hours to
72 hours in culture there was a decrease in the positive normal nuclei, while an
increase in both the positive and negative larger nuclei. From 72 hours to 120 hours
in culture the number of cells with positive normal nuclei remained the same, the
percentage of cells with positive larger nuclei decreased while the number of cells
with negative larger nuclei decreased (Figure 4.7 A). The total proliferation rate was
about 10 % throughout the culturing period.
The larger nuclei may be the consequence of incomplete or partial cytokinesis in
mitosis, a feature noted in liver cells by time lapse videomicroscopy (S. Prost,
personal communication). This phenomenon is known as endoreduplication and is
defined as an unscheduled round of DNA replication (Bates et ah, 1998; Chang et ah,
2000; Jiang et ah, 2000). p2iWa,1/ClP| can 5e an important factor leading to
endoreduplication. Bates et ah, (1998) have shown that p2iwafl/Cipl can induce both a
G1 arrest and G2 delay, but fails to significantly delay progress through S-phase in
the p53/pRB null osteosarcoma cells line, Saos-2. p2iwafl/c,P1 expression
significantly inhibited all cyclin dependent kinase activity and several of the
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Figure 4.7 - BrdU incorporation in primary Clara cell culture.
BrdU incorporated nuclei are stained brown, cells were counterstained with
haematoxylin (blue nuclei). Over the culture period, the BrdU incorporation
counts were relatively constant throughout the culture period (A). (B)
represents a typical normal and larger positive nuclei. Magnification x400.
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4.9 Feulgen staining
Feulgen staining is a method of quantifying DNA content. From the morphology
and size of the nucleus, it is possible to determine whether a cell is in mitosis,
apoptotic or necrotic stage.
Mitosis is an essential phase of the cell cycle, which leads to cell division. In
mammalian cells, mitosis usually takes about an hour. During that period the cell
first builds up and then breaks down a specialised microtubular structure, the mitotic
apparatus, and structure larger than the nucleus that is designated to capture the
chromosomes (prophase), align them (metaphase) and finally separate them and
daughter chromosomes (anaphase) (Elledge, 1996; Grana and Reddy, 1995; Ji et al.,
1997; Murakami and Nurse, 2000; Nurse et al., 1998; Sherr, 1996). Typical mitotic
Clara cells are shown in figures 4.8 C & D.
The morphological changes in apoptosis have been extensively reviewed. In
apoptotic cell, cells shrink in volume, lose contact with their neighbours and lose
specialised surface elements such as microvilli and cell-cell junctions (Bellamy et al.,
1995; Dowen, 1993; Guo and Hay, 1999; Haake and Polakowska, 1993; Kerr et al.,
1972; Vaux et al., 1994; Vitale et al., 1999; Wyllie, 1987; Wyllie et al., 1998; Wyllie
et al., 1994; Yamasaki, 1999). Apoptosis of Clara cells in primary culture is shown
in figure 4.8 B.
Necrotic cells characteristically swell rather than shrink. Plasma membrane damage
leads to a loss of calcium and water balance, which is followed by drop in pH
(acidosis) and osmotic shock. The acidosis, leads to the general condensation of
chromatin, leading to a darkened or 'pyknotic' nucleus. Both the inner and outer
compartments of the mitochondria become distended and dense deposits of matrix
lipoprotein appear. Finally the endoplasmic reticulum and lysosomes swell and burst
(Born et al., 1999; Dwyer-Nield et al., 1998; Kanekal et al., 1990; Kerr, 1971; Sauer
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et al., 1997; Shirakawa et al., 2001). A typical necrotic Clara cell is shown in figure
4.8A.
The mitotic rate of Clara cells throughout culturing from time 24 hours to 120 hours
in culture was about 1%. This means that at any time point, 1% of the cells in
culture undergo mitosis. No significant changes in necrosis or apoptosis rate were













Figure4.8-FeulgenstaiofprimaryCla acellultures.(A)Typic lnecroticlshowingbre kd nofentire nucleusandcytoplasmico tent(arrow);BTypicalap ptoticcellindica inga optoticb y( r w);C&Dmi Claracellstdifferentstagesinlldivision(arrow ).Magnific tionx400Nsignifica tcha gesp p osis,n cr sid mitosiswereobse v dinCla ac lluponcultureti(E). 135
4.10 Integrin characterisation.
Integrins are a family of cell-surface glycoproteins that act as receptors for ECM
proteins, or for membrane-bound counter-receptors on other cells. Integrin-mediated
cell-ECM adhesion sites are complex specialised structures termed focal contact or
focal adhesions (Aplin et ah, 1998). Each integrin is a heterodimer that contains an a
and a (3 subunit with each subunit having a large extracellular domain, a single
membrane-spanning region, and in most cases (other than (34), a short cytoplasmic
domain (Hynes, 1992; Hynes, 2000; Frisch and Ruoslahti, 1997). The integrin
receptor family of vertebrates includes at least 16 distinct a subunits and at least 8 (3
subunits which can associate to form more than 20 distinct integrins (Hynes, 1992;
Liapis and Hutton, 1997; Coraux et al., 1998; Frisch and Ruoslahti, 1997; Ingber,
1991; Mizejewski, 1999; Schwartz, 1997).
The integrins expressed in diverse cell types display different ligand specificities. In
addition, during dynamic and complex processes, such as organ development and
tumour progression and metastasis, the cellular distribution and/or intensity of
expression may change (Giancotti, 1997; Arroyo et ah, 2000; Boudreau and Jones,
1999; Brown, 2000; Coraux et ah, 1998; Dedhar and Hannigan, 1996; Felding-
Habermann et ah, 2001; Frisch and Ruoslahti, 1997; Giancotti, 1997; Hemler, 1998;
Howe et ah, 1998; Hynes, 1992; Ingber, 1991; Legier et ah, 2001; Schwartz, 1997;
Shyy and Chien, 1997).
There are no published reports describing integrin characterisation in mouse lung
tissue and mouse Clara cells. Six integrins were investigated mainly a5, av, Ok, Pi, P3
and p4. Most of the antibodies, mainly as, av, a6, Pi, and p3 were obtained as a gift
from Prof. Hideo Yagita, Department of Immunology, Juntendo University School of
Medicine, Tokyo, Japan while p4 antibody was commercially available from
Chemicon. The Pi antibody obtained from Prof. Yagita, is now commercially
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available from PharMingen (Catalogue No. 553837) and this is a functional (3i
blocking antibody (Burns et al., 2001; Noto et al., 1995).
Various conditions were evaluated in order for the detection to be successful. The
best results were obtained when the microwave antigen retrieval method (section
2.2.1.2.2) was used on methocarn (Appendix 1) fixed tissue sections. The use of
microwave heating on formalin-fixed tissue for integrin detection have not been
successful (Cattoretti et al., 1993), with the exception of a relatively recent report
(Liapis and Hutton, 1997; Gladson et al., 1996). Liapis and Hutton, (1997) were still
unable to detect specific immunoreactivity with several antibodies they used. A
number of alternative buffers (Alsbeh and Battifora, 1995), varying the buffer pH
(Grossfeld et al., 1996), or use of newly developed tissue fixatives (Muller et al.,
1996)have been described. Even though the exact mechanism through which
microwave heating works is still unclear (Shi et al., 1995; Shi et al., 1991), signal
detection for many commonly used antibodies is superior compared to other methods
such as autoclave or water bath (Tani and Phillips, 1995).
ccv, a6, Pi, and P4 were all present in both mouse lung tissue sections and in primary
Clara cell culture. The integrin p3 was absent in both mouse lung tissue (figure 4.9)
and primary Clara cell culture (figure 4.10; table 4.2). Although various
modifications were carried out (as explained above), the integrin p3 was still absent.
The absence p3 integrin in mouse lung and Clara cells could be either due to the non-
reactive nature of the antibody or because the integrin p3 was not present. The latter
hypothesis is more plausible since p3 integrin is absent in the human bronchiolar
region (Pilewski et al., 1997).
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alpha 6 alpha 5 alpha v beta 1 beta 3 beta 4
tissue
sections
++ ++++ +++ +++ 0 ++++
24 hours ++ ++++ +++ +++ 0 ++++
72 hours + +++ +++ +++ 0 ++++
120 hours + ++++ +++ +++ 0 ++++




± very weak positive
0 no stain
Table 4.2 - Integrin characterisation
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4.11 Proliferating Cell Nuclear Antigen (PCNA)
expression.
Proliferating cell nuclear antigen (PCNA) is an acidic nuclear non-histone protein
whose rate of synthesis is modulated during the cell cycle. It increases during S-
phase and correlates directly with the proliferative state of normal cells (Bravo and
Celis, 1985; Bravo et al., 1981; Bravo et ah, 1987; Bravo and Macdonald-Bravo,
1987; Bravo and Macdonald-Bravo, 1985; Tanno et al., 1996; Tanno and Taguchi,
1999). PCNA is required for both DNA replication and DNA repair (Li et al., 1995a;
Moriuchi, 1990; Oku et al., 1998; Rossi et al., 1999; Rousseau et al., 1999; Yu et al.,
2001). Although the total cellular level of PCNA is relatively constant through the
cell cycle, it is tightly associated with the nucleus only in S-phase cells and in UV-
irradiated non-S-Phase cells (Bravo and Macdonald-Bravo, 1987; Bravo et al., 1981).
There are three forms of PCNA, the L and H types are found in the nucleus, while
the P and L types are found in the cytoplasm. The L-type (eluted at low
concentrations of KC1 from a phosphocellulose column) and H type (eluted at high
KC1 concentrations) were observed in the nucleoplasm of regenerating livers 24 and
27 hours after surgery. PCNA in the cytoplasm are P type (eluted in the pass through
fraction) and L type. Surprisingly, the total amounts of P type and L type in the
cytoplasm extracts are comparable to those of L type and H type in nucleoplasm.
This data suggests that newly synthesised PCNA is immediately converted into the P
and L complex forms. The P type and some of the L type that lacks a nuclear
localisation signal remain in the cytoplasm, the rest of the L type with nuclear
localisation signal is transferred to into the nucleus (Tanno and Taguchi, 1999).
In the mouse lung bronchiolar region about 10% of the cells were nuclear PCNA
positive while about 40% cytoplasmic PCNA positive (Figure 4.11 A). From 24
hours to 120 hours in culture, a decrease (p < 0.05) in cytoplasmic PCNA while an
increase (p < 0.05) in nuclear PCNA expressions were observed (Figures 4.11 B, C,
D&E).
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4.12 p21 expression.
p21WAFi/cipi 5e]ongs to the Cip/Kip family of CKIs (P21Cipl/Wafl, p27Kipl, p57KIP2)
(Elledge, 1996; Murakami and Nurse, 2000; Nigg, 1995; Nurse et al., 1998). The
functions of p21 are not yet fully understood but it is known that p21 is involved in
cell proliferation, differentiation and death (Sheikh et al., 1997; Cayrol et al., 1998;
Li et al., 1995a; Asada et al., 1999; Bates et al., 1998; Bulavin et al., 1999; Butz et
al., 1998; Cai and Dynlacht, 1998; Clarke et al., 1995; Costanzi-Strauss et al., 1998;
Donato and Perez, 1998; Dotto, 2000; Howe, 2001; Jabbur et al., 2000; Lu et al.,
1998; McKay et al., 1998; Rancourt et al., 2001; Sheikh et al., 1997; Tchou et al.,
1996; Wang et al., 2000; Wang et al., 1999; Wu et al., 1998a; Yamamoto et al.,
1998; Zhang et al., 1999). p21 was shown to promote apoptosis, protect cells from
undergoing apoptosis and inhibits differentiation (Oku et al., 1998; Rousseau et al.,
1999; Asada et al., 1999; Bulavin et al., 1999; Clarke et al., 1995; Donato and Perez,
1998; Gervais et al., 2000; Jiang et al., 2000; Lu et al., 1998; McKay et al., 1998; Wu
etal., 1998a;Zhang et al. 1999).
p21 was also found to be in the cytoplasm and various different form/sizes were
described including 21kDa, 20kDa, 19kDa, 16kDa, 15kDa and 14kDa (Tchou et al.,
1996; Asada et al., 1999; Donato and Perez, 1998; Poon and Hunter, 1998; Orend et
al., 1998; Gervais et al., 2000; Zhang et al., 1999). The functional role of
cytoplasmic p21 is not clear. Asada et al., (1999) showed that cytoplasmic p21
complexes with ASK1 and inhibits apoptosis whereas Zhang et al., (1999) showed
that cytoplasmic p2lWafl/Cipl converts cancer cells from growth arrest to undergo
apoptosis.
In a normal mouse bronchiole, 1-2% of the cells were positive for nuclear p21, but
most of the cells had cytoplasmic staining (Figure 4.12 A & B). No significant
increase in the expression of cytoplasmic and nuclear p21 in Clara cells cultures from
24 hours to 120 hours in culture.
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4.13 p53 expression.
The p53 proteins are potent inhibitor of cell growth, able to arrest the cell cycle at
several points and under some circumstances activate the apoptotic machinery
leading to cell death (Brambilla and Brambilla, 1997; Hupp et al., 2000; Ji et al.,
1997; Jimenez et al., 1999; Kaelin, 1999b; Kamijo et al., 1998; Lakin and Jackson,
1999; Lane, 1992; May and May, 1999; Morgenbesser et al., 1994; Sigal and Rotter,
2000; Stewart et al., 2001; Vaziri and Benchimol, 1999; Vitale et al., 1999; Wyllie et
al., 1994; Yap et al., 1999). Although p53 gene mutation or deletions occur in a
substantial proportion of human cancers, many tumours contain p53 that is
functionally inactivated through other mechanisms. One such mechanism involved
aberrant sub-cellular localisation. Cytoplasmic localisation of wildtype p53 has been
reported in inflammatory breast carcinoma, colorectal adenocarcinoma,
undifferentiated neuroblastoma (Ostermeyer et al., 1996; Moll et al., 1995),
hepatocellular carcinoma and retinoblastoma (Morgenbesser et al., 1994). p53
cytoplasmic sequestration could result from its anchorage to a cytoplasmic tether or
by an imbalance in nuclear-cytoplasmic shuttling (Jimenez et al., 1999). The
functional significance of cytoplasmic p53 is still unclear.
In the mouse bronchiolar region no cells were nuclear positive for p53
immunohistochemistry, but most of the cells had cytoplasmic p53 as determined by
confocal microscopy. No significant changes in the expression of both cytoplasmic
and nuclear p53 were observed in cultured Clara cells (figure 4.13).
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4.14 Epithelial growth factor receptor (EGF-R)
expression.
Growth factors regulate the growth and development of many organs, including
lungs. Most growth factors signal their mitogenic activities through tyrosine kinase
receptors. Epithelial growth factor receptor (EGF-R) is perhaps the best studied
member of this larger receptor family (Miettinen et al., 1997). EGFR consists of a
large cysteine-rich extracellular domain, a single transmembrane segment, and a long
cytoplasmic domain, which contains the 11 subdomains characteristic of kinases
(Schlessinger and Ullrich, 1992; Ullrich et al., 1984). A number of structurally
related ligands including EGF, TGF-a, HB-EGF, amphiregulin, and beta cellulin,
bind to the EGF-R (Miettinen et al., 1997; Ohtsubo et al., 1998; Oksvold et al., 2000;
Sibilia and Wagner, 1995; Skarpen et al., 1998; Taupin et al., 1999; Threadgill et al.,
1995; Wu et al., 1999). Ligand binding leads to receptor dimerisation and
autophosphorylation of the kinase domain, followed by recruitment of cytoplasmic
effector proteins through their SH2 domains to the tyrosine-phosphorylated sites,
initiates signalling cascades which lead to cell proliferation and differentiation
(Schlessinger and Ullrich, 1992).
At high concentrations EGF inhibits growth in A431 cells. Growth suppression at
high concentrations of EGF was demonstrated to correlate with increased expression
of the cyclin-dependent kinase (CDK) inhibitor p21Kipl/Cipl. At growth stimulatory
concentrations of EGF increased levels of p21Kipl/Cipl were not observed (Skarpen et
al., 1998; Haugh et al., 1999). Stimulation of EGF-R was also observed to cause
activation of STAT 1 and STAT 3 and activated STAT 1 has been shown to induce
p21Kipi/Cipi and thereby inhibit proliferation of A431 cells (Grandis et al., 1998;
Coqueret and Gascan, 2000).
Ligand-bound EGF-R is rapidly internalised through receptor-mediated endocytosis
and sorted to multivesicular bodies. The receptor either recirculates to the plasma
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membrane after ligand dissociation or is degraded through the lysosomal pathways
(Oksvold et al., 2000). Ligand-activated and internalised EGF-R appears to be
phosphorylated and adaptor protein-associated, but the importance and function of
endosomal signal transduction is controversial (Oksvold et al., 2000; Skarpen et al.,
1998; Di Guglielmo et al., 1994; Emlet et al., 1997; Futter et al., 1993; Lai et al.,
1989; Nesterov et al., 1994).
In mouse bronchiolar region most of the cells expressed EGF-R on the plasma
membrane but no endocytosed EGF-R staining was visible. EGF-R expression was
higher in unattached cells (freshly isolated Clara cells at time 0 hours) compared to
cultured cells at time 24, 72 and 120 hours. No significant changes in the expression
of EGF-R were observed though the culture period (Figure 4.14).
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4.15 p27Kip1 expression.
The cyclin-dependent kinase (Cdk) inhibitor p27Kipl is an important regulator of the
mammalian cell cycle ((Resnitzky et ah, 1995; Reed et ah, 1994; Sherr, 1996;
Yamamoto et ah, 1998; Lloyd et ah, 1999). p27 negatively regulates G1 progression
by binding to cyclin-Cdk2 complexes and preventing their activity. Both p27 and
p21 form complexes with cyclin-Cdk4/6 and positively regulate the cell cycle
(Yamamoto et ah, 1998; Orend et ah, 1998; Lloyd et ah, 1999; Harvat et ah, 1998;
Cheng et al., 1999).
The activity of p27 depends on its concentration, its distribution among cellular
complexes and its subcellular localisation (Ekholm and Reed, 2000; Slingerland and
Pagano, 2000; Rodier et al., 2001; Ishida et al., 2000). p27 needs to be transported
into the nucleus to have its inhibitory action (Slingerland and Pagano, 2000; Lloyd et
al., 1999; Orend et al., 1998; Tomoda et al., 1999). The regulation of p27 cellular
localisation is poorly understood and the function of cytoplasmic p27 still remains
unknown.
In mouse lung bronchiolar region about 2% of the cells were nuclear p27 positive,
but most of the cells were cytoplasmic p27 positive. The cytoplasmic p27 expression
was lower (p < 0.05) in freshly isolated Clara cells at time 0 compared to cultured
cells at time 24, 72 and 120 hours. No significant changes in the expression of p27
both cytoplasmic and nuclear were observed during the culture period (Figure 4.15).
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4.16 Discussion
4.16.1 Isolation and characterisation of Clara cells.
Clara cells have been successfully isolated and cultured in serum free medium for up
to 120 hours. Most of the cells were healthy looking Clara cells, as determined by
CC10 but some of the cells might have lost their functionality as seen by the decrease
in the NBT assay.
From the lectin binding studies, it can be concluded that when Clara cells were
grown on fibronectin (FN) and cultured in basal condition, cells dedifferentiate. The
lectin binding in unattached freshly isolated cells at time 0 hours was different from
cultured cells. This could be attributed to either cell injury during the digestion or
due to cell-matrix disruption during the isolation. By time 24 hours in culture, cells
seem to have recovered from the minor damage occurred during the isolation.
Most cells were cytokeratin positive which indicates that few non-epithelial cells
were present. This observation was also confirmed by electron microscopy.. From
0 hours to 24 hours in culture there seem to be a slight increase in necrotic cells, this
could be attributed due to cell attachment to the matrix. The number of mitochondria
dropped from 24 hours to 120 hours in culture and there was also an increase in the
number of vacuoles inside the cells. The actual significance of the decrease in the
number of mitochondria is still unclear.
Six integrins were investigated alpha 5, alpha v, alpha 6, beta 1, beta 3 and beta 4.
Alpha 5, alpha v, alpha 6, beta 1 and beta 4 integrins were present in Clara cells both
in tissue sections and cultures. Beta 3 integrin was found to be absent in mouse Clara
cells. Beta 3 integrins have been previously described to be absent in human
bronchiolar epithelium (Damjanovick et al., 1992; Pilewski et al., 1997). During the
culture there seems to be a decrease in alpha 6 from 24 hours to 120 hours in culture.
152
From 24 hours to 72 hours in culture there was a decrease in alpha 5 integrin
expression.
4.16.2 Cell cycle progression in Clara cells.
Two populations of nuclei were observed, normal regular sized and larger nuclei.
Although the proliferation rate as assessed by BrdU incorporation was constant from
24 hours to 120 hours in culture, there seems to be more proliferating cells having
the larger abnormal nuclei rather than normal nuclei. One of the suggestions for this
could be that the cell cycle was stopped at the cytokinesis stage thus the two nuclei
did not separate. One could also hypothesise that p21 is involved since it has been
shown previously that p21 could lead to cell cycle arrest and DNA endoreduplication
(Chang et al., 2000; Bates et al., 1998; Jiang et al., 2000), but further studies need to
be carried out.
The mitotic rate was about 1% throughout the culture period, as determined by
Feulgen staining. The average BrdU incorporation in the Clara cell culture was
about 10% throughout culture period. The proliferation rate in the lung bronchiolar
region of both mammals (Ayers and Jeffery, 1988; Ji et al., 1995) and humans
(Boers et al., 1998; Boers et al, 1999) was estimated to be about 1%.
From 24 hours to 120 hours in culture, there a decrease (p < 0.05) in cytoplasmic
PCNA expression, but an increase (p < 0.05) in nuclear PCNA expression was
observed. PCNA is known to be involved both cell proliferation and repair (Bravo
et al., 1985; Bravo and Celis, 1985; Moriuchi 1990; Hall et al, 1995 Kelman 1997).
Although there was an increase in PCNA at 120 hours in culture, there was no
increase in either BrdU positive nuclei or mitotic index. This finding could be
attributed to a growth arrest at the G1 phase or DNA endoreduplication suggesting
that p21 might be involved. p21 can associate with PCNA, a subunit of DNA
polymerase 8 and can inhibit DNA replication directly, without affecting DNA repair
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(Li et al., 1995a; Cayrol et al., 1998; Oku et al., 1998; Rousseau et al., 1999; Stillman
1996; Funk et al., 1997).
In normal bronchiole only a small number of cells have a positive nuclear staining
for p21 (about 1-2%), but most of the cells have cytoplasmic staining. Similarly,
none of the cells expressed nuclear p53, but most of the cells expressed cytoplasmic
p53. No significant changes in the expression p53 and p21 (both cytoplasmic and
nuclear) were observed in cultured Clara cells.
No significant changes in the apoptotic and necrotic rates were observed during
Clara cell cultures. This could be due the constant expression of both p21 and p53.
The actual role of cytoplasmic p21 is still unclear, but it has been shown that
cytoplasmic p21 is involved in apoptosis (Asada et al., 1999). Further studies have
to be carried out to determine the functional role of cytoplasmic p21 in Clara cells.
EGFR is one of the important receptors by which p21 can be up regulated or
stabilised (Miettinen et al., 1997; Oksvold et al., 2000; Sibilia and Wagner, 1995;
Skarpen et al., 1998; Threadgill et al., 1995; Wu et al., 1999). No significant
changes in the expression of EGF-R were observed in Clara cell cultures, and as
expected the p21 expression was constant through the culture period.
p27 is a CKI which is in the same family as p21. (Harvat et al., 1998; Juan et al.,
1998; Lloyd et al., 1999; Moro et al., 1998; Orend et al., 1998; Resnitzky et al.,
1995; Yamamoto et al., 1998). In normal mouse bronchiolar region and in cultured
Clara cells, p27 was predominantly expressed in the cytoplasm. No significant
nuclear p27 expression was observed upon Clara cell culture. A lower expression of
cytoplasmic p27 (p < 0.05), was observed in unattached freshly isolated cells at time
0, indicating that lack of cell attachment or the disruption of cell-matrix interactions
could lead to changes in the cell cycle regulation. Thus, further studies have to be
carried out to study this hypothesis.
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4.16.3 Conclusion.
Functional Clara cells have been isolated and cultured in serum free medium for up
to 120 hours. Clara cells express alpha 5, alpha v, alpha 6, betal and beta 4
integrins but beta 3 subunit was absent in both tissue sections and cultured cells.
The isolated Clara cells seem to be quite constant throughout the culture period from
24 hours to 120 hours in terms of differentiation, proliferation and death. The
expression of p21, p27 and p53 was constant throughout the culture period.
Disruption of the cell-matrix interaction seems to influence the cell cycle
progression, thus the ECM combinations could influence the cell fate. Further
studies need to be carried out to manipulate the expression of p21 and to understand
why the p21 expression in some diseases was lower while in other disease was
higher.
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Chapter 5 Effect of ECM on Clara cell
proliferation, differentiation and death through p21
regulation.
5.1 Introduction
Extracellular matrix (ECM) is a general term that encompasses components of the
basement membrane and interstitial connective tissue. The extracellular matrix
contains signals that control cell shape, migration, proliferation, differentiation,
morphogenesis and survival (Lukashev and Werb, 1998; Boudreau and Jones, 1999;
Streuli, 1999).
After an injury to the lung epithelial cells, changes in the ECM composition could be
a key regulator in restoring the epithelial barrier otherwise the injury could progress
into a disease (Roskelley et al., 1995; Lukashev and Werb, 1998; Dunsmore and
Rannels, 1996; Chintala and Rao, 1996; Talpale and Keski-Oja, 1997; Boudreau and
Jones, 1999; Streuli, 1999; Ebihara et al., 2000). Cell-matrix interactions or
disruptions affect the cell cycle regulation in various ways. A number of studies
have shown that by the disruption of cell-matrix interactions, regulated cell cycle
progression and influences the expression of a number of cell cycle regulatory
proteins such as p21, p27 and p53 (Guadagno et al., 1993; Assoian, 1997; Schwartz
and Assoian, 2001; Bao et al., 2002; Ilic et al., 1998; Nagaki et al., 2000; Wu and
Schonthal, 1997). Other studies have shown that cell-matrix disruption could lead to
apoptosis (Ruoslahti and Reed, 1994; McGill et al., 1997; Frisch and Francis, 1994;
Bourdoulous et al., 1998; Kettritz et al., 1999; Sethi et al., 1999; Day et al., 1997).
The main hypothesis of this chapter is that cell-matrix interaction or disruption
regulates cell cycle progression through p21. To study this hypothesis Clara cells
from both wt and p21 ko mice were isolated and cultured on seven different ECM
compositions: Fibronectin/Collagen IV/Laminin (Fn/Coll IV/Lam);
156
Fibronectin/Collagen IV (Fn/Coll IV), Collagen IV/Laminin (Collagen IV/Laminin
(Coll IV/Lam); Fibronectin/Laminin (Fn/Lam); Collagen IV (Coll IV); Laminin
(Lam); Fibronectin (Fn). The final concentration of each ECM composition was 50
pg/ml. The effect of ECM composition on Clara cell behaviour (proliferation,
differentiation, death and expression of cyclin kinase inhibitors (CKI) was studied.
The main objectives of this chapter are:
1. To find out whether cell-matrix interaction is important in the regulation of
Clara cell proliferation, differentiation and death both in the presence and absence of
p21.
2. To describe the functional roles of p21 in Clara cell cultures.
3. To find out whether p21 is involved in cell-matrix interactions.
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5.2 Effect of ECM variation on Clara cell
differentiation in wt and p21 ko mice.
Cytokeratins are a good marker of epithelial cells differentiation (Gunning et al.,
1992; McBride et al., 1999). In this study three cytokeratins 8, 18 and 19 were
studied all of which are present in lung epithelial cells including Clara cells. The
variation in the degree of cytokeratin expression gives a good indication on the
degree of differentiation from one cell type to another to an intermediate cell.
When cells were freshly isolated, thus unattached at day 0, cytokeratins 8, 18 and 19
expressions were found to be lower (p < 0.05) in p21 ko mice when compared to wt
mice. (Figures 5.1 & 5.2).
In p21 ko mice, the cytokeratins 8, 18 and 19 expressions at time 0 when cell are
freshly isolated and not attached to ECM, were significantly lower (p < 0.05) when
compared to attached cells at time 24, 72 and 120 hours.
In wt mice, the ECM composition did not influence significantly the cytokeratins 8,
18 and 19 expression and the expression of cytokeratins 8, 18 and 19 did not change
significantly over the time in culture.
When Laminin was part of the ECM composition in cultured Clara cells from p21 ko
mice, cytokeratins 8 and 19 expressions were significantly higher (p < 0.05) when
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5.3 Effect of ECM variation on Clara cell
proliferation in wt mice and p21 ko mice.
Clara cell proliferation was evaluated by three method: BrdU incorporation, mitotic
counts and PCNA immunocytochemistry and counts (Figure 5.3, 5.4 & 5.5).
No significant changes in mitosis, and BrdU incorporated positive nuclei of Clara
cells isolated from wt mice when compared to p21 ko mice was observed. A
decrease (p < 0.05) in the cytoplasmic PCNA expression and an increase (p < 0.05) in
nuclear PCNA expression in Clara cells from p21 ko mice was observed when
compared to wt mice.
ECM composition did not significantly affect rates of mitosis, BrdU incorporation,
cytoplasmic and nuclear PCNA expression of Clara cells from either wt or p21ko
mice.
Mitosis counts were lower (p < 0.05) at time 24 hours compared to cultured cells at
72 and 120 hours from wt and p21 ko mice. Cytoplasmic and nuclear PCNA
expressions were lower (p < 0.05) from freshly isolated cells at time 0 hours
compared to cultured cells at 24, 72 and 120 hours from wt mice. Nuclear PCNA
expression was lower (p < 0.05) in freshly isolated cells at time 0 hours compared to
the cultured cells from p21 ko mice. No change of BrdU incorporation was noted
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5.4 Effect of ECM variation on Clara cell death
in wt and p21 ko mice.
The necrotic and apoptotic dead cells were counted in primary Clara cell cultures at
times 24, 72 and 120 hours respectively using Feulgen staining technique and
morphological assessment (Figures 5.6).
The necrotic rates at time points 72 and 120 hours in Clara cells from wt mice were
significantly higher (p < 0.05) when compared to cells from p21 ko mice. The
necrotic rate in Clara cell cultures at 24 hours from wt mice were significantly lower
(p < 0.05) than cells cultured at time points 72 and 120 hours. The apoptotic rate in
Clara cells from wt mice at time point 24 hours was significantly lower (p < 0.05)
than cells at 72 hours in culture. The apoptotic rate at 72 hours was significantly
higher (p < 0.05) in cells from wt mice compared to cells from p21 ko mice.
No significant differences in apoptosis or necrosis were observed when Clara cells

























■Fn/CollIV/Lam□Fn/Coll VnColllV/LamF La®lI■L n
Figure5.6-Apoptoticandnecroticra eCl rac llculturesfromwtndp21kmi e.Thapoptosisa eic lfr mwt mice(A)washigh rp<0.05)attimpoint72hoursc mparedt ellsfr m21k ice(B .Thn c oticrat sellfromwtice timepoints72and120hour(C)wereigherp<0. 5)thanc llsfr mp21komice(D).Tn croticratt 4ourswalo r(p<0.05)whencomparedt theripointsinCla ac llfr mwtice(C).Nosignificantdiffer ncesap ptosisdecrwere observedwhenc llsreultu dodiffe entECMcompo itionsfr mb thwap21k ice. 166
5.5 Effect of ECM variation on the expression of
cyclin kinase inhibitors p21, p27 and p53 in Clara
cells from wt mice and p21 ko mice.
Three cyclin kinase inhibitors p21, p27 and p53 were studied by
immunocytochemistry (Figures 5.7, 5.8, 5.9, 5.10).
Nuclear p21 expression increased (p < 0.05) from time 0 to 120 hours in culture.
Cytoplasmic p21 expression was higher (p < 0.05) at time 0 when compared to time
24 hours.
The expression of cytoplasmic p53 was lower (p < 0.05) whereas the expression of
nuclear p53 was higher (p < 0.05) in Clara cells from p21 ko mice compared to cells
from wt mice. The expression of cytoplasmic p53 is increasing (p < 0.05) from
culture times 24 to 120 hours in cells from wt mice. The expression of nuclear p53
is increasing (p < 0.05) from time 0 to time 120 hours in culture in cells from p21 ko
mice.
The expression of cytoplasmic p27 was found to be higher (p < 0.05) in cells from
p21 ko mice compared to cells from wt mice at 24 hours in culture. No significant
differences in the expression of nuclear p27 were observed between cells from wt
and p21 ko mice.
No significant differences in the expression of p21, p27 and p53 were observed when
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5.6 Discussion.
5.6.1 Lower expression of cytokeratins 8, 18 and 19 in
unattached Clara cells from p21 ko mice compared to wt
mice.
Differences in cytokeratin expression in lung cells have been established and have
been used as differentiation markers in lung epithelial cells. (Gunning et al., 1992;
Moll et al., 1982; Moll, 1987; Blobel et al., 1984). The expression of cytokeratin 8,
18 and 19 in freshly isolated Clara cells from p21 ko mice was significantly lower (p
< 0.05) than cultured cells. By disrupting the cell-matrix interactions, in this case
during the isolation procedure, the unattached Clara cells from p21 ko mice could be
undergoing differentiation and thus cytokeratins 8, 18 and 19 expression was lower.
No significant changes in the expression of cytokeratin 8, 18 or 19 was observed in
Clara cells from wt mice upon the cell-matrix disruption and when cultured on
different ECM. Thus changes in cell-matrix interactions could be an important factor
for cells to undergo differentiation through a p21-dependent pathway. In p21 ko
mice, normal differentiation has been observed, thus p21 is not a mutually exclusive
agent that promotes differentiation (Paramio et al., 2001; Cox, 1997; McDonald et
al., 1996; Deng et al., 1995).
When Clara cells from p21 ko mice were attached and cultured to an ECM which
contained laminin, the expression of cytokeratin 8 and 19 was significantly higher (p
< 0.05) than cells cultured in the absence of laminin. Thus in the absence of p21, the
presence of laminin was found to be quite important for cells to undergo normal
differentiation. The actual pathway by which the presence of laminin and p21 are
involved in differentiation in Clara cells is still unclear and further studies need to be
carried out.
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5.6.2 ECM composition does not influence Clara cells
proliferation both in the presence and absence of p21.
No significant changes in the proliferation rate were observed in Clara cells from wt
mice as compared to cells from p21 ko mice. Thus under these serum-free cell
culture conditions, p21 does not affect Clara cell proliferation. Although p21 was
shown to inhibit proliferation (Balomenos et al., 2000; Sugibayashi et al., 2002;
Harper et al., 1993; El-Deiry et al., 1993; Harper et al., 1995; Niculescu et al., 1998),
normal development and proliferation was also described in mice lacking p21
(Brugarolas et al., 1995; Deng et al., 1995; Waldman et al., 1996; McDonald et al.,
1996; Weinberg et al., 1997; Alan Wang et al., 1997). The role of p21 regarding
proliferation is still unclear and this could be due to different cell types and also due
to different culture conditions. A significant increase in proliferation in Clara cells
from p21 ko mice was observed as compared cells from wt mice, when serum was
used in the culture medium (unpublished results).
Although culturing Clara cells on different ECM composition did not affect the
proliferation rate, the mitotic rate was lower (p < 0.05) at culture time 24 hours
compared to cultured cells at 72 and 120 hours from both wt and p21 ko mice. This
could be due that cells at 24 hours in culture are not as attached to the ECM as cells
at 72 and 120 hours in culture. Thus proliferation in Clara cells is anchorage
dependent although not directly influenced by ECM composition.
A significant (p < 0.05) decrease in cytoplasmic PCNA and an increase (p < 0.05) in
nuclear PCNA expression was observed in Clara cells from p21 ko mice as compared
to wt mice. PCNA is required for both DNA replication and DNA repair (Li et al.,
1995a; Moriuchi, 1990; Oku et al., 1998; Rossi et al., 1999; Rousseau et al., 1999;
Yu et al., 2001). Since no significant changes in proliferation were observed using
BrdU incorporation and mitotic counts, these changes in the PCNA expression could
be attributed to repair.
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Nuclear PCNA expression was lower in the freshly isolated cells at time 0 compared
to cultured cells from both wt and p21 ko mice, while cytoplasmic PCNA expression
was lower only in cells from wt mice. Thus it can be hypothesised that the cell-
matrix disruption increases the nuclear PCNA expression in Clara cells from both wt
and p21 ko, which is most probably involved in DNA repair. Most probably p21 has
a role in controlling transportation of PCNA to the nucleus, since a decrease (p <
0.05) in cytoplasmic PCNA expression but an increase (p < 0.05) in nuclear PCNA
expression was observed in Clara cells from p21 ko mice when compared to cells
from wt mice. The role of p21 in transportation of PCNA to the nucleus has been
leported (Li et al., 1994; Li et al., 1995a; Funk et ah, 1997; Warbrick et ah, 1997;
Cayrol et ah, 1998; Oku et ah, 1998; Rousseau et ah, 1999).
5.6.3 p21 can induce apoptosis and necrosis in Clara
cells.
Necrotic rate of Clara cells from wt mice at 72 and 120 hours in culture were
significantly higher (p < 0.05) than cell from p21 ko mice. Apoptotic rate was higher
(p < 0.05) in Clara cells from wt mice at 72 hours in culture compared to cells from
p21 ko mice. Thus p21 seems to be involved in promoting necrosis and apoptosis
death pathways.
There were no significant changes in the apoptosis and necrosis rates by culturing
Clara cells on different ECM. A number of studies has shown that when cells are
detached from substrate or anchorage is prevented they usually undergo apoptosis
(Ruoslahti and Reed, 1994; Frisch and Ruoslahti, 1997; Frisch and Francis, 1994;
Schwartz, 1997; Assoian, 1997; Day et ah, 1997; Meredith et ah, 1993; McGill et ah,
1997; Ilic et ah, 1998; Vitale et ah, 1999; Kettritz et ah, 1999; Sethi et ah, 1999).
The necrotic and apoptotic rates were lower (p < 0.05) at culture time 24 hours
compared to cultured Clara cells at 72 hours from wt mice. Cells at 24 hours in
culture are most probably less attached to the ECM compared to cells at 72 and 120
hours in culture, thus some cells could have been detached and not detected in the
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counts thereby explaining the unexpected low death at 24 hours in culture. On the
other hand, due to the fact that Clara cells were cultured in a serum free condition,
there could be some growth factors missing in the medium and so as culture time in
culture increases, the cell death rate also increases. Most probably both statements
are correct and the truth somewhere in between. Further studies need to be carried
out to find out whether disruption of cell-matrix interaction leads to apoptosis via a
p21-dependent pathway.
5.6.4 Decrease in cytoplasmic p21 upon adherence.
In this study an increase (p < 0.05) in the nuclear p21 expression was observed from
time 0 to 120 hours in culture. Cytoplasmic p21 expression was higher in unattached
Clara cells at time 0 compared to cells at 24 hours in culture thus cytoplasmic p21
expression could be increased upon cell-matrix disruption. The functional role of
cytoplasmic p21 is still unclear (Asada et al., 1999; Tchou et al., 1996; Poon and
Hunter, 1998; Donato and Perez, 1998; Zhang et al., 1999; Jin et al., 2000; Gervais et
al., 2000), thus further studies need to be carried out to understand its functional role.
Culturing different Clara cells on a variation of ECM combinations did not
significantly affect the expression of p21 thus cell-matrix disruption rather than ECM
composition seems to be more important.
5.6.5 Nuclear p53 expression increases in Clara cells
lacking p21.
The expression of cytoplasmic p53 was lower whereas the expression of nuclear p53
was higher (p < 0.05) in Clara cells from p21 ko mice as compared to cells from wt
mice. Thus it seems that in the absence of p21, there is an increase in p53
stabilisation. The p53 protein is a potent inhibitor of cell growth, arresting the cell
cycle at several points and under some circumstances, activating the apoptotic
machinery leading to cell death (Brambilla and Brambilla, 1997; Hupp et al., 2000; Ji
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et al., 1997; Jimenez et al., 1999; Kaelin, 1999b; Kamijo et al., 1998; Lakin and
Jackson, 1999; Lane, 1992; May and May, 1999; Morgenbesser et al., 1994; Sigal
and Rotter, 2000; Stewart et al., 2001; Vaziri and Benchimol, 1999; Vitale et al.,
1999; Wyllie et al., 1994; Yap et al., 1999). The role of cytoplasmic p53 is still
unclear although cytoplasmic localisation of wildtype p53 has been reported in
inflammatory breast carcinoma, colorectal adenocarcinoma, undifferentiated
neuroblastoma (Ostermeyer et al., 1996; Moll et al., 1995), hepatocellular carcinoma
and retinoblastoma (Morgenbesser et al., 1994). Culturing different Clara cells on a
variation of ECM combinations did not affect the expression of p53.
5.6.6 Increase in the cytoplasmic p27 in Clara cells
lacking p21 at 24 hours in culture.
The expression of cytoplasmic p27 was found to be higher (p < 0.05) in Clara cells
from p21 ko mice compared to cells from wt mice at 24 hours in culture, but no
significant differences in the expression of nuclear p27 were observed in cells from
wt and p21 ko mice at any time point in culture. Nuclear p27 negatively regulates G1
progression by binding to cyclin D-cdk 4/6 complexes, cyclin A/cdk2 and cyclin E-
cdk 2 preventing their activity (Lloyd et al., 1999; Harvat et al., 1998; Cheng et al.,
1999; Rodier et al., 2001; Reed et al., 1994), but the functional role of cytoplasmic
p27 is still unknown although it is thought to be involved in the activation of Cdk 2
complexes (Orend et al., 1998; Rodier et al., 2001; Levkau et al., 1998a). Thus the
absence of p21 could lead to an increase in cytoplasmic p27 upon cell attachment to
ECM and therefore inhibiting G1 progression and maybe lead to cell differentiation.
Cytoplasmic p27 was shown previously to be able to inhibit G1 progression (Orend
et al., 1998; Rodier et al., 2001; Tomoda et al., 1999; Tomoda et al., 1999;
Reynisdottir and Massague, 1997; Soucek et al., 1998; Lloyd et al., 1999; Nakayama
et al., 1996; Ishida et al., 2000; Resnitzky et al., 1995). The p27 expression did not
significantly change upon culturing different Clara cells on a variation of ECM




Although the presence of laminin was found to be important in cytokeratin 8 and 19
expression in Clara cells from p21 ko mice, the cell-matrix disruption rather than
ECM combinations seems to have greater influence on cell cycle progression in the
absence of p21. It has been previously shown that disruption of cell-matrix
interactions affects the expression of p21 (Assoian, 1997; Wu and Schonthal, 1997;
Nagaki et al., 2000; Ilic et al., 1998; Bao et ah, 2002) but the exact mechanism is still
unclear. Specific integrins that bind to laminin rather than different ECM
combinations seem to be more important in the regulation of cell cycle progression in
Clara cells. Thus, further studies have to be carried out in order to understand the
role of specific integrins adhesion or detachment on p21 expression and on cell cycle
progression in Clara cell cultures.
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Chapter 6 Effect of beta-1 integrin blocking
on Clara cell proliferation, differentiation and death
through p21 regulation.
6.1 Introduction
Integrins are the primary receptors used by cells to interact with extracellular matrix.
Both ECM and integrins play an important part in the survival, proliferation and
death of cells. When an injury occurs in lung epithelial cells signals through the
integrins could significantly effect whether disease or repair occur.
As observed from chapter 5, cell-matrix disruption rather than ECM compositions
itself seems to influence cell cycle progression. When primary Clara cells were
cultured on an ECM composition where Laminin was present, differences in the cell
cycle progression in wt mice could be seen when compared to p21 ko mice.
Laminin attaches to a number of integrins including otiPi, CX2P1, asPi, c^Pi, a7 J3i and
0^(34 (Belkin and Stepp, 2000; Sannes et al., 1998; Vivinus-Nebot et al., 1999;
Klinowsks et ah, 1999; Burkin et ah, 2000; Pance et ah, 2001; Hynes, 1992; Kumar,
1998; Damsky and Werb, 1992; Fomaro and Languino, 1997; Sheppard, 2000; van
der Flier and Sonnenberg, 2001). Various (3i and (34 integrin complexes were shown
to be involved in the activation of a number of cell cyclin inhibitors (Giancotti, 1997;
Pu and Streuli, 2002; Montgomery et ah, 1994; Ruoslahti and Reed, 1994; Clarke et
ah, 1995; Dixiti et ah, 1996; Vivinus-Nebot et ah, 1999; Miyata et ah, 2000;
Schwartz and Assoian, 2001).
cx6p4 was shown to activate p53 function in carcinoma cells (Bachelder et ah, 1999a)
and p53 was found to inhibit 0^4 integrin survival signalling (Bachelder et ah,
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1999b). The p4 integrin cytoplasmic domain was shown to be involved in the
activation of p21 pathways of growth arrest and apoptosis (Clarke et al., 1995). T
cell proliferation in the human thymus was found to be controlled via CQ3P4 by
laminin 5 (Vivinus-Nebot et al., 1999).
a5Pi, a fibronectin binding integrin, was found to negatively regulate cell growth in
the absence of attachment to fibronectin (Varner et al., 1995). (X5P1 was reported to
be involved in the expression of tumour suppressor pl6INK4a upon loss of anchorage
(anoikis) in a number of human cancer cells (Plath et al., 2000) and also supports
survival of cells by up-regulating Bcl-2 expression (Zhang et al., 1995). Trypsin was
also found to stimulate integrin CC5P1 dependent adhesion to fibronectin (Miyata et
al., 2000). a<3pi was shown to be an essential step accompanying the neoplastic
transformation of hepatocytes (Carloni et al., 1998).
The main hypothesis of this section is that integrins that bind to laminin influence
cell cycle progression possible through the regulation of p21. To study this
hypothesis, Clara cells from both wt and p21 ko mice were cultured on Laminin at a
concentration of 50 pg/ml and incubated with either a Pi blocking antibody (HMPi)
or with a cytokeratin 8 antibody as a control. Both antibodies were used at a
concentration of 10 pg/ml. The HMPi antibody has been shown previously to react
with mouse Pi and has an inhibitory effect on cell adhesion to ECM proteins (Noto et
al., 1995; Bums et al., 2001). The cytokeratin 8 antibody does not have an inhibitory
function.
The main objectives of these experiments are:
1. To study the roles of cell-adhesion of p4 integrin and cell-disruption of Pi
integrin in primary Clara cell cultures..
2. To determine the effect on cell cycle progression upon cell-matrix disruption.
3. To determine the functional role of p21 upon cell-matrix disruption.
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6.2 Effects of beta 1 integrin blocking on
cytokeratins expression in Clara cells from wt and
p21 ko mice.
No significant changes in the expression of cytokeratins 8, 18 and 19 were observed
upon beta-1 integrin blocking in cells from wt mice as compared to cells from p21 ko
mice at any time point in culture.
The expression of cytokeratin 8 was significantly lower (p < 0.05) in the control
cells (not beta-1 integrin blocked) from p21 ko mice at time 72 and 120 hours
compared to cells from wt mice control and beta-1 blocked cells from p21 ko mice at
the same time points.
A significant decrease (p < 0.05) in the expression of cytokeratin 18 was observed in
cells from wt mice at time 72 hours in culture upon beta-1 integrin blocking.
A significant increase (p < 0.05) in the expression of cytokeratin 19 was noted in
both cells from wt and p21 ko mice at time 120 hours in culture upon beta-1 integrin
blocking.
180
ACytokeratin8g18Qytokeratin9 Time/hoursTime/hoursTime/hours □controlwt■beta1int grinl ckt lp21k
□beta1int grinlockp21ko
Figure6.1-Changesit expressionofcytok ratins8,18dl ellm24,7220hournb thw andp21komiceuponbeta-integrilocking.Nsignifi a tch gestheexpress ofcy ok ratins8,18a d9we e observeduponbeta-1l cki gincellsfr mwtmicascompart llp21k i(A,B&C).ytokeratin8expr s ion waslo er(p<0.05)incontrolellfromp21kmiceatultureti e7 d120h rA).Cytoker tin8expressioaslo
(p<0.05)inbeta-1lockedcellsfr mwtmiceaulturti72h rB).Cyt k ratin19xpressiosighe. )i beta-1lockedcellsfr mthwtandp2komiceul ureti120h rs(C). 181
Figure6.2-Changesithexpressionofcytok ratins8,18dl ellncultufromwtap21kmicup n beta-1integrinlocking.Cy okeratin8xpressiowlo r(<0.05)cont olellfr mp21kmiceA)acultuti12 hourscomparedtbeta-1l kedClarell(B).yt k ratin18expressionwlo<0.05)inbet -1lock dcellfr t miceatculturti e72ho rs(D)omparednt olnbeta-1l ck )wcellsC).Cytok ratin19expressioshigh r< 0.05)inbeta-1lockedcellsfr mthwt(F)andp2komiceHculturti12ho rscomparedntrols[w(E)&p21 ko(G)].Iisthenegativecontrolfimmunofluorescencwhe ebyprimaryantib dasmi t d.Magnific ionx200. 182
6.3 Effects of beta 1 integrin blocking on Clara
cell proliferation in wt and p21 ko mice.
Clara cell proliferation was evaluated by three different methods: BrdU
incorporation, mitosis count and PCNA immunocytochemistry and counts.
The expression of cytoplasmic PCNA was significantly higher (p < 0.05) in cells
from wt and p21 ko mice upon beta-1 integrin blocking at time 120 hours in culture
as compared to the control (using a non-blocking antibody). The expression of
nuclear PCNA increased significantly (p < 0.05) in cells from wt mice upon beta-1
integrin blocking at time 72 and 120 hours in culture.
A significant decrease (p < 0.05) in BrdU incorporation was observed in cells from
wt mice upon beta-1 integrin blocking at times 24 and 72 hours in culture. A
decrease (p < 0.05) in BrdU incorporation was noticed in cells from p21 ko mice
upon beta-1 blocking at 24 hours in culture.
No significant changes in the mitosis were observed both in cells from wt and p21 ko
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6.4 Effect of beta 1 integrin blocking on Clara
cell death in Clara cells from wt and p21 ko mice.
Necrotic and apoptotic cells were counted in primary Clara cell cultures at times 24,
72 and 120 hours respectively using Feulgen staining technique (Figure 6.5).
A significant increase (p < 0.05) in apoptosis was observed upon beta-1 integrin
blocking in Clara cells from wt and p21 ko mice at 72 and 120 hours in culture.
Apoptosis was higher (p < 0.05) in cells from wt mice compared to cells from p21 ko
mice at 72 hours upon beta-1 integrin blocking.
No significant differences in necrosis were observed upon beta-1 integrin blocking in
both cells from wt and p21 ko mice.
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6.5 Effect of beta 1 integrin blocking on cyclin
kinase inhibitors p21, p27 and p53 in Clara cells in wt
and p21 ko mice.
Three cyclin kinase inhibitors p21, p27 and p53 were studied by
immunocytochemistry (Figures 6.6, 6.7, 6.8 & 6.9).
The expression of cytoplasmic p21 increased (p < 0.05) upon beta-1 integrin
blocking at 120 hours in culture. The expression of nuclear p21 increased (p < 0.05)
upon beta-1 integrin blocking at 72 and 120 hours in culture. The expression of
nuclear p21 increased (p < 0.05) in culture from time 24 to 120 hours upon beta-1
integrin blocking.
A decrease (p < 0.05) in the expression of cytoplasmic p27 was observed in cells
from wt mice at 24 hours in culture and in cells from p21 ko mice in all time points
in culture, upon beta-1 integrin blocking. A significant increase (p < 0.05) in the
nuclear p27 expression was observed in cells from p21 ko mice at 24 hours and in
cells from wt mice at 72 hours in culture upon beta-1 integrin blocking.
The expression of nuclear p53 increased significantly (p < 0.05) in cells from wt and
p21 ko mice upon beta-1 integrin blocking at 72 and 120 hours in culture. Upon beta-
1 blocking, there was an increase (p < 0.05) in the expression of nuclear p53 from 24
to 120 hours in culture in cells from both wt and p21 ko mice. No significant
differences in the nuclear and cytoplasmic expression of p53 were noted in Clara
cells from wt mice when compared to p21 ko mice. No significant changes in the
expression of cytoplasmic p53 were observed upon beta-1 integrin blocking in cells
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6.6 Discussion.
6.6.1 p21 is not involved in the expression of
cytokeratins 8, 18 and 19 when Clara cells are attached to
laminin via a6(34.
No significant changes in the expression of cytokeratins 8, 18 and 19 were observed
upon beta-1 blocking in Clara cells from both wt and p21 ko mice. Thus when Clara
cells are attached to laminin via 0604, the presence or absence of p21 did not
influence expression of cytokeratin 8, 18 and 19.
As seen in the results from the previous chapter (chapter 5), cytokeratin 8, 18 and 19
were lower at time 0 (unattached cells) in Clara cells from p21 ko mice. Thus it can
be concluded that Clara cell interactions via 0^04 are important for the expression of
cytokeratin 8, 18 and 19 and p21 is most probably involved. Since as number of
differences in the cytokeratins expression has been shown in lung cells and
cytokeratins have been used a differentiation markers in lung epithelial cells
(Gunning et al., 1992; Moll et al., 1982; Blobel et al., 1984; Moll, 1987) , it can
hypothesised that Clara cell differentiation is influenced by cell-matrix adhesion
through O604 integrins.
The activation of p53 and p21 by 04integrin was previously described (Clarke et al.,
1995; Bachelder et al., 1999a) and p53 was also found to inhibit survival signalling
through 0(604 integrin (Bachelder et al., 1999b). Thus most probably the levels of
expression of both p21 and p53 are important in the control of cell differentiation.
p21 has previously been shown to be able to both promote (Matsumura et al., 1997;
Baccini et al., 2001; Liu et al., 1996a; Liu et al., 1996b; Hiraoka et al., 2002; Kramer
et al., 2002; Park and Chung, 2001; Park and Chung, 2001; Billon et al., 1996)
(Halevy et al., 1995; Nadal et al., 1997) and inhibit differentiation (Di Cunto et al.,
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1998; Yamamoto et al., 1998). In the p21 null mice, normal differentiation has been
observed thus implying that p21 is not a mutually exclusive agent that promotes
differentiation (Paramio et al., 2001; Cox, 1997; McDonald et al., 1996; Deng et al.,
1995).
Disruption of cell-c^fU interaction in Clara cells lacking p21 could lead to
differentiation and maybe the generation of another cell type or an intermediate cell
type. This could be one of the possible mechanisms by which Clara cells differentiate
into other cells such as ciliated cells and it could also be a possible mechanism by
which Clara cells respond after epithelial cells injury when neighbouring cells are
damaged and maybe shed.
Cytokeratin 8 expression was lower (p < 0.05) in control Clara cells at 72 and 120
hours in cultures, from p21 ko mice. Cytokeratin 19 expression was also found to be
lower (p < 0.05) in control Clara cells at 120 hours in cultures, from p21 ko mice.
This decrease could be due beta-1 integrin interactions. Thus cell-beta-1 integrin
interactions both in the absence and presence of p21, could influence cell
differentiation.
Cytokeratin 18 expression was lower (p < 0.05) in beta-1 blocked Clara cells from wt
mice at 72 hours in culture. As observed in chapter 5, the presence or absence of
laminin in the ECM did not vary significantly the expression of cytokeratin 18. This
could due to other factors influencing the expression of cytokeratin 18 such as cell-
beta-1 integrin interactions.
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6.6.2 Beta-1 integrin is involved in Clara cell
proliferation.
Upon beta-1 integrin blocking, a decrease (p < 0.05) in BrdU incorporation was
observed in cells from wt mice at 24 and 72 hours in culture, and in cells from p21
ko mice at 24 hours in culture. Thus the cell-beta-1 integrin interaction could be
promoting proliferation in Clara cells and disruption of this interaction could result in
a decrease in proliferation. (3i integrin complexes has been previously shown to be
involved in cell proliferation (Rosales and Juliano, 1995; Varner et ah, 1995; Howe
et ah, 1998; Miyata et ah, 2000; Carloni et ah, 1998; Zhang et ah, 1995). ocsPi, a
fibronectin binding integrin, was found to decrease cell proliferation in the absence
of attachment to fibronectin and that ligation of this receptor with fibronectin
reverses this process (Varner et ah, 1995). Trypsin was shown to stimulate the
integrin OC5P1 dependent adhesion to human gastric carcinoma cells to fibronectin and
increases cell proliferation (Miyata et ah, 2000). Since trypsin was used to isolate
Clara cells, the OC5P1 integrin complexes could have been stimulated but since beta-1
integrin was blocked and thus was not bound to a suitable receptor, there was a
decrease in cell proliferation.
6.6.3 Apoptosis rate increases upon beta-1 integrin
blocking.
Upon beta-1 integrin blocking, an increase in apoptosis was observed in Clara cells
from both wt and p21 ko mice at 72 and 120 hours in culture. This result was
expected since a number of studies have shown that when cells are detached from
substrate or anchorage is presented they usually undergo apoptosis (Ruoslahti and
Reed, 1994; Frisch and Ruoslahti, 1997; Frisch and Francis, 1994; Schwartz, 1997;
Assoian, 1997; Day et ah, 1997; Meredith et ah, 1993; McGill et ah, 1997; Ilic et ah,
1998; Vitale et ah, 1999; Kettritz et ah, 1999; Sethi et ah, 1999; Montgomery et ah,
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1994; Clarke et al., 1995). Thus disruption of Clara cell- beta-1 integrin interactions
results in apoptosis.
Upon beta-1 integrin blocking, the apoptosis rate was higher (p < 0.05) in cells from
wt mice compared to cells from p21 ko mice at 72 hours. In the absence of p21,
there was a reduction of the apoptosis rate, thus p21 seems to induce apoptosis in
Clara cell culture upon beta-1 integrin blocking. p21 has been previously shown to
be able to both induce (Kondo et al., 1997; Fotedar et al., 1999) and inhibit apoptosis
(Polyak et al., 1996; Gorospe et al., 1998; Wang et al., 2000; Gorospe et al., 1997;
Mahyar-Roemer and Roemer, 2001).
6.6.4 PCNA expression is increased upon beta-1
integrin blocking but PCNA requires p21 for its nuclear
localisation.
Interesting results were obtained with regards to the PCNA expression. Cytoplasmic
PCNA expression was found to be higher (p < 0.05) in cells from both wt and p21 ko
mice upon beta-1 integrin blocking at 120 hours. The expression of nuclear PCNA
expression significantly increased (p < 0.05) in cells from Clara cells from wt mice
only upon beta-1 blocking at 72 and 120 hours in culture. In the absence of p21,
there was an increase in cytoplasmic PCNA expression but not nuclear PCNA
expression. Thus upon beta-1 blocking the expression of PCNA seems to be increase
in cells from both wt and p21 ko mice but p21 is essential in the nuclear PCNA
localisation. The role of p21 in the nuclear localisation of PCNA and the
importance of this complex in cell cycle progression have been previously described
(Li et al., 1994; Li et al., 1995a; Vairapandi et al., 1996; Funk et al., 1997; Warbrick
et al., 1997; Chuang et al., 1997; Cayrol et al., 1998; Oku et al., 1998; Rousseau et
al., 1999).
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6.6.5 Nuclear p21 and p53 expression increase upon
beta-1 integrin blocking in Clara cells culture.
Upon beta-1 integrin blocking, an increase (p < 0.05) in the nuclear p21 expression
was observed in Clara cells. p21 expression was previously shown to be increased
by the beta-4 cytoplasmic domain. Lower levels of 06p4 surface expression were
shown to induce p21 sufficient to induce partial G1 arrest and some apoptosis, while
higher levels of expression resulted in more p21 expression and more
widespread apoptotic death (Clarke et ah, 1995). Thus in this case, due to the fact
that beta-1 integrin was blocked, there could have been a hypothetical increase in
either the expression of or relatively more a6p4 integrin adhered to an
appropriate receptor and thus results in an increase in p21. More work needs to be
carried out, to find out the exact mechanism by which p21 expression increases upon
beta-1 integrin blocking. The literature about this topic is so far very limited.
Upon beta-1 integrin blocking, the nuclear p53 expression increased (p < 0.05) in
Clara cells from both wt and p21 ko mice. was shown to activate p53
(Bachelder et ah, 1999a), whereas p53 itself was found to inhibit oc<5P4 integrin
survival signalling (Bachelder et al., 1999b). The reason for the increase in the
nuclear p53 could be the same as for the p21, but whether the increase of p21 is
dependent or independent of p53 is not known.
In this study no significant differences in the nuclear and cytoplasmic expression of
p53 were observed in Clara cells in the presence or absence of p21 upon beta-1
blocking. Results from the previous section (Chapter 5) suggest, that in the absence
of p21 there was an increase in p53. It seems that apart from beta-1 and beta-4
integrins, other integrins are involved, possibly beta-3, beta-6 or beta-7 (see Table
1.2, Introduction). Although beta-3 was found not to be present in lung epithelium
cells (results from Chapter 4) and others (Damjanovich et al., 1992; Pilewski et al.,
1997) and in Clara cell cultures (Chapter 4), beta-3 expression was found to be
present in the epithelial cells of fibrotic lungs (Huang et al., 1996; Munger et al.,
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1999; Kaminski et al., 2000; Sheppard, 2000; Sheppard, 2001a; Sheppard, 2001b;
Reynolds et al., 2002). Beta-3 integrin was shown to be involved in the p53 and p21
expressions (Montgomery et al., 1994; Stromblad et al., 1996). av complexes either
to (33, (35 or (3g were also found to be involved in the expression of p53 and p21
(Stromblad et al., 2002; Milner et al., 1999; Cambier et al., 2000; Arroyo et al., 2000;
Hakkinen et al., 2000). Thus, it can be hypothesised that the increase in p53
expression in the absence of p21 could be mediated via integrins, but further studies
have to be carried out to determine which integrins are involved and to determine the
exact mechanism.
6.6.6 p27 translocation to the nucleus occurs faster in
the absence of p21 upon beta-1 integrin in Clara cells.
Upon beta-1 integrin blocking, there was a decrease (p < 0.05) in the expression of
cytoplasmic p27 at all time points in culture. An increase in nuclear p27 expression
in cells from p21 ko mice at 24 hours and in cells from wt mice at 72 hours in
culture, were observed upon beta-1 integrin blocking. Thus upon beta-1 integrin
blocking, the translocation of p27 from the cytoplasm to the nucleus seems to be
faster in the absence of p21. It has previously been hypothesised that p27 expression
could be influenced via beta-1 integrin (Fornaro et al., 1999; Bao et al., 2002;
Henriet et al., 2000), but the exact mechanism is still unclear, and the literature so far
is quite limited. Thus further studies need to be carried out to describe the
relationship of p27 with integrins.
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6.6.7 Conclusion
When cells are attached to 0^4, p21 is not involved in the cytokeratins 8, 18 and 19
expressions of Clara cells, while when cell-0C6P4 interaction is disturbed the presence
of p21 is important for the cytokeratins expression. Cell-beta-1 interactions could
also be involved in the cytokeratins expressions. Therefore the expression levels of
p21 could be a determinant factor in Clara cell differentiation. Cell-beta 1
interactions were described as a potential factor in cell proliferation. The lack of
binding of beta-1 integrin to an appropriate receptor could lead to a decrease in cell
proliferation.
Beta-1 integrin disruption could also lead to an increase in PCNA expression but for
an increase in nuclear PCNA p21 was shown to be an essential factor. Upon
blocking beta-1 integrin there is an increased nuclear expression of p21, p27 and p53
and an increase in apoptosis rate.
Thus as originally hypothesised, integrins that bind to laminin are important for cell




The functions of p2lWafl/c,pl are complex and contradictory. p21 Wafl/ClP1 was shown
to promote apoptosis (McKay et al., 1998; Gervais et al., 2000), protect cells from
undergoing apoptosis (McKay et al., 1998; Lu et al., 1998; Bulavin et al., 1999;
Asada et al., 1999; Zhang et al., 1999; Gervais et al., 2000), to promote proliferation
(Mantel et al., 1996; Lai et al., 2002), inhibit proliferation (Balomenos et al., 2000;
Sugibayashi et al., 2002; Harper et al., 1993; El-Deiry et al., 1993; Harper et al.,
1995), inhibit differentiation (Yamamoto et al., 1998; Harvat et al., 1998) and
promote differentiation (Steinman et al., 1994; Liu et al., 1996a; Liu et al., 1996b;
Billon et al., 1996; Matsumura et al., 1997; Nadal et al., 1997).
The cell-cycle inhibitory activity of p2iCipl/WafI is associated with its nuclear
localisation. However a number of cytoplasmic forms of p21 have been described.
So far six different forms of cytoplasmic p21 have been described each of which
have different sizes: 21 kDa protein (Asada et al., 1999), 20 kDa protein (Tchou et
al., 1996), 19 kDa protein (Poon and Hunter, 1998), 16 kDa protein (Donato and
Perez, 1998), 15 kDa protein (Zhang et al., 1999) and a 14 kDa protein (Jin et al.,
2000; Gervais et al., 2000).
A physical association between cytoplasmic p21 and ASK1 was described and was
found to suppress the activity of ASK 1 and MAPK (SAPK/JNK) cascade activation
thus preventing the cell from undergoing apoptosis (Asada et al., 1999). It has been
suggested that cytoplasmic p21 is formed by cleavage or truncation during apoptosis.
(Prabhu et al., 1997; Donato and Perez, 1998; Gervais et al., 2000; Jin et al., 2000;
Zhang et al., 1999). The role of cytoplasmic p21 is still unclear (Dotto, 2000).
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Changes in expression of p21 were shown to be involved in animal models of lung
diseases such as asthma and fibrosis (chapter 3) and its regulation and expression
could be affected by disruption of cell-matrix interactions (as shown in chapter 5 and
6). Thus by studying cytoplasmic and nuclear p21 and their relative complexes, one
might understand the actual pathways by which p21 might be involved in the injury
and repair processes of the lung. The main objectives of this chapter are to describe
the cytoplasmic and nuclear p21 proteins found in Clara cell cultures and to try to
describe their functional roles in terms of the complexes formation.
7.2 Cytoplasmic and nuclear p21 proteins in Clara
cells.
As shown previously (results chapters 3, 4, 5 and 6), p21 was observed in both the
cytoplasm and nucleus. An important question to ask is to determine whether the
protein seen in the cytoplasm was the same as the one found in the nucleus.
Cytoplasmic and nuclear protein extractions were carried out from cultured Clara
cells at 72 hours. The extracts of which were separated on an appropriate gel and
blotted using a p21 antibody raised against the full-length p21. Protein extracts from
Clara cells from p21ko mice were used as the negative control.
The nuclear extract had a 20kDa protein that corresponds to the full-length p21,
while the cytoplasmic extract had a 17 kDa protein (Figure 7.1 A).
7.3 Cytoplasmic p21 is a 17kDa protein and is
truncated at the C-terminus.
The next aim was to determine whether the cytoplasmic form is truncated and where
the truncation is, that is either towards the N-terminal or towards the C-terminal.
Total protein extracts from cultured Clara cells at 72 hours were immunoprecipitated
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with either an antibody raised against the full-length p21 or towards the C-terminus
of p21. Protein extracts from Clara cells from p21ko mice were used as the negative
control.
Two proteins were obtained when immunoprecipitated with the antibody raised
against full-length p21, the 20 and 17kDa proteins that were previously observed.
Only the 20 kDa was obtained when immunoprecipitated with the antibody raised
against the C-terminus of p21. Thus the cytoplasmic p21 is a 17 kDa protein and is
truncated in the C-terminus (Figure 7.1 B).
7.4 Complexes of cytoplasmic and nuclear
p2-| Waf1/Cip1
The next question was to determine the cytoplasmic and nuclear p21 complexes.
Total protein extracts from cultured Clara cells at 72 hours were immunoprecipitated
with a number of antibodies, namely PCNA, cdk2, cdk4, cdk6, cyclin D3 and cyclin
E. The immunoprecipitated proteins were then blotted using antibody raised against
the full-length p21 protein. Protein extracts from Clara cells from p21ko mice were
used as the negative control.
Nuclear p21 protein (20 kDa) was found to form complexes with PCNA, cdk 2, cdk
4, cdk 6, cyclin D3 and cyclin E. Cytoplasmic p21 protein (17 kDa) was found to
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Figure 7.1 - Cytoplasmic and Nuclear p21. Cytoplasmic and nuclear
protein extracts from Clara cells at 72 hours in culture were blotted against an
antibody raised against full length p21 (F-p21). Cytoplasmic p21 was found to
be a 17 kDa protein while nuclear p21 was found to be 20 kDa protein (A).
Total protein extracts from Clara cells at 72 hours culture were blotted against
either F-p21 or an antibody raised against the C-terminal of p21 (C-p21). The
two proteins were observed when F-p21 was used, but only the 20 kDa protein
was observed when C-p21 was used, thus the 17 kDa protein (cytoplasmic) is C-
terminal truncated (B). Total protein extracts from Clara cells at 72 hours
culture were immunoprecipitated against a number of antibodies and blotted
against F-p21. Nuclear p21 (20 kDa) was found complexed with PCNA, cdk2,
cdk4, cdk6, cyclin D3 and cyclin E, while cytoplasmic p21 (17 kDa) was found
complexed with cdk 4 and cyclin D3 (C). [Top membrane in C was exposed for
10 minutes, while lower membrane in C was exposed for 3 hours.]
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7.5 Discussion.
Two types of p21 were found in cultured Clara cells, a 20 kDa and 17 kDa protein.
The 20 kDa is the full-length p21 protein (20 kDa in mouse while 21 kDa in human)
while the 17 kDa is a C-terminal truncated form of p21. The 20 kDa is found in the
nucleus while the 17 kDa protein is found in the cytoplasm. The nuclear localisation
signal (NLS) of p21 is localised at the C-terminal of p21 (Dotto, 2000), thus the
truncated 17 kDa cytoplasmic p21 does not have a NLS and maybe this is the reason
for its localisation.
The 17 kDa protein obtained from Clara cell cultures seems to be a different protein
from the cytoplasmic p21 described in the literature so far. Six different forms of
cytoplasmic p21 have been described, having different sizes varying from 21 kDa
protein (Asada et al., 1999), 20 kDa protein (Tchou et al., 1996), 19 kDa protein
(Poon and Hunter, 1998), 16 kDa protein (Donato and Perez, 1998), 15 kDa protein
(Zhang et al., 1999) to a 14 kDa protein (Jin et al., 2000; Gervais et al., 2000).
The cytoplasmic 21 kDa protein described by Asada et al., (1999), is most probably
located in the cytoplasm due to a mutation in the nuclear localisation signal, was
found to complex with MEKKs (ASK1) and thus inhibited apoptosis. The 15 kDa
(Zhang et al., 1999) and the 14 kDa (Gervais et al., 2000; Zhang et al., 1999) p21
proteins are in the cytoplasm as a consequence of caspase-dependent cleavage of its
nuclear C-terminus domain and are unable to suppress growth as well as apoptosis.
This truncation would also compromise the ability of p21 to promote cyclin/CDK
nuclear localisation, with the same biological end point effect (Gervais et al., 2000).
The 16 kDa cytoplasmic p21 protein described by Donato and Perez, (1998) resulted
from TNF-induced proteolysis by an apoptotic protease. The 14 kDa cytoplasmic
p21 described by Jin et al., (2000) was found to occur due to proteolytic cleavage of
p21 that is associated with cyclin A-cdk2 which is a major mechanism for up-
regulation a cyclin A-Cdk2 kinases activity in the early stages of apoptosis. 20 kDa
(Tchou et al., 1996) and 19 kDa (Poon and Hunter, 1998; Orend et al., 1998) proteins
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truncated at the C-terminal and localised in the cytoplasm due to insufficient signals
for nuclear localisation were described. The 19 kDa p21 protein described by (Poon
and Hunter, 1998) was found bound to cyclin E-cdk 2 (Orend et ak, 1998).
Mutated p21 lacking Cdk-inhibitory activity was found not to be able to prevent
apoptosis in human colorectal carcinoma cells (Lu et ah, 1998). The expression of
either the N- and C-terminal regions of p21 was found to inhibit DNA synthesis and
cell growth, but not as efficiently as full length p21. The effectiveness of the two
domains was found to be dependable on the stability via the ubiquitin-proteasome
pathway (Rousseau et ah, 1999).
The mouse homologue of p21 has been identified as a 20 kDa protein (Gu et ah,
1993). As expected, the 20 kDa (full length) p21 was found to form complexes with
PCNA, cdk 2, cdk 4, cdk 6, cyclin D3 or cyclin E. The truncation of the 17 kDa
cytoplasmic protein was found to bind with cyclin D3 and cdk 4. Such a complex
has not been described before.
Over-expression of positive regulators including cyclin D3 and cdk4 is thought to
contribute to cancer of the breast, colon and other tissues (Sherr, 1996; Suhardja et
ah, 1999; Ortega et ah, 2002; Wong et ah, 2001). Thus inhibitors of cdks are
anticipated to posess therapeutic utility against a wide variety of proliferative
diseases, especially cancer (Toogood, 2001).
Cdk4/6-cyclin D complexes help cells to pass through the restriction point (R) in the
cell cycle and drive them from early to late G1 phase (Grana and Reddy, 1995; Nigg,
1995; Paggi et ah, 1996; Sherr, 1996; Elledge, 1996; Beijersbergen and Bernards,
1996; Nurse et ah, 1998; Sherr, 1995). This is accomplished by two independent
mechanisms. First, Cdk4/6-cyclin D phosphorylates pRb, which results in activation
of E2F transcription factors required for the synthesis of cyclin E (Beijersbergen and
Bernards, 1996; Paggi et ah, 1996; Herwig and Strauss, 1997; Philips et ah, 1997;
Dosaka-Akita et ah, 1997; Day et ah, 1997; Amellem et ah, 1998; Marchetti et ah,
1998). Secondly, Cdk4/6-cyclin D complexes bind to the Cip/Kip family of cell
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cycle inhibitors, whose primary role is to inhibit Cdk2-cyclin D-Cip/Kip complexes
which contributes to G1 progression by the removal of these inhibitors and thus
preventing them from binding and inactivating Cdk2-cyclin E complexes (Cheng et
ah, 1999; Grana and Reddy, 1995; Hiyama et ah, 1997; Ekholm and Reed, 2000;
Grana and Reddy, 1995; Hiyama et ah, 1997; Ortega et ah, 2002).
p21 promotes the assembly of Cdk4/6 and cyclin D in vitro and associates with
cyclinD/Cdk4 complexes during cell-cycle progression (LaBaer et ah, 1997;
Morisaki et ah, 1999; Cheng et ah, 1999; Wong et ah, 2001). p21 was also shown to
complex with cdk2 and thus lead to growth arrest (Niculescu et ah, 1998; Shiyanov
et ah, 1996; Jones et ah, 1997; Orend et ah, 1998; Morisaki et ah, 1999; Aikawa et
ah, 2001). The role of p21 as an assembly activator or inhibitor depends on its
expression level. At low and intermediate concentrations it is an assembly factor,
while at high concentrations it is an inhibitor (LaBaer et ah, 1997; Hiyama et ah,
1997; Morisaki et ah, 1999).
Primary mouse embryonic fibroblasts cells from p21 ko and p27 ko mice, failed to
assemble detectable amounts of cyclin D-Cdk complexes, express cyclin D proteins
at a reduced levels, and are unable to efficiently direct cyclin D proteins to the cell
nucleus (Cheng et ah, 1999). On the other hand, it was suggested that neither p21
nor p27 are required for the formation of cyclin D3-cdk4 complexes and that cyclin
D3-cdk4 complexes containing p21 or p27 are inactive. Thus it is unlikely that the
formation of these complexes would be dependent on their association with proteins
that would ultimately prevent this activation (Bagui et ah, 2000). Thus, it is still
unclear to what extent sequestering of p21 inhibitor by Cdk4/cyclin D complexes
contributes to G1 progression (Ortega et ah, 2002).
A complex of cdk4/cyclin D with cytoplasmic p21 was never previously described.
There are a number of possibilities how p21 can regulate the cell cycle through the
cdk 4/cyclin D complexes. There is no direct proof that the cytoplasmic p21 protein
is derived directly from p21 but RT-PCR/Southern analysis of p21 mRNA argues
against the possibility that the cytoplasmic p21 protein is encoded from an
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alternatively spliced mRNA (Tchou et al., 1996). The truncation of the p21 could
occur at either the nucleus or the cytoplasm. If the truncation occurs within the
nucleus the truncated p21 could possibly bind to the cdk 4/cyclin D3 complex or to
cyclin D3 or cdk4 individually and exporting them out of the nucleus to the
cytoplasm. p21 truncation could also occur in the cytoplasm. Since both cdk 4 and
cyclin D3 lack a nuclear localisation signal, if either cdk 4 or cyclin D3 or
cdk4/cyclin D3 complexes bind to the cytoplasmic p21 protein, they cannot be
transported to the nucleus thus most probably they would be inactive and would
localised in the cytoplasm.
Based on these data, it can be hypothesised that the functional role of the 17 kDa
cytoplasmic is to inhibit DNA synthesis and cell growth via the inactivation of cdk
4/cyclin D3 complexes and therefore suppression of the E2F activity by preventing
the phosphorylation of the retinoblastoma protein. Since cdk 4/cyclin D3 complexes
are also involved in promoting apoptosis pathways, cytoplasmic p21 could also be
involved in the control apoptosis processes.
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Chapter 8 Conclusions.
Changing p21 expression was seen in three animal models of lung disease. Due to
limited availability of time points and tissue the significance of these observations is
unknown. All that can be said is that p21 may have a role in lung diseases and in the
regulation of epithelial cell proliferation, differentiation and death.
However, p21 status was found to effect Clara cell differentiation modulation
through laminin receptors. This may be an indirect action. External stimuli such as
cell-matrix interactions had an effect on expression of p21 in Clara cells in vitro.
The presence of p21 was also shown to be important for the increase in apoptosis of
Clara cells. In the absence of p21, the expression levels of p53 were higher implying
a compensatory mechanism for the lack of p21. The up-regulation of p21 through
p53 dependent pathway is well described in the literature but the actual mechanism
for the up-regulation of p53 in the absence of p21 is unclear.
p21 status affected Clara cell proliferation and apoptosis triggered through beta-1
integrin blocking. p21 was shown to be important for PCNA nuclear localisation and
cell-beta 1 integrin disruption leads to an increase in PCNA expression. Disruption of
cell-matrix interaction by blocking beta 1 integrin was shown to increase apoptosis
and decrease proliferation in Clara cell cultures. p2I and p53 were upregulated upon
beta 1 integrin blocking. Thus as originally hypothesised, Clara cells respond to
changes in the environment through integrin mediated changes in p21. Upon beta 1
integrin blocking and in the absence of p21, the nuclear localisation of p27 occurs
faster. This could be another compensatory mechanism for the lack of p21 in Clara
cells in vitro upon disruption of cell-matrix interaction.
Two forms of p21 were found in Clara cells; a nuclear and a cytoplasmic form. The
cytoplasmic p21 was found to be a 17 kDa truncated protein of the full-length p21.
The cytoplasmic p21 protein seemed to be a novel form of p21 compared to
cytoplasmic p21 proteins previously described in the literature. From pull-down
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assays it was determined that nuclear and cytoplasmic p21 bind to different proteins.
The cytoplasmic p21 is most probably functionally active and inhibits the cell cycle
progression at the G1 phase of the cell cycle and via the inactivation of cdk4/cyclin
D complexes and therefore suppression of the E2F activity.
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Future Work.
Although a number of important questions have been answered, there are still an
even larger number of questions which need to be investigated. In this thesis,
significant changes in Clara cell cultures were obtained by altering the cell-matrix
interactions, for example by beta 1 integrin signal blocking. Thus it would be
interesting use beta 1 integrin blocking in an in vivo animal model of lung disease
such as fibrosis or asthma to see whether this treatment modulates cell growth and
affects disease outcome.
Since the 17 kDa cytoplasmic p21 is probably a novel protein and was shown to have
a functional role, it would be important to investigate it further. This might be done
by generating a p21 knockout mouse expressing the 17 kDa protein as a transgene.
Another interesting aspect which needs further studies is the importance of cell-cell
interactions. This includes both epithelial cells interacting with each other as well as
the interactions of epithelial cells with other cells including inflammatory cells.
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APPENDIX 1 - Buffers and solutions.
Bouin's fixative
425ml methanol
25ml glacial acetic acid
50 ml 40% formalin
Cytoplasmic extraction buffer
50mM sodium fluoride





20mM disodium hydrogen phosphate
20mM monosodium dihydrogen phosphate
Protease inhibitor (1 cocktail tablet per 10ml) Boehringer Mannheim
Nuclear extraction buffer
50mM sodium fluoride





20mM disodium hydrogen phosphate
20mM monosodium dihydrogen phosphate
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300mM sodium chloride
Protease inhibitor (1 cocktail tablet per 10ml) Boehringer Mannheim
PBS
9g NaCl
0.262g monobasic sodium phosphate monohydrate (RMM 138)
1.15g dibasic sodium phosphate (RMM 142)
made up to 1 litre with ddH20, pH7.4, autoclaved
Tween PBS




made up to 1 litres with ddH20, pH 7.6 with HC1
TBST
TBS with 0.1% Tween-20
Towbin transfer buffer (pH 8.2-8.4)
25mM Tris (30.3 g, RMM 121.1)
192mM glycine (144. lg, RMM 75.07)
lOg SDS
make up to 8 litres with ddH20 add 2 litres of methanol
Do not add acid or base to adjust pH
Hydrogen peroxide blocking solution




made up fresh prior to use.
use 4.8ml ofDAB buffer.




pH adjusted to pH 7.6
use 100(11 DAB substrate
lOOpl frozen aliquots at 25mg/ml (50x stock)
add 100/al of 1% hydrogen peroxide:
10(Ltl hydrogen peroxide (30% w/w stock, Sigma) in 290|ul ddFFO
Schiffs reagent
Make up in fume hood
2.5g Feulgen grade Fuchsine in 500ml boiled water
cool to 50°C and add 5g potassium metabisulphate
cool to room temp and add 10% HC1 mix, 2g activated charcoal and leave
overnight in dark
filter through Whatman filter paper and store at 4°C.
TAE 50x
242gTris base
57.1 ml glacial acetic acid
100 ml, EDTA (0.5M, pH 8.0)






made up to 1 litre with ddH20
6 x sample treatment buffer (SDS-PAGE solution)




1.2 mg Bromophenol Blue
dissolve and aliquot into 1ml and stored at -70
+Ca/Mg solution
500ml 0.9% sodium chloride
10ml 0.11M calcium chloride
20ml 0.15M potassium chloride
5ml 0.15M magnesium sulphate
15ml 0.1M phosphate buffer pH 7.4
30ml 0.2M HEPES
0.63g glucose
adjust pH to 7.4 and filter sterilize
-Ca/Mg solution
500ml 0.9% sodium chloride
20ml 0.15M potassium chloride
15ml 0.1M phosphate buffer pH 7.4
30ml 0.2M HEPES
0.63g glucose



















50 mM Tris-HCl, pH 7.5
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Summary
Lung epithelial cell differentiation pathways remain unclear. This is due in part to the plasticity of these cells and the lack
of markers which accurately reflect their differentiation status. The aim of this study was to determine if lectin binding
properties are useful determinants of functional differentiation status in vitro. Mouse Clara cells were cultured for 5 days.
During this time, no alteration in differentiation was evident by electron microscopy. No significant alteration in binding
reactivity of Bauhinia purpurea (BPA), Maclura pomifera (MPA), Concanavalin A, Wheat germ or Helix pomatia lectins
occurred in cultures compared with Clara cells in mouse lung tissue. In contrast, nitrotetrazolium blue reductase activity and
CC10 expression declined in culture. Rat type II cells were cultured for 8 days. Between days 0 and 4, the number of type II
cells identified by electron microscopy was constant at 70-80%, decreasing to 8% by day 6. In contrast, by day 4, only 42%
cells retained alkaline phosphatase activity. BPA and MPA reactivity was altered at day 0 and day 4 respectively, compared
with cells in situ. Therefore, the reactivity of lectins analysed here does not reflect functional differentiation status of cultured
mouse Clara cells. However, BPA and MPA reactivity may be a sensitive indicator of alterations in rat type II cell differentiation
in vitro.
Introduction
The bronchiolar and alveolar regions of the lung are lined
by a single layer of epithelial cells. At least 8 subpopula-
tions have been described within this epithelium, each with
important, and often overlapping roles in lung function. For
example, bronchiolar Clara cells and alveolar type II cells
store and secrete components of the protective mucous and
surfactant layers respectively. They contain high levels of
biotransforming enzymes involved in detoxification, but also
activation, of certain compounds (Myles et al. 1989, Kudo
1994, Quondamatteo et al. 1998). In addition, they both
serve as progenitor cells in their respective regions (Massaro
1989, Voelker & Mason 1989). Methods for isolating rel¬
atively pure populations of Clara and type II cells have
been described for several species, including human, pro¬
viding excellent opportunities to study specific cell functions
described above. However, the propensity of both of these
cell types for rapid differentiation and loss of characteristic
features once placed in culture has hindered full exploitation
of these model systems. In addition, the identities of the cell
types which subsequently arise in culture are, as yet. unclear.
A lack of cell specific markers along with the ability of certain
lung epithelial cell types apparently to differentiate, dediffer¬
entiate and redifferentiate under various conditions (Johnson
et al. 1990), has meant that cultures of such cells are poorly
defined. Consequently, studies have mainly focused on in vivo
animal experiments and more stable transformed cell lines.
Lectins have been used as tools to distinguish between
lung cell types on the basis of their binding to specific car¬
bohydrate groups, usually at the cell surface (Geleff et al.
1986, Tatrai et al. 1994). These lectin binding sites may
be involved in intracellular recognition (Sato & Muramatsu
1985) and binding of yeast, bacteria and other microorgan¬
isms to host cells (Mouricout 1997). For example, Maclura
pomifera agglutinin (MPA) binds to galactose (ce-D-Gal) or
^-acetylgalactosamine (a-D-GalNAc) residues while Con¬
canavalin A (ConA) binds to glucose (a-D-Glc) and mannose
(a-D-Man) residues. The specific nature of these interactions
means that lectins are potentially useful markers for early
epithelial changes in lung disease (Kasper et al. 1994) and
ontological studies (Joyce-Brady & Brody 1990) as well as
markers for in vitro differentiation investigations. However,
as yet, few such in vitro studies have been carried out. Fur¬
thermore, many of the reports of lectin binding to either lung
tissue or cultured cells published so far are contradictory.
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For example, Brandt (1982) reported that ConA bound to
type II cells in rat lung tissue while Dixon and Jersild (1983)
and Williams (1984) found little to no binding of ConA to
these cells. Similarly, Brandt (1982) found that Ricinus com¬
munis (RCA) bound to type I but not type II cells in rat lung
tissue while Taatjes et al. (1990) observed RCA binding to
both type I and type II cells in rat lung. In addition, in cultured
rat type II cells, Dobbs et al. (1985) reported that MPA was
bound progressively less and RCA bound more over time in
culture while Kovacikova et al. (1999) observed no change
in the levels of MPA or RCA binding to these cells in cul¬
ture. Interspecies variations are also apparent with Buahinia
purpurea agglutinin (BPA) reportedly binding to both type I
and type II cells in human lung (Sarker et al. 1994) but only
to type I cells in rat lung tissue (Kasper et al. 1994).
In an attempt to clarify this contentious area and to assess
the potential of lectins as markers in primary lung cell culture
studies, we have examined the binding of a panel of lectins to
rat lung tissue as well as cultured rat type II cells in conjunc¬
tion with measurements of alkaline phosphatase acitivity as
an indicator of cell function, and ultrastructural characterisa¬
tion by electron microscopy (EM). We have also carried out
the first in-depth study of lectin binding to cultured mouse
Clara cells, again in parallel with analyses of other Clara cell
biochemical markers and EM to further characterise the phe-
notypes of mouse Clara cells and their derivatives in culture.
Materials and methods
Animals
Mice used were C57/Black 6, bred in-house and weighed
on average 35 g. Male Sprague-Dawley rats (Charles River,
Hungary, Isaszeg) weighing 190-210 g were used after
1 week quarantine in our animal house (accredited according
to GLP). The animals were fed with the standard chow diet
from the same supplier.
Isolation and culture ofmouse Clara cells
Mice were sacrificed by intraperitoneal injection of pentabar-
bitone. Lungs were perfused with saline, digested with
trypsin and Clara cells were isolated as described previously
(Masek & Richards 1990). The procedure used here dif¬
fered from that of Masek and Richards (1990) as follows;
gentamycin and anti-PPLO were omitted from all solutions
and the medium used throughout the isolation and for cul¬
ture was a 1 : I mixture of Hams F12 (Gibco) and M-199
medium (Gibco) supplemented with 2mM L-glutamine,
lOpg/ml insulin, 5 pg/ml transferrin, lOOng/ml hydrocor¬
tisone, 10 ng/ml EGF, 0.1 ng/ml retinyl acetate and Pen/Strep
(Gibco, lOOU/ml penicillin. lOOpg/ml streptomycin). Once
isolated, cells were either cytospun onto glass slides (day
0) or plated onto 16-well glass chamber slides (Gibco) which
had been pre-coated with 50 (xg/ml fibronectin, and incubated
at 37 C, 5% C02. Cells were allowed to attach overnight
after which the medium was replaced to remove dead and
unattached cells. Medium was subsequently replaced every 2
days.
Isolation and culture of rat type II cells
Rats were deeply anaesthetised with 60mg/kg pentobarbi¬
tone (Nembutal, Sanofi, Paris, France) intraperitoneally, and
then killed by severing the abdominal aorta. Type II cells were
isolated according to methods described previously (Richards
et al. 1987, Hoet et al. 1994). Cells were cytospun onto
glass slides (day 0) or plated onto 24-well plates (Falcon)
and incubated at 37 C, 5% C02. Culture medium was
DMEM (Sigma) supplemented with 10% FCS (Gibco) and
Pen/Strep (Sigma; lOOU/ml penicillin, lOOpg/ml strepto¬
mycin). Medium was replaced every 2 days.
Lectin histochemistry
For lectin binding to cultured cells, cytospun cells and
plated cells were fixed at appropriate time points by incu¬
bating at room temperature in 4% buffered neutral for¬
malin (pH 7.4) for 10 s. The following biotinylated lectin
agglutinins (Sigma) were used: Bauhinia purpurea (BPA,
specificity: /l-Gal(l-^-3)GalNAc), Concanavalin A (ConA,
specificity: cr-D-Man, a-D-Glc), Helix pomatia (HPA, speci¬
ficity: a-D-GalNAc), Maclura pomifera (MPA, specificity:
a-D-Gal,a-D-GalNAc), Wheat germ (WGA, specificity: (D-
GlcNAc)2,NeuNAc). Lectins were diluted to a final concen¬
tration of 20 pg/ml in Tris-buffered saline (TBS), pH 7.4.
which contained 10 mM CaCl2, 0.2 mM MgCL and ImM
MnCl2. All incubations were carried out at room temper¬
ature. Cells were incubated with lectins for 20min, rinsed
with TBS and incubated for 30 min with either avidin-biotin-
alkaline phosphatase (AB-AP) or avidin-biotin-horseradish
peroxidase (AB-HRP) (Vector Laboratories). Binding was
visualised by staining for 10-15 min with Vector Red or 3,3'-
diaminobenzidine (DAB) which are substrates for AP and
HRP respectively. As controls for specificity, lectins were
pre-incubated overnight at 4 C with appropriate hapten sug¬
ars before incubation with cells (BPA: NAcGal; MPA: D-Gal;
HPA: NAcGal; WGA: NAcGlc; ConA: Man + Glc).
For lectin binding to tissue, lungs were fixed in 10%
buffered neutral formalin (pH 7.4) for 2 days before rou¬
tine processing and embedding in Paraplast (Sigma). Sections
were cut at 4-5 pm, dewaxed, rehydrated and lectin binding
was carried out and visualised as described above.
Immunocytochemistry
For CC10 and keratin immunocytochemistry, cells were fixed
respectively in formalin as above and in methanol for 7 min at
—20 C. Cells were incubated with primary antibody for 2 h.
rinsed with TBS-0.1 % Tween 20, incubated with biotinylated
secondary antibody for 30 min, rinsed and binding was visu¬
alised as above with AB-AP and Vector Red or Vector Blue
substrate. For CC10 binding to lung tissue, tissue sections
Lectin binding to cultured lung epithelial cells 35
were obtained as described above, dewaxed, rehydrated and
CC10 immunohistochemistry was carried out as described
above for cells. The CC10 antibody was a generous gift from
Dr. Gurmukh Singh, Deptartment of Veterans Affairs Medical
Center, Pittsburgh, Pennsylvania, USA. The keratin antibody
(clone MNF116), a pan-keratin antibody which recognised
keratins 5, 6, 8, 17 and 19, was bought from DAKO, UK.
Nitrotetrazolium blue assay
The nitrotetrazolium blue (NBT) solution consisted of 100 p.1
NBT stock solution (Boehringer Mannheim) in 10 ml 0.1 M
Tris pH 9.5,0.05 M MgCl,, 0.1 M NaCl, 0.1 % NADPH. Cells
were fixed in formalin as above and incubated with the NBT
solution for lOmin at 37 C. Positive cells stained strongly
purple.
Alkaline phosphatase
One tablet of Naphthol AS-TR phosphate (Sigma) was dis¬
solved in 10 ml deionised water and 3 tablets of Fast Red RC
(Sigma) were dissolved in 5 ml Tris-buffered saline (pH 8.4-
8.6). Cells were incubated in a mixture of 5 ml AS-TR and
5 ml Fast Red for 30 min at room temperature. Positive cells
were stained bright red. Red cells with 4 or more lamellar
bodies were considered to be type II cells.
Electron microscopy
Day 0 cells were pelleted by centrifugation and cultured
cells were harvested by trypsinisation and pelleted. Pellets
were fixed in 2% glutaraldehyde in 0.1 M sodium cacody-
late buffer (pH 7.2) overnight and post-fixed in buffered 1%
osmium tetroxide (0.1 M with respect to sodium cacodylate,
and 0.04 M with respect to potassium ferrocyanide) for 2 h.
After thorough washing in distilled water, the pellets were
stained en bloc in 5% aqueous uranyl acetate overnight at
4°C, followed by dehydration through an alcohol series,
and embedding followed by polymerisation in Araldite resin
(TAAB Laboratories Ltd., Aldermaston, UK). Ultrathin sec¬
tions of approximately 90 nm thickness were cut into 300-
mesh copper grids, and stained with lead citrate. The sections
were examined in a Jeol 100 CX-II transmission electron
microscope at an accelerating voltage of 80 kV.
Results
Mouse Clara cells
Lectin binding - lung tissue
BPA, MPA, ConA and WGA reacted strongly with the api¬
cal membranes of bronchiolar Clara cells in mouse lung tis¬
sue. HPA showed no reactivity. BPA and MPA reactivities
are illustrated in Figure 1A and D. Lectin binding was com¬
pletely blocked or significantly weakened by control hapten
treatment.
Lectin binding - cultured cells
The binding activities of the above lectins to mouse Clara
cells were examined over 5 days in culture (Table 1). By day
7, cultures had begun to visibly appear necrotic, therefore
day 5 was used as the final time point. ConA and WGA both
showed very strong binding activity to freshly isolated cells,
and all cells were stained. Staining remained strong at day 1
and day 5 in culture. BPA showed no reactivity with freshly
isolated cells (Figure IB) and only a few scattered positive
cells (less than 5%) were present at day 1. However, at day 5,
30-^-0% cells bound BPA (Figure 1C). MPA produced mod¬
erately positive staining in freshly isolated cells (Figure IE)
and cultured cells at day 1 and day 5 (Figure IF) were all
strongly positive. HPA showed no reactivity with isolated or
cultured cells at any stage.
Electron microscopy
When examined by EM, fresh isolates were found to consist
of approximately 78% Clara cells, indicating relatively high
levels of purity. The remainder were almost all ciliated cells.
Day 1 and day 5 cultures consisted of approximately 80% and
85% Clara cells respectively and again, the remaining cells
were almost exclusively ciliated cells. Clara cell viability was
high at each time point with less than 25% cells appearing
apoptotic or necrotic. However, at day 5, there appeared to be
a drop in the mitochondrial size and number per cell compared
to day 1.
CC10
CC10 is a protein primarily expressed by bronchiolar Clara
cells in rodents and humans (Singh & Katyal 1997). Its func¬
tion is unclear but it may play a role in regulation of inflamma¬
tion. CC10 immunoreactivity was demonstrated in the apical
membrane regions of bronchiolar cells in mouse lung tis¬
sue (Figure 1G). Freshly isolated cells were strongly posi¬
tive for CC10 immunoreactivity and remained so at day 1
(Figure 1H). Staining appeared stronger within clumps of
cells which had not spread fully compared with larger, flat¬
tened cells. However, this could be because the unspread cells
had a less visible volume than those that had spread, but had
an equivalent amount of stain. By day 5 in culture, CC10
immunoreactivity appeared slightly reduced (Figure II).
NBT assay
Functional Clara cells contain high levels of NADPH-
dependent reductase activity. This can be detected his-
tochemically using an NBT assay in which a colourless
NBT solution is converted to a purple formazan product by
NADPH-dependent reductase. Brief fixation with formalin
prior to staining eliminates the low levels of enzyme activity
in other cell types likely to be present. Following staining,
approximately 75% freshly isolated cells were dark purple in
colour, indicating that these were functional Clara cells (Fig¬
ure 1 J). Most positive cells were present within clumps. The
number of NBT- positive cells declined in culture. At day 1
and day 5 (Figure 1K), approximately 50% and 40% respec¬
tively stained dark purple. Again, most positive cells were
Figure 1. Characterisation of cultured mouse Clara cells. (A) BPA reacted with apical membranes of bronchiolar Clara cells in mouse lung tissue.
(B) No BPA reactivity was apparent in freshly isolated (day 0) cells but (C) reactivity was detectable again at day 5 in culture. (D) MPA also reacted
with apical membranes of bronchiolar Clara cells in mouse lung tissue. Reactivity was also evident in (E) freshly isolated (day 0) cells and (F) cultured
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Table 1. Lectin binding to mouse Clara cells in lung tissue and during culture.
BPA ConA HPA MPA WGA CC10 NBT Keratin EM
Lung tissue ++ ++++ 0 +++ +++ ++++ n.d. n.d. n.d.
Cells day 0 0 ++++ 0 ++ +++ +++ 75% 95% 78%
Cells day 1 + ++++ 0 +++ +++ +++ 50% 100% 80%
Cells day 5 ++ ++++ 0 +++ +++ ++ 40% 100% 85%
Note: ++++ = very strongly positive; +++ = strongly positive; ++ = moderately positive; + =
weak/occasional positive; 0 = no stain; NBT = nitrotetrazolium blue; EM = electron microscopy;
n.d. = not determined; n=3.
present within clumps of cells which had not spread fully,
rather than in the areas of flattened, spread cells.
Keratin immunocytochemistry
Approximately 95% freshly isolated cells contained keratin,
as detected immunocytochemical ly, indicating their epithelial
origin. At day 1 and day 5 (Figure 1L), all cells were keratin
positive suggesting that contaminating non-epithelial cells
such as macrophages or fibroblasts present in initial isolates
had either failed to attach or survive in culture.
Rat type II cells
Lectin binding - lung tissue
BPA reacted strongly with the surface membranes of type I
cells in rat alveolar tissue but there was no reaction in the
apical membranes of type II cells (Figure 2A). Very strong
reactivity was demonstrated with MPA in the membranes of
type II cells whereas type I cells did not show reactivity with
MPA (Figure 2C). Lectin binding was completely blocked or
significantly weakened by control hapten treatment.
Lectin binding - cultured cells
Lectin binding capacity was studied for 8 days and the results
are summarised in Table 2. BPA reacted with freshly isolated
type II cells and reactivity remained for the duration of the
cultivation. MPA reactivity on day 1 was identical with BPA
reactivity (Figure 2B and D). MPA membrane staining could
be detected on 90-95% of cells, however, intensity signifi¬
cantly declined by day 4. ConA. HPA and WGA bindings
varied during the culture period.
Electron microscopy
The purity of the type II cell cultures was similar to that of
the Clara cell cultures up to day 4, with over 70% of cells
identifiable by EM as type II, that is, containing at least 4
lamellar bodies. However, by day 6, a dramatic reduction in
the number of identifiable type II cells occurred, and by day 8,
no cells contained lamellar bodies.
Alkaline phosphatase
There was a progressive loss of alkaline phosphatase activity
during the culture period with no detectable activity remain¬
ing by day 8 (Table 2).
Discussion
Our understanding of the various differentiation pathways
operating in lung epithelium is limited. This is due in part
to the apparent ability of lung epithelial cells to differenti¬
ate along multiple pathways (Johnson et al. 1990) and also
the occurrence of various 'intermediate' phenotypes, both
in vivo and in vitro, which have features characteristic of
more than one cell type, hindering accurate identification
(Jeffery & Li 1997). Demonstration of cell surface glyco¬
proteins using lectin histochemistry has been proposed as a
possible method for identifying specific lung cells in vivo
and in vitro, and tracking subsequent routes of differentia¬
tion which occur, for example, during normal homeostasis,
following injury or during disease, or in culture. However,
many of the lectin histochemical studies reported in lung
epithelial cells to date are conflicting or have not included
alternative methods of cell identification for comparison with
lectin receptor expression. This makes interpretation ofobser¬
vations difficult. In this study we have attempted to clarify
the lectin binding properties of 2 subpopulations of cultured
lung cells and to evaluate the potential of lectins as mark¬
ers of differentiation in these cells. Mouse Clara cells and
rat type II cells were cultured for 5 and 8 days respectively.
During this time, their capacity to bind each of a panel of 5
lectins was determined and compared with binding to cor¬
responding cells in mouse and rat lung tissue in situ. In
addition, parallel biological and EM analyses were carried
out to provide a comprehensive evaluation of the relevance
of lectin receptor expression to cell differentiation in cul¬
ture.
At the ultrastuctural level, EM analysis indicated that the
mouse Clara cell cultures consisted of approximately 80%
Clara cells at each time point, as identified by the presence
of high numbers of mitochondria, secretory granules and
cells at day 5. CC10 immunoreactivity was present in bronchiolar Clara cells in (G) mouse lung tissue and (H) cultured cells at day 1. However, (I)
immunoreactivity had decreased by day 5 of culture. (J) Approximately 75% freshly isolated Clara cells were NBT positive but (K) positivity had
decreased by day 5. (L) All cells present in day 5 cultures were keratin positive. Magnification, A and D: x400; all others, x200.
38 S. McBride et al.
Figure 2. Characterisation of cultured rat type II cells. (A) BPA reacted strongly with apical membranes of alveolar type I cells (arrows) but not type II
cells (asterisks) in rat lung tissue. In contrast, (B) BPA reacted with the majority of cultured type II cells (arrows) at day 1. (C) MPA reacted strongly with
apical membranes of alveolar type II cells (arrows) in rat lung tissue and (D) reactivity remained at day 1 in culture (arrows). Magnification. A, B and
D: x650; C: x320.
abundant endoplasmic reticulum. Ciliated cells accounted for
almost all of the remaining 20% of cells at each time point.
Interestingly, in these EM studies, there was no evidence of
Clara cell differentiation over the time in culture. Keratin
immunohistochemistry confirmed the lack of contaminating
non-epithelial cells in the cultures. However, the decline of
NADPH-dependent reductase activity demonstrated by NBT
histochemistry and the reduction in CC10 immunoreactivity
suggested that the Clara cells were losing at least some of their
more specialised functions, a common occurrence in cultured
cells. The reactivity of 4 of the 5 lectins (ConA. MPA, WGA
all strongly reactive and HPA non- reactive) was identical
when examined in Clara cells in situ in mouse lung tissue
and in Clara cells cultured for 5 days. Only BPA showed
altered reactivity in vitro compared to in vivo. The loss of
BPA reactivity at day 0 and its reappearance at day 1 and
day 5 in cultured Clara cells suggests that the BPA-reactive
glycoprotein was altered or damaged during the isolation pro¬
cedure, possibly being cleaved during trypsinisation, but was
subsequently repaired or resynthesised in culture.
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Table 2. Lectin binding to rat type II cells in lung tissue and during culture.








++++ +++ n.d. n.d.
++++ + 85% 80%
++++ +++ 81% 85%
++++ ++ 50% 71%
++ ++ 42% 70%
++ + 5% 8%
++ +++ 0% 0%
Note: ++++ = very strongly positive; +++ = strongly positive; ++ =
moderately positive; + = weak/occasional positive; 0 = no stain; AP = alkaline
phosphatase activity; EM = electron microscopy; n.d. = not determined; n = 3.
These findings indicate that at the ultrastuctural and cell
surface glycoprotein levels, Clara cells cultured under the
conditions described here closely resemble Clara cells in vivo.
The repertoire of cell surface glycoproteins of cultured Clara
cells was very similar to that in vivo. Except for the temporary
alteration in BPA reactivity, the composition of the culture
medium or the culturing process itself appeared to have no
effect on the expression of the glycoproteins involved, or alter
their chemical composition to render them unrecognisable by
the lectins. Despite this, however, specialised functions such
as NADPH-dependent reductase activity and CC10 expres¬
sion declined in culture. While future optimisation of the cul¬
ture conditions may improve retention of such functions, it
appears that ultrastructural or lectin binding studies alone
do not provide an accurate reflection of Clara cell function
in vitro. Biochemical measurements such as NBT reductase
activity, CC 10 production and cytochrome p450 activity, for
example, should be carried out in parallel.
Cultured rat type II cells, in contrast to mouse Clara cells,
reacted with HPA although the reactivity was found to vary
during the time in culture. As is already known, ConA bind¬
ing was not specific to type II cells, but also bound to type
I cells. The cells showed variable reactivity with WGA also.
Cultured type II cells showed altered reactivity for MPA and
BPA compared with type II cells in vivo. BPA binding capac¬
ity, which we found to be characteristic of type I cells but
not type II cells in vivo, appeared during the type II cell isola¬
tion and its intensity did not change during the culture period.
The intensity of MPA binding in the cells decreased by day 4.
At the same time, alkaline phosphatase activity, a functional
parameter of type II cells, rapidly decreased (only 42% of
cells were AP positive at day 4), in contrast to EM analysis
which indicated that 70% of cells had the characteristic fea¬
tures of type II cells containing 4 or more lamellar bodies.
At day 6, EM findings were more consistent with AP activity
(5%) with only 8% of cells containing 4 or more lamellar
bodies. By day 8, AP activity had ceased and the cells did not
exhibit the characteristic ultrastructure of type II cells.
On the basis of the above results, the appearance of BPA
positivity appears to be an early sign of altered surface prop¬
erties. The decrease in AP activity and MPA reactivity are
similarly early and sensitive signs of morphological and
functional alterations in type II cells, although at this early
stage the cell ultrastructure still resembles type II cells. The
aetiology of changes in ConA, HPA and WGA bindings was
not dealt with in this study.
The stability of BPA binding and the decrease in MPA reac¬
tivity and AP activity suggest that in the course of cultivation,
intermediate type cells develop. These intermediate cells dif¬
fer from in vivo type II cells, showing some surface properties
(MPA positivity) but revealing also stable oligosaccharide
sequences characteristic of type I cells.
It is, therefore, proposed that lectin histochemistry com¬
bined with enzyme histochemistry may offer a very sensitive
and useful tool for monitoring type II cells in culture as well
as in vivo.
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